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ABSTRACT 
 
Bovine mastitis remains one of the costliest diseases affecting the dairy industry. 
Individual susceptibility to mastitis and severity of infection varies between animals and 
can only be partially explained by genetics. As such, understanding how genetic 
predisposition coordinately interacts with epigenetic modifications and environmental 
exposures is necessary to bridge the gap in missing heritability. The role of DNA 
methylation in regulating the response to bacterial lipopolysaccharide (LPS) was first 
determined by performing reduced representation bisulfite sequencing on fibroblasts 
isolated from heifers at 5- and 16-months of age that exhibit an age-dependent up-
regulation in LPS-responsiveness. More than 14,000 differentially methylated sites were 
identified between the two sets of cultures with a trend towards decreased methylation with 
age. Young cultures were also hyper-methylated in gene promoters regulated by NF-κB 
and exhibited lower expression in genes that regulate the innate immune response, 
suggesting that methylation contributes to gene regulation in fibroblast innate response.  
 
Previously, TLR4 expression was shown to differ in the age-dependent fibroblast 
model, however, it was not known if variation in TLR4 expression would affect mastitis 
severity. Therefore, fibroblasts were isolated from sixty lactating, adult Holstein cows and 
their expression of TLR4, along with LPS-induced production of IL-8 and IL-6, was used 
to rank the animals from high to low. Six high responders and six low responders were 
then experimentally infected in one mammary gland with E. coli. Overall, severity of 
mastitis was quite variable, with a few notable differences between high and low 
responders. High responding animals had an earlier increase in somatic cell count and 
febrile response that coincided with more efficient bacterial clearance. However, tissue 
damage and milk production did not differ between the two groups, indicating that while 
rapid up-regulation of the innate response addresses bacterial clearance, subsequent down-
regulation is required to alleviate damage within the mammary gland.  
 
Finally, one-week old bull calves were subjected to treatment with either saline or 
LPS to determine if neonatal exposure to endotoxin would make calves less responsive to 
a second LPS challenge at 32-days of age. The initial treatment showed a large effect of 
LPS as measured by higher plasma IL-6 and TNF-α concentrations in calves treated with 
LPS over saline. Subsequent treatment of all 10 calves with LPS showed a very similar 
response between the two treatment groups and significant inter-animal variability in 
clinical response. Fibroblasts and monocyte-derived-macrophages (MDMs) were also 
isolated following initial treatment to determine if any changes occurred at the cellular 
level as a result of LPS exposure. Fibroblasts isolated from calves at 20-days of age had a 
very low response to LPS that did not differ between the early life treatments. MDMs 
isolated from calves at 28-days of age were more responsive to LPS, but again no 
differences were detected between the early life treatments. In summary, our results 
suggest that DNA methylation likely plays a role in the cellular response to LPS and may 
partially contribute to differences between animals in severity of E. coli mastitis, however, 
the appropriate in vitro phenotype to detect susceptible animals still needs to be 
characterized before epigenetic biomarkers can be identified, and perhaps modified by 
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 CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW 
 
1.1 Bovine Mastitis: Prevalence and Economic Impacts 
Mastitis, simply defined as inflammation of the mammary gland, is a significant 
source of economic losses in the dairy industry. It is a disease that shows worldwide 
prevalence as evidenced by numerous reports detailing the impacts of mastitis in every 
inhabitable continent (Verbeke et al., 2014, Boujenane et al., 2015, Oliveira et al., 2015, 
Yang et al., 2015). According to the 2014 USDA NAHMS Dairy Report, nearly a quarter 
of all cows (24.8%) experienced a clinical case of mastitis in the United States in 2013, 
ranging from 25.6%, 16.4% and 26.9% in small, medium and large operations, respectively 
(USDA, 2014). In terms of economic effects, a single case of clinical mastitis that occurs 
within the first 30 days of lactation costs the producer $444 (Rollin et al., 2015). In addition, 
throughout the entire 305-day lactation period, primiparous cows cost $325 per case of 
mastitis and multiparous cows cost $426 (Liang et al., 2017). The main source of economic 
losses is due to lowered milk quantity and non-saleable milk, but also include direct costs 
such as veterinary care, treatment, additional labor and early culling of high-producing 
animals (Liang et al., 2017). Furthermore, clinical mastitis has a deleterious effect on cow 
fertility, which reduces farm productivity and profitability, and it has been shown that the 
negative economic impacts of lowered fertility are especially high among cows infected 
with Gram-negative pathogens, Escherichia coli (E. coli) and Klebsiella spp. (Hertl et al., 
2014, Fuenzalida et al., 2015).  
 2
1.2 Causative Agents of Mastitis  
Mastitis is caused by a large variety of etiologic agents that are mainly bacterial 
in origin. To highlight the diversity of microorganisms that can cause mastitis, 
researchers in the United Kingdom analyzed the causative agent in 6,005 milk samples 
from clinical (43.8%) and subclinical (56.2%) mastitis cases and reported over 100 
different organisms, with E. coli, Streptococcus uberis (S. uberis) and Staphylococcus 
aureus (S. aureus) being the three most common bacteria isolated (Payne, 2013). While 
E. coli and S. aureus are widely regarded as the two most common-mastitis causing 
pathogens, pathogen prevalence is also dependent on geographic location, management 
practices and identification method. A recent Finnish study based on PCR identification 
rather than culture-based methods revealed coagulase-negative Staphylococci (CNS) as 
the most prevalent pathogen among 93,529 cows with clinical or subclinical mastitis 
(Vakkamaki et al., 2017), while in the United States non-traditional laboratory culture 
showed greater prevalence of Streptococcus spp. and E. coli (Ganda et al., 2016). 
However, the latter study contradicts earlier data generated from >100,000 milk samples 
submitted to the Wisconsin Veterinary Diagnostic Laboratory, whereby CNS represented 
the largest proportion (13.22%) of mastitis-causing pathogens by standard culture-based 
methods (Makovec and Ruegg, 2003), a result that is more consistent with the known 
prevalence of CNS (Vanderhaeghen et al., 2014).  
Mastitis-causing pathogens are also sub-divided into contagious and 
environmental pathogens. Contagious pathogens, such as S. aureus, are transmitted 
between cows, while environmental pathogens, such as E. coli, are acquired from the 
environment. Improvement of management practices in regards to herd hygiene through 
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mastitis control plans, such as the Five Point Plan developed in the 1960s, has alleviated 
much of the effect of contagious pathogens. However, opportunistic, environmental 
pathogens remain a significant and increasing concern for the dairy industry. Data from 
741 clinical mastitis cases across 50 Wisconsin dairy farms showed that environmental 
species of bacteria (E. coli, Klebsiella, and environmental streptococci) represented 
42.2% of all mastitis cases, with very few being caused by the contagious pathogen S. 
aureus (2.8%) (Oliveira et al., 2013). This data is representative of most large, modern 
dairy farms in that management practices have reduced cow-to-cow transmission of 
mastitis causing pathogens, however, the ability to deal with environmental pathogens 
remains a significant challenge. 
 
1.3 Between-Animal Variation in Mastitis Severity 
 
Mastitis severity is highly variable, and among one of the first observations 
describing the range in severity of mastitis was in the 1950s, when J.M Murphy (1956) 
noted that clinical stages of mastitis ranged from non-clinical to mild to severe. He also 
mentioned that while there were four major causative agents of mastitis, the severity of 
mastitis within the different organisms did not occur at the same frequency, whereby 
some organisms typically caused mild infection while others caused more severe 
infection. His observations remain mostly true today in that clinical mastitis can be mild, 
with only a few milk abnormalities, moderate, with changes in milk and local udder 
swelling, or severe, which occurs with systemic signs of disease. Infections can also be 
subclinical, resulting in no obvious signs of infection. As Murphy alluded to, severity of 
mastitis does not occur equally among causal organism. Subclinical infections are 
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typically caused by Gram-positive pathogens, such as coagulase-negative Staphylococci 
and S. aureus (Oliver et al., 2004, Thorberg et al., 2009). Conversely, environmental 
pathogens, such as E. coli, rarely persist and more frequently result in severe infection 
(Oliveira et al., 2013). However, even among bacterial pathogens that typically cause 
clinical signs, the severity of infection differs between animals and is shown to be heavily 
reliant on host variables, such as age, stage of lactation, and parity of the animal (Shuster 
et al., 1996, Burvenich et al., 2003, Burvenich et al., 2007). Additionally, there is 
evidence of a dose-dependency in the probability of infection, whereby different doses of 
bacteria cause variable rates of infection in experimental challenges (Bramley, 1976), 
indicating that a threshold of bacteria must be reached that supersedes innate mammary 
defenses to cause infection.  
Bacterial strain type is another factor that has the potential to determine the 
severity of infection, however, reports showing whether this occurs in mastitis caused by 
E. coli have been equivocal. Recently, it has been suggested that experimental bovine and 
murine mastitis caused by environmental versus mammary pathogenic strains of E. coli 
results in mastitis that differs in severity as evidenced by elevated milk cytokine levels 
and somatic cell count in animals infected with pathogenic strains versus a commensal 
strain (Blum et al., 2017, Roussel et al., 2017). However, an assessment of 25 E. coli 
genomes, including 16 mammary associated strains, 8 fecal commensal strains and one 
milk commensal strain, showed well-known E. coli virulence factors were present in both 
mastitis-causing and fecal commensal strains. Furthermore, it was shown that genome 
content is significantly associated with the likelihood of virulence or fitness factors 
regardless of pathotype and that pathotypes are dispersed across phylogenetic groups. 
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The lack of an association between mammary associated strains and well-known 
virulence factors suggests that commensal and mastitis associated strains may be equally 
able to cause infection and likely cause infection through a variety of mechanisms, 
however, this hypothesis should be confirmed experimentally (Leimbach et al., 2017). In 
addition, even under experimental conditions, where cattle from different breeds were 
challenged with the same E. coli strain, severity of infection varied within and between 
breeds, indicating that the host response has a substantial role in infection outcome 
(Bannerman et al., 2008).  
 
1.4 Immune Response to Mastitis  
Knowledge of how the immune system responds to mammary gland infection is 
critical to understanding how between-animal variation in severity of mastitis is 
regulated. As previously mentioned, the magnitude of the immune response and the 
mediators that are activated are highly pathogen dependent. Transcriptional analysis 
comparing the very early innate response events that occur within the udder post 
infection with E. coli and S. aureus, the two-major mastitis-causing pathogens, has shown 
a clear difference in their magnitude of response. Just one hour after experimental 
infection, E. coli induces a response that is greater than 25 times stronger than S. aureus 
and also enhances expression of several immune response genes that are not activated by 
S. aureus (Petzl et al., 2016). This difference in early innate response is indicative of the 
progression of infection mediated by the two pathogens, whereby E. coli induces a rapid, 
acute, highly inflammatory response and S. aureus tends to elicit a more subdued 
response that can lead to chronic infection. 
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In a second, similar study, whole transcriptome analysis of E. coli and S. aureus 
infection (1-3 hrs. post-infection) showed the rapid induction of pro-inflammatory genes 
by E. coli that are regulated by LPS, TNF-α and IL-1ß signaling pathways (Gunther et al., 
2017a). Again, this response is consistent with many reports that indicate E. coli induces 
the rapid activation of Toll-like receptors (TLRs) and other pattern recognition receptors 
(PRRs) to activate pro-inflammatory gene transcription resulting in acute mastitis (Petzl 
et al., 2008, Schukken et al., 2011). Conversely, S. aureus failed to activate the majority 
of pro-inflammatory signaling pathways and instead the response was found to be 
regulated by immune-dampening transcription factors, TGFB1, ESR1 and SFR. Bacterial 
invasion and cytoskeletal rearrangements were also detected in S. aureus infected cell 
cultures, a result that was not seen in similar E. coli treated cultures (Gunther et al., 
2017a). The ability for S. aureus to invade epithelial cells is likely dependent on its 
activation of immune-dampening mechanisms within the udder. Interestingly, E. coli 
gains the ability to invade epithelial cells in mice deficient in TLR4/LPS signaling 
(Elazar et al., 2010). This key difference in inflammatory response versus immune-
dampening mechanisms explains the much higher prevalence of chronic S. aureus 
infections and acute E. coli infections. 
Pathogen dependent differences aside, the early cellular responses to mastitis-
causing pathogens are largely activated by sentinel cells that reside within the mammary 
gland, the majority of which are mammary epithelial cells and some resident leukocytes 
and lymphocytes. Epithelial cells are known to rapidly respond to infection by increasing 
expression of pro-inflammatory cytokines, cathelicidins, and acute phase proteins prior to 
leukocyte infiltration (Brenaut et al., 2014, Cubeddu et al., 2017). In addition, stromal 
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fibroblasts have recently been shown to be activated during mastitis infection and exhibit 
cross-talk with mammary epithelial cells (Chen et al., 2016, Zhang et al., 2016).  
Following activation of sentinel cells within the mammary gland, the main cellular 
responders are neutrophils, followed by monocyte-derived-macrophages and natural 
killer cells (Sipka et al., 2016). The infiltrating leukocytes are responsible for the increase 
in somatic cell count (SCC) that is quickly seen following a mastitis infection. Moreover, 
neutrophils are the primary leukocyte that are responsible for bacterial killing through the 
release of a large arsenal of antimicrobial proteases, peptides, reactive oxygen species, 
and neutrophil extracellular traps (Pechous, 2017). Ideally, bacterial killing by 
neutrophils will be short-lived and effective to clear bacteria but with their effects limited 
appropriately to reduce the cytotoxic effects of the neutrophil-derived molecules. 
The adaptive immune response has been relatively understudied in comparison 
to the innate response in bovine mastitis. However, the production of the IL-17 family of 
cytokines (IL-17A, IL-17F and IL-22), typically produced in abundance by CD4 T helper 
cells of the Th17 lineage, although also produced by innate lymphoid cells called ILC3s, 
are up-regulated following intra-mammary challenge with E. coli and S. aureus, a finding 
that is in line with a predominantly neutrophilic response. In addition, it has been shown 
that IL-17 has synergistic effect on the production of a number of pro-inflammatory and 
chemotactic proteins in cellular and in vivo mastitis models (Roussel et al., 2015, Rainard 
et al., 2016) and aids in neutrophil-dependent bacterial clearance (Porcherie et al., 2016). 
Therefore, Th-17 cells are likely to contribute to the mammary gland response to mastitis. 
Knowledge of how other CD4+ and CD8+ T-cell subtypes respond are limited; however, 
it is known that CD8+ cells proliferate and increase in their proportion in mammary 
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glands infected with E. coli (Mehrzad et al., 2008). Interestingly, in a recent study it was 
shown that antibodies seem to be somewhat inessential to mammary gland response to E. 
coli mastitis (Herry et al., 2017), a finding that is line with previous work where large 
differences in milk IgG response were measured in response to experimental S. aureus 
mastitis, with no difference in bacterial clearance (Benjamin et al., 2015b).  
 
1.5 Inflammatory Response Regulation: What is the Appropriate Response? 
The cellular and non-cellular components of immunity that define the 
appropriate response depend on the type of infecting organism (e.g. bacterial, viral or 
eukaryotic) and the location of intrusion. Response to infection is regulated at the level of 
gene transcription, mRNA stabilization and processing, protein translation, and through 
post-translational modifications, such as protein phosphorylation. Dysregulation of any of 
these steps may influence the effective response to infection, potentially resulting in more 
severe pathology or lowered ability to control infection. Under normal circumstances, 
bacteria are prevented from entering the mammary gland through physical barriers 
provided by the teat canal, including a keratin plug that seals off the mammary gland 
from the outside environment during the dry period and between milkings. Variation in 
cow and environmental factors appears to influence the probability that pathogens breach 
these physical barriers. For example, cow teat shape and teat sphincter length and patency 
are associated with pathogen specific susceptibility to infection, and reducing teat end 
bacterial contamination through environmental and udder hygiene practices reduces 
infection risk. If bacteria breach the physical barriers and escape killing by humoral milk 
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components, a prompt leukocyte response is required to neutralize bacteria before 
uncontrolled growth can occur (Rainard and Riollet, 2006).  
The adequate response by the neutrophil has been the subject of years of 
discussion. In numerous reports it has been suggested that a rapid neutrophil response is 
essential to limiting severity of infection (Burvenich et al., 2003) and that during 
parturition, when an animal is very susceptible to severe mastitis, host neutrophil 
response is either suppressed or insufficient resulting in unnecessary damage to the 
mammary gland (Vangroenweghe et al., 2005b). Differences in the kinetics of neutrophil 
influx could be regulated at the level of extravasation. Successful neutrophil diapedesis 
depends on the interaction of L-selectin with selectin molecules on endothelial cells and 
by subsequent up-regulation and binding of ß2-integrins (CD11a, b, c & CD18) with 
ICAM molecules on endothelial cells. An earlier report assessing the role of neutrophil 
CD11a and CD11b expression in cows that experience severe versus moderate responses 
to mastitis did not find a significant difference in receptor expression, however, they 
noted a negative correlation between the severity of mastitis and total circulating pre-
infection neutrophil numbers and percent of both mature and phagocytic neutrophils in 
blood (Dosogne et al., 1997). A number of other studies have researched the role of ß2-
integrins and L-selectin molecules on neutrophil function during parturition or in 
response to E. coli or LPS-induced mastitis, with inconclusive results (Diez-Fraile et al., 
2002). Neutrophil properties, such as pre-infection neutrophil viability (Mehrzad et al., 
2004), elevated production of reactive oxygen species (Mehrzad et al., 2002) and 
increased expression of genes downstream of the TLR4 signaling (Stevens et al., 2011) 
have all been implicated in reducing severity of mastitis. In addition, both a causal and 
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protective role have been hypothesized for complement protein and neutrophil 
chemoattractant C5a. Expression of the C5a receptor (C5aR) is reduced in neutrophils 
from early lactation cows, however, high concentrations of C5a contribute to excessive 
cytokine production that is ultimately detrimental to the host and can result in sepsis-
related complications typical of very severe mastitis (Stevens et al., 2012).  
In contrast to previous reports of immune-suppression during the transition 
period, an overzealous innate immune response has also been associated with an increase 
in mastitis severity during parturition. Mononuclear cells isolated from early lactation 
cows produce significantly more TNF-α in response to LPS in comparison to mid-
lactation cows (Sordillo et al., 1995).  Induction of endotoxin tolerance within the 
mammary gland has been shown reduce the severity of experimental mastitis for at least 
72 hours post LPS pre-treatment, reducing SCC influx and febrile response and 
increasing bacterial clearance. The protective effect of tolerance was shown to occur with 
the concurrent down-regulation of CXCL8, SAA3 and IL-6 (Petzl et al., 2012). Similarly, 
treatment with a steroidal anti-inflammatory together with antibiotic treatment reduces 
the extent of mastitis severity in comparison to no treatment and to antibiotic treatment 
alone (Sipka et al., 2013). Finally, animals ranked as high responders based on their 
fibroblast production of IL-8 exhibit a prolonged neutrophil response to experimental E. 
coli mastitis that delays their recovery to pre-infection milk production levels and 
increases tissue damage within the mammary gland (Kandasamy et al., 2011) 
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1.6 Cellular Models for in vivo Response 
Due to the inherent variability of outbred species, such as dairy cattle, it may be 
necessary to study a large number of animals to glean biologically relevant and 
significant data. However, it is also often not feasible at the financial or ethical level to 
experimentally infect a large number of cows. To address these issues, cellular models 
have been developed to study how an animal might respond in vivo through in vitro 
characterization of their cells. Numerous cellular models have been developed to study 
mastitis and other infectious diseases, however, each has their inherent limitations and 
applicability. Monocyte-derived-macrophages have been successfully used to model 
response to bovine tuberculosis, whereby virulent strains of Mycobacterium bovis induce 
expression of numerous pro-inflammatory genes to a greater extent in macrophages 
isolated from resistant versus susceptible cattle (Alfonseca-Silva et al., 2016). This result 
makes sense for M. bovis infection because the bacteria primarily infect macrophages and 
often escape killing through immune-dampening mechanisms. On the other hand, using 
macrophages to model mastitis infection does not seem to accurately portray disease 
progression. Bovine-derived macrophages, which may be useful to measure broad non-
specific responses, have been shown to lack the ability to distinguish between the 
pathogen-specific immune responses elicited by E. coli versus S. aureus (Gunther et al., 
2016b) and therefore, may not be a sensitive enough model to measure the variable 
responses that occurs between-animals to the same pathogen.  
The mammary epithelial cell is another potential cell model that has been used 
extensively to study the pathogenicity of mastitis-causing organisms (Pang et al., 2017), 
along with the differential host innate immune response to various pathogens and sub-
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strains of the same pathogen (Gunther et al., 2016a, Gunther et al., 2016b).  Interestingly, 
a novel use for the primary bovine mammary epithelial cell has very recently been 
developed to identify new expression biomarkers from cows that were described as high 
or low responders based on antibody production in response to Clostridium difficile 
immunization, in an effort to produce milk with high levels of anti-C. difficile IgA 
(Hillreiner et al., 2017). Epithelial cells isolated from high responders, in agreement with 
antibody production in vivo, expressed higher levels of numerous innate response genes, 
including CXCL8, CXCL5, C3 and SAA3. 
To avoid primary sampling of mammary epithelial cells, bovine mammary 
epithelial cell lines have also been used to study the immune response to mastitis causing 
pathogens (Roussel et al., 2015) and to study the effects of haplotypes in response to the 
same pathogen (Meade et al., 2012). However, mammary epithelial cell line response to 
different strains of E. coli did not accurately reflect the murine response to the identical 
pathogens, whereby the P4 strain of E. coli caused the most severe infection, with high 
levels of milk cytokines, but elicited a much more subdued cellular cytokine response in 
comparison to other strains (Roussel et al., 2017). Epithelial cell lines may be useful for 
studying the overall biological response to pathogens as they are less variable than 
primary cells, but for the same reason may not be a good tool for understanding between-
animal or between-pathogen responses. 
The primary fibroblast is another, more easily accessible, cell type that responds 
to TLR agonists and bacteria and are reflective of host response to infection (Gunther et 
al., 2016b). Primary fibroblasts have been used to study the immunological mechanisms 
that constitute response to infection in a number of host species, including human 
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response to Chikungunya virus (Selvamani et al., 2014), non-natural host response to 
herpes subtypes with varying degrees of virulence (Rogers et al., 2007) and in bovine 
response to LPS in relation to mastitis (Kandasamy et al., 2011) and systemic LPS 
response (Green et al., 2011a). Furthermore, primary dermal fibroblasts have been 
utilized to discern animal-to-animal variation in mastitis severity. Production of IL-8 
following fibroblast stimulation with synthetic TLR agonists (LPS and PAM2CSK4) has 
been used as a marker to categorize animals as high or low responders and subsequent 
experimental mastitis has shown that high responders respond more severely to E. coli or 
S. aureus infection, respectively (Kandasamy et al., 2011, Benjamin et al., 2015b). Given 
this, the primary dermal fibroblast is suggested to be the preferable cell model for their 
ease of isolation, amenability to cryopreservation, responsiveness, and repeatability. 
Furthermore, it has been shown that mammary stromal fibroblasts are an active cell in 
response to mastitis, in that fibroblasts isolated from glands infected with mastitis versus 
healthy glands exhibit a number of inflammation related changes and have the capacity to 
decrease ß-casein secretion and up-regulate expression of TNF-α and IL-8 in 
unstimulated epithelial cells (Chen et al., 2016). Alternatively, activated epithelial cells 
can induce an inflammatory response in fibroblasts isolated from healthy cattle (Zhang et 
al., 2016).  
 1.7 Genetics of the Immune Response to Mastitis  
Ideally, the producer would like to be able to select animals that are inherently 
less susceptible to mastitis, as has been done for milk production traits. Doing so would 
reduce the costs associated with mastitis treatment and lowered milk production, and 
decrease the use of antibiotics in food-producing animals. However, this is not a simple 
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task. Resistance to mastitis is undoubtedly highly polygenic, and traits associated with 
lower risk for one pathogen may increase the risk for other pathogens or even other 
infectious diseases. The correct phenotype for mastitis resistance is also difficult to 
elucidate in that mastitis is caused by such a varied group of microorganisms.  
Unfortunately, unlike milk yield, genetic heritability of clinical mastitis has been 
measured to be quite low.  Heritability estimates have been reported anywhere from 0.02 
to 0.10 depending on the model used (Lund et al., 1999, Rehbein et al., 2013, Govignon-
Gion et al., 2016). Heritability based on characteristics that are correlated with mastitis, 
such as somatic cell count or somatic cell score (SCS), has shown improved estimates for 
heritability. Using a recursive model, based on the closest test-day before and the closest 
test-day after clinical mastitis, one study showed that SCS has heritability of 0.12 and 
0.16, respectively, between test day one and test day two (Rehbein et al., 2013). Splitting 
test measurements among different stages of lactation improves heritability, albeit 
slightly, to 0.17 (Jamrozik and Schaeffer, 2012). However, although correlation between 
mastitis and SCS is high, in practice this may only work for chronic or subclinical 
infections. Somatic cell measurements are typically only taken on a monthly basis and 
would likely miss many short-lived, acute infections, such as those caused by E. coli. 
Genetic differences in immune response genes, resulting in differential mastitis severity, 
is another potential method for genetic selection. Genome-wide association studies 
(GWAS) have been performed to try to identify specific gene regions that are associated 
with risk of clinical mastitis. One GWAS found a number of QTLs with immune-relevant 
genes across nine chromosomes, confirming the polygenic nature of mastitis resistance 
(Tiezzi et al., 2015). Again, since the authors did not distinguish between pathogen type, 
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this may also reflect that the importance of genes is variable in response to different 
organisms. Other GWAS have tried to identify SNPs that are associated with increases in 
SCS and clinical mastitis, and found QTLs on chromosomes 14 (Wang et al., 2015), 18 
(Brand et al., 2011) and 20 (Kadri et al., 2015), associated with genes such as LIFR and 
CARD6. Unfortunately, the functional consequences of genetic variation have not been 
reported for most SNPs and QTLs.  
Interestingly, one study that identified different haplotypes based on five SNPs 
in the CXCR1 gene challenged three different haplotype combinations with Streptococcus 
uberis to determine the effect of haplotype on severity of mastitis. Severity based on 
SCC, bacterial counts, mammary and milk scores was significantly higher in one 
homozygous haplotype and significantly lower in one heterozygous haplotype (Siebert et 
al., 2017). Notably, CXCR1 is the receptor for IL-8, and genetic differences in the IL8 
gene have also been found whereby two distinct haplotypes have been identified, one of 
which is more responsive to LPS in vitro (Meade et al., 2012) and to intravenous LPS 
treatment (Stojkovic et al., 2016). Furthermore, in response to in vitro stimulation with a 
viral agonist, the opposite haplotype has the higher phenotype, suggesting that the two 
haplotypes may have evolved based on exposure to bacterial or viral antigens (Stojkovic 
et al., 2017).  
1.8 Regulation of Immunity by Non-Genetic Mechanisms 
There is substantial evidence that regulation of gene expression also occurs 
through heritable non-genetic, or epigenetic, mechanisms. Epigenetic regulation has been 
shown to occur through modification of histone proteins, regulation by miRNAs, and 
through DNA modifications, such as CpG methylation and hydroxy-methylation. There 
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are also varying degrees on what is known about how each of these modifications 
functions in generating changes in immunity. For instance, very few studies have 
identified a role for 5-hydroxymethylcytosine (5-hmC) in the regulation of the immune 
response. However, relatively recent reports have shown that 5-hmC may contribute to 
the regulation of T-cell development and activity (Ichiyama et al., 2015), along with 
increased risk of systemic lupus erythematosus (Zhao et al., 2016). There are elevated 
levels of 5-hmC in isolated CD4+ T-cells from patients with systemic lupus 
erythematosus that results in a concurrent increase in gene expression of 131 genes, a 
result that is in agreement with previous findings that 5-hmC up-regulates the expression 
of genes through DNA de-methylation. In addition, 5-hmC was shown to contribute to T-
cell differentiation (specifically Th1 and Th17 cells) through the up-regulation of lineage 
specific transcription factors and cytokines, mediated by the Tet2 de-methylating enzyme 
(Ichiyama et al., 2015).  
Micro-RNAs (miRNAs or miRs) regulate the expression of genes post-
transcriptionally through binding and de-stabilization of mRNA. There is substantially 
more data to support the role of micro-RNAs in the immune response and in particular, 
the regulation of TLR signaling in response to immune stimulus or infection (Drury et al., 
2017). Activation of TLR4 signaling in primary human monocytes increases the 
expression of miR-187, which subsequently down-regulates pro-inflammatory cytokine 
production in an IL-10 dependent manner. It was shown that miR-187 specifically targets 
TNF-α and IκBζ mRNA, resulting in reduced expression of TNF-α, IL-6 and IL12-p40 
(Rossato et al., 2012). Similarly, miR-146a inhibits TLR4 signaling through its 
interactions with TRAF6 and IRAK1, and miR-146a is temporally regulated with miR-
 17
155, another miRNA that enhances TLR4 signaling through its interactions with 
transcripts of inhibitory proteins SHIP1 and SOCS1 (Mann et al., 2017). Interestingly, 
expression of miR-146a is sufficient to induce endotoxin tolerance in the monocyte cell 
line THP-1 and it can elicit its effects in both the presence and absence of LPS (Nahid et 
al., 2009).  
Numerous histone modifications have been identified that also contribute to the 
regulation of the innate and adaptive immune response. Histone acetylation, typically 
associated with transcriptional activation, contributes to cellular response to TLR3 
ligands. Specifically, H3K9 and H4K8 acetylation is increased in cells following 
treatment with a TLR3 agonist poly (I:C) and is hypothesized to contribute to early HIV-
1 trans-activation that occurs to a higher degree with TLR3 stimulation (Bhargavan et al., 
2016). In addition, bronchial epithelial cells that are primed with IFN-γ exhibit increased 
expression of the antiviral protein RIG-I through the reduction of H3K9 tri-methylation 
(H3K9me3), a histone modification that represses gene expression. This epigenetic effect 
of IFN- γ on bronchial epithelial cells may partially protect against early-life 
susceptibility to viral infection and/or increased asthma-associated viral infections 
(Spalluto et al., 2017).  
Finally, and by far the most extensively studied, is the role of DNA methylation 
in differential susceptibility and severity of infection and other inflammation-related 
disorders. In fact, TLRs themselves are frequently regulated by differential methylation, 
making them the ideal candidates for assessing mechanisms of immune response 
regulation (Hennessy and McKernan, 2016).  It has been shown that infection with 
Mycobacterium tuberculosis induces extensive re-programming of methylation patterns 
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found within the TLR2 promoter that results in changes in TLR2 expression and also 
correlates with the extent and severity of infection (Chen et al., 2014). Chondrocytes 
isolated from patients with osteoarthritis versus healthy patient controls express 
significantly higher IL-8 that occurs with decreased methylation of the IL8 promoter and 
reduced transcription factor trans-activation (Takahashi et al., 2015). In summary, 
epigenetic modifications significantly impact how the immune system responds to 
infection. Epigenetic changes may also occur as the result of infection inducing an innate 
“memory” response, as is the case in endotoxin tolerance and “trained” immunity (Netea 
et al., 2016).  
 
1.9 Epigenetic Regulation of Immunity in Agricultural Species 
 Epigenetic regulation of gene expression in agricultural species has been gaining 
attention in recent years and has led to advances in both our understanding of the 
biological consequences of epigenetic regulation and in the sequencing technologies 
needed to identify epigenetic modifications in animals of agricultural importance. One 
study has recently addressed the role of epigenetic regulation in bovine response to 
Mycobacterium bovis. In comparison to their healthy counterparts, animals infected with 
M. bovis acquire a number of DNA methylation changes within their CD4+ T-cell 
population that is unique to their infected status. T-cells in infected animals become 
significantly hypo-methylated in a number of genes that are regulated by TGF-ß, a 
cytokine that regulates T-cell development and differentiation. In addition, the canonical 
TH1 cytokine, IFNG, encoding IFN-γ, was discovered to be significantly hypo-
methylated and up-regulated in infected animals, whereas, TNFRSF4, a gene that 
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transcribes the OX-40 co-receptor responsible for T-cell survival and proliferation, was 
hyper-methylated and significantly repressed (Doherty et al., 2016).  
 Treatment of bovine peripheral blood mononuclear cells (PBMCs) with LPS 
reduces the expression of key enzymes that mediate DNA methylation and histone de-
acetylation, consistent with up-regulation of gene expression (Doherty et al., 2013). 
However, it is interesting to note that in the same study, treatment of PBMCs with 
trichostatin A (TSA), an inhibitor of the histone de-acetylase enzyme, decreased the 
expression of pro-inflammatory cytokines in response to LPS compared to untreated cells 
stimulated with LPS. Since TSA is a pan-HDAC inhibitor it is possible that up-regulation 
of anti-inflammatory proteins occurred as a result of treatment and over-shadowed the 
effects of LPS. In addition, the mixed cell population may have confounded the study, 
making these results difficult to interpret. It is thought that endotoxin tolerance is the 
result of epigenetic modifications, however, treatment of primary bovine epithelial cells 
with a number histone-modifying enzyme inhibitors also has very little effect on 
subsequent response to E. coli (Gunther et al., 2017b). These results suggest that histone 
modifications may play a lesser role than originally thought in response to LPS.  
A number of epigenetic changes occur in the livers of animals challenged with 
E. coli and as a result of increased concentrations of LPS induced by sub-acute ruminal 
acidosis (SARA). Following E. coli mastitis, liver biopsies showed chromatin de-
condensation in genes transcribing TLR2, TLR4, haptoglobin (HP) and 
lipopolysaccharide binding protein (LBP) along with increased expression. Interestingly, 
correlation of TLR4 expression and chromatin remodeling was not as strong as for the 
other three genes, however, TLR4 was also significantly hypo-methylated (Chang et al., 
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2015a). Differential methylation of TLR4 has also been shown to occur during SARA, a 
metabolic condition in ruminants that decreases rumen pH such that microbial death 
occurs and leads to the release of LPS into the circulation. When induced experimentally 
in goats and dairy cows, the systemic release of LPS leads to an enhanced expression of 
TLR4 and cytokine response in the liver that occurs concurrently with TLR4 chromatin 
de-condensation and a substantial decrease in promoter methylation (Chang et al., 
2015c). In cows, increased hepatic expression of HP, SAA3 and LBP also occurs with a 
significant reduction in promoter methylation and chromatin loosening (Chang et al., 
2015b).  
Differential methylation of TLR4, therefore, seems like a potential mechanism of 
gene regulation that may determine the susceptibility and severity of E. coli mastitis.   
Using the primary dermal fibroblast as a model cell type, it has been previously shown 
that as animals increase in age from 5- to 16-months, their fibroblasts exhibit a much 
higher response to in vitro LPS treatment and increased expression of TLR4. Age-
dependent differences in fibroblast IL-8 production in response to LPS is also abolished 
upon treatment with the DNA methylation inhibitor 5-aza-2′deoxycytidine (AZA), 
indicating that DNA methylation plays a role in the age-dependent difference in response 
(Green et al., 2015). As these cells were isolated from the same animals at two separate 
ages and will not be confounded by genetic factors, this model is ideal for discovering 
epigenetic differences that regulate response to LPS.    
1.10 Environmental Effects on Epigenetic Modifications and Immunity 
 In addition to the identification of genetic and epigenetic markers that confer 
susceptibility or resistance to severe mastitis, it is of interest to determine if epigenetic 
 21
differences can be altered through early life environmental interventions. If financially 
feasible, this would provide producers with another tool to lower the susceptibility of 
their animals to severe mastitis. There is considerable data to suggest that environmental 
exposures, particularly when they occur early in life, can influence disease susceptibility. 
For example, there is a substantial difference in the prevalence of asthma in Hutterite 
versus Amish children, whereby Amish children have a much lower risk of developing 
asthma (Stein et al., 2016). The lowered prevalence and increased protection against 
developing asthma is thought to occur as a result of a much higher (6.5-times) level of 
endotoxin measured in house-dust collected from Amish households, resulting in a more 
tolerant, hypo-responsive phenotype to everyday allergens. In support of this hypothesis, 
stimulation of peripheral blood leukocytes isolated from Amish and Hutterite children 
with LPS results in significantly lower cytokine concentrations in challenge supernatant 
from the Amish population. Furthermore, treating mice with house-dust collected from 
either Amish or Hutterite households showed a significant protective effect induced by 
Amish house-dust to airway hyperresponsiveness and eosinophilia and suppression of 
IgE and cytokine response to challenge with ovalbumin. 
 The aforementioned study is further supported by a number of other reports that 
have found an immune-tolerizing effect of early life endotoxin on adult immunity. Rat 
pups that were exposed to a single dose of LPS in early gestation exhibited lower 
leukocyte recruitment into their lungs following ovalbumin-induced experimental asthma 
(Kirsten et al., 2011). In addition, an earlier study showed that neonatal LPS treatment of 
rat pups at 14-days of age has a significant effect on a subsequent LPS exposure in 
adulthood. In comparison to their saline treated counterparts, LPS-treated pups had a 
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lower response to a second LPS exposure that was reflected in an attenuated circulating 
cytokine response along with a lower fever response. The authors attributed the LPS-
induced suppression to increased corticosterone signaling in rats treated with LPS as pups 
(Ellis et al., 2005). Interestingly, although similar results were measured in LPS-induced 
circulating cytokine response in mice that were exposed to LPS at conception versus 
saline treated mice, no differences were measured in corticosterone levels, indicating that 
this may not be the only factor in determining neonatal LPS-induced suppression of adult 
innate immunity (Williams et al., 2011). Finally, calves treated with LPS in late gestation 
also exhibited changes to their innate immune response as young adults when exposed to 
a second treatment with LPS. LPS-treated heifers tended to be less effected by LPS, 
based on temperature response and sickness score, and also express higher levels of 
neutrophil ß-defensin genes (Carroll et al., 2017).  
Although substantial evidence for the effect of early life endotoxin exists, few 
studies have addressed the mechanisms behind the phenotypic differences. One study, 
however, revealed a large change in the regulatory T-cell (Treg) population found in cord 
blood of pregnant mothers exposed to a farm environment in comparison to unexposed 
mothers. The Treg population from farm-exposed mothers was more abundant and had an 
increased capacity to down-regulate effector T-cell function (Schaub et al., 2009). 
Notably, the change in Treg phenotype occurred in conjunction with decreased 
methylation and increased expression of FOXP3, a transcription factor that is necessary 
for Treg development. 
 Differences in early life maternal care have also been shown to affect epigenetic 
programming in adult animals. Rat pups reared by low maternal care dams, as measured 
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by lower levels of licking and grooming and arched back nursing, exhibit increased 
methylation and reduced expression of hippocampal glucocorticoid receptor that is 
reversible through cross-fostering or treatment with TSA, both of which result in de-
methylation of the glucocorticoid receptor promoter region. The effect of maternal care 
on methylation of the glucocorticoid receptor was specifically attributed to differences in 
care in the first 6 days of life, and as a result, low maternal care adult rats exhibit a 
significantly higher corticosterone response to stress (Weaver et al., 2004). Interestingly, 
a similar difference in maternal care exists in the upbringing of Angus versus Holstein 
calves. In early life, Angus calves are allowed to remain with their dams and receive 
maternal care through nursing and grooming, whereas Holstein calves are separated from 
their dams soon after birth and raised by a calf handler in individual hutches. While not 
yet directly correlated to differences in maternal care, fibroblasts isolated from the two 
breeds exhibit disparate responses to LPS, with Holstein cows being much more hyper-
responsive to the effects of LPS treatment (Benjamin et al., 2016a). How this difference 
is regulated, either epigenetically or otherwise, remains to be determined.  
1.11 Unanswered Questions 
The relationship between genetic, epigenetic, and environmental factors and 
their regulation of immunity in the bovine, especially how each of these contributes to 
mastitis severity, has yet to be fully elucidated. It is known that there is substantial inter-
animal variation in mastitis severity to the same pathogen, such that some animals are 
quick to recover and others suffer from severe, systemic responses that may result in 
death of the animal. Genetic differences have been suggested to partially regulate the 
difference in mastitis susceptibility and severity, but for the most part have not been 
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tested in experimental models. The one exception to this is the role of CXCR1 haplotypes 
in response to S. uberis, which may prove useful in future selection strategies (Siebert et 
al., 2017). However, it is very likely that susceptibility to severe mastitis is polygenic and 
pathogen-dependent. Clinical mastitis also has very low estimates of heritability, 
however, the majority of studies classify the incidence of clinical mastitis categorically, 
without addressing the severity of each case. As such, heritability of severe clinical 
mastitis may be higher than initially predicted. 
It has also become increasingly clear that the optimum innate response is under-
characterized and is not all or nothing. Many studies have used the transition cow as a 
model for a “severe responder”, due to the increased risk of animals developing severe 
mastitis at parturition. These studies suggest that the transition cow is immune-
compromised. Therefore, much past and on-going research on mastitis control focuses on 
boosting the immune system. However, mastitis severity is also associated with increased 
production of TNF-α, IL1-ß and IL-8 (Wenz et al., 2010), and studies suggesting overall 
immune-suppression fail to address the variability between animals in mastitis severity 
even during early lactation. Therefore, it is of the author’s opinion that a dysregulated 
rather than immune-suppressed response be attributed to the increased risk of severe 
mastitis in transition cows. Efficient neutrophil response is necessary but it should not be 
so exuberant to cause excessive tissue damage. Therefore, identifying the factors that 
contribute to effective response and then recovery following infection are required, and 
this may be facilitated by access to an accurate cellular model.  
Beyond genetics, the study of the phenotypic effects of epigenetic differences is 
still in its infancy in the bovine. As previously discussed, a variety of epigenetic 
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modifications have been shown to contribute to regulation of the immune response in 
several different species; as such, it is unlikely that this will be any different for the 
bovine and suggests there is significant room for improving genetic resistance to mastitis.  
Finally, it is of interest to identify treatments, such as dietary interventions or immune 
stimulants, that are easy to implement and can be utilized early in calf development to 
generate an adult phenotype that has a lower susceptibility to severe mastitis. In this case, 
training the immune response to effectively respond to a pathogen without creating 
excess damage or undermining immunity elsewhere, is highly desired.  
To discover how genetic, epigenetic and the environmental factors collectively 
regulate the bovine innate immune response and potentially alter susceptibility to severe 
mastitis, I used a primary dermal fibroblast cell model to assess phenotypic differences 
between animals in their innate response to LPS. The dermal fibroblast is a readily 
accessible and TLR-responsive cell type that is useful for measuring the responses of a 
large cohort of animals. Furthermore, the cell model was used in conjunction with in vivo 
experiments to address my hypothesis:   
Between-animal variation in the severity of E. coli mastitis is partially mediated 
by differential methylation of genes that regulate the innate immune response, 
resulting in susceptible and resistant phenotypes that can be altered through 
early-life environmental interventions.  
To first determine how DNA methylation regulates innate immunity, fibroblasts 
that exhibit an age-dependent up-regulation in their response to LPS were used to identify 
genome-wide differences in DNA methylation. As these cells were isolated from the 
same animals at 5- and 16-months of age and show clear differences in their response to 
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LPS, they are an ideal model to identify epigenetic differences that regulate the innate 
response without the confounding effect of genetic variables. Next, to identify how 
differential regulation of the TLR4 pathway contributes to mastitis severity, either at the 
genetic or epigenetic level, expression of TLR4 and downstream signaling components 
were measured in fibroblasts isolated from a large cohort of lactating adult cows. Cows 
identified as either high or low responders were subsequently challenged with E. coli in 
an experimental mastitis model to determine if high responders would experience more 
severe mastitis, as was predicted.  
Finally, since early life LPS exposure has been shown in numerous reports to 
down-regulate immunity, presumably through epigenetic mechanisms, neonatal bull 
calves were treated with either LPS or saline at one-week of age. Subsequent in vivo and 
cellular responses were then analyzed to determine the effects of early life treatment. If 
found to be beneficial, it may be of interest to producers to stimulate heifer calves at a 
young age with a low-dose of endotoxin, or another immune stimulant, to modulate 
heifer and adult cow response to E. coli. These works contribute to our understanding of 
epigenetic regulation of bovine innate immunity, addresses the utility of the fibroblast 
model to determine genetic and epigenetic biomarkers of mastitis resistance and, adds to 


















CHAPTER 2: GENOME-WIDE METHYLATION ANALYSIS REVEALS 
DIFFERENTIALLY METHYLATED LOCI THAT ARE ASSOCIATED WITH 
AN AGE-DEPENDENT INCREASE IN BOVINE FIBROBLAST RESPONSE 
TO LPS  
2.1. Abstract  
Background: Differences in DNA methylation are known to contribute to the 
development of immune-related disorders in humans, but relatively little is known about 
how methylation regulates immune function in cattle. Utilizing whole-transcriptome 
analyses of bovine dermal fibroblasts, we have previously identified an age and breed-
dependent up-regulation of genes within the toll-like receptor 4 (TLR4) pathway that 
correlates with enhanced fibroblast production of IL-8 in response to lipopolysaccharide 
(LPS). Age-dependent differences in IL-8 production are abolished by treatment with 5-
aza-2-deoxycytidine and Trichostatin A (AZA-TSA), suggesting epigenetic regulation of 
the innate response to LPS. In the current study, we performed reduced representation 
bisulfite sequencing (RRBS) on fibroblast cultures isolated from the same animals at 5- 
and 16-months of age to identify genes that exhibit variable methylation with age. To 
validate the role of methylation in gene expression, six innate immune response genes 
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that were hyper-methylated in young animals were assessed by RT-qPCR in fibroblasts 
from animals at different ages and from different breeds.  
Results: We identified 14,094 differentially methylated CpGs (DMCs) that 
differed between fibroblast cultures at 5- versus 16-months of age. Of the 5065 DMCs 
that fell within gene regions, 1117 were located within promoters, 1057 were within gene 
exons, 2891 were within gene introns, and 67% were more methylated in young cultures. 
Transcription factor enrichment of the promoter regions hyper-methylated in young 
cultures revealed significant regulation by the key pro-inflammatory transcriptional 
enhancer, NF-κB. Additionally, five out of six chosen genes (PIK3R1, FES, NFATC1, 
TNFSF13, and RORA) that were more methylated in young cultures showed a significant 
reduction in expression post-LPS treatment in comparison with older cultures. Two of 
these genes, FES and NFATC1, were similarly down-regulated in Angus cultures that 
also exhibit a low LPS response phenotype. 
Conclusions: Our study has identified immune-related loci regulated by DNA 
methylation in cattle that may contribute to differential cellular response to LPS, two of 
which exhibit an identical expression profile in both low-responding age and breed 
phenotypes. Methylation biomarkers of differential immunity may prove useful in 
developing selection strategies for replacement cows that are less susceptible to severe 
infections, such as coliform mastitis.   
Keywords: DNA Methylation, Innate Immunity, LPS, Inflammation, RRBS 
2.2. Introduction  
The innate immune response is an organism’s first line of defense against 
pathogenic microorganisms and the primary response to tissue damage. Innate immunity 
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is mediated by specialized leukocytes and other cells that serve as a barrier to the 
environment, such as epithelial cells and dermal fibroblasts. Innate immune cells are 
characterized by their expression of germ-line encoded pattern recognition receptors 
(PRRs), which recognize conserved molecular patterns (PAMPs), such as 
lipopolysaccharide found on the outside of Gram-negative bacteria and viral nucleic 
acids, and elicit the appropriate defense response upon recognition. The most thoroughly 
characterized of these PRRs are Toll-like receptors (TLRs), a family of type-I 
transmembrane proteins first discovered in Drosophila melanogaster when the Toll gene 
was found to be essential for bacterial and fungal defenses (Lemaitre et al., 1996, Michel 
et al., 2001).  Upon TLR-ligand binding, an intracellular signaling cascade is activated 
that allows for the transcription of numerous pro-inflammatory proteins, such as IL-6, 
TNF-α and IL1-β, through the action of transcription factors NF-κB, AP-1, and Interferon 
Response Factors (IRFs), among others (De Nardo, 2015). While it is clear that the 
response elicited by TLRs and other PRRs are crucial to the defense against a variety of 
bacterial, viral and eukaryotic pathogens (Sturdevant and Caldwell, 2014, Sacramento et 
al., 2015, Uchiyama et al., 2015), an exacerbated or dysregulated innate response also 
contributes to infection related inflammatory disorders, such as in antibody dependent 
enhancement and the subsequent “cytokine storm” characteristic of Dengue hemorrhagic 
fever (Callaway et al., 2015). In addition, the type I interferon response, normally 
beneficial to the host during a viral infection, has been shown to actually increase 
susceptibility to some bacterial, viral and protozoan infections (Stifter and Feng, 2015). 
The innate immune response is also a key contributor to a number of sterile pro-
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inflammatory conditions, such as rheumatoid arthritis and asthma (Starkhammar et al., 
2015, Lacerte et al., 2016).  
The severity of bovine mastitis, a primary cause of economic losses to dairy 
milk production, is similarly more often associated with increased production of pro-
inflammatory mediators, such as, TNF-α, IL1-ß, and IL-6, than it is with the number of 
bacteria present within the mammary gland. Mastitis severity has also been shown to vary 
greatly, even under controlled experimental settings in which pathogen factors are held 
constant. This suggests host factors play a significant role in mastitis outcome 
(Kornalijnslijper et al., 2003). Several studies have shown a dysregulated population of 
milk and serum neutrophils, along with greater concentrations of TNF-α and reactive 
oxygen species, during the peri-partum period when animals are highly susceptible to 
severe mastitis (Ballou, 2012). Interestingly, priming of the mammary gland with 1 µg of 
LPS, which causes a substantial but short-lived inflammation, reduces severity of 
experimentally induced Escherichia coli (E. coli) mastitis 10 days post LPS priming 
(Petzl et al., 2012). In an effort to explain the mechanism behind this reduction in mastitis 
severity, a study by Gunther et al. (Gunther et al., 2012) measured gene expression in 
response to heat killed E. coli in primary mammary epithelial cells following pre-
treatment with LPS. Priming of cells was found to increase expression of ß-defensins 
while decreasing pro-inflammatory and apoptotic gene expression, including IL1-ß, 
TRAF6, and TNF superfamily proteins (TNFSF13B and TNFSF10), indicating that the 
previously measured benefit of LPS priming in an intra-mammary infection with E. coli 
was due in part to a reduction in inflammatory response (Gunther et al., 2012). In a 
murine mastitis model, administration of LPS into the mammary gland of TLR4(-/-) mice 
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to induce mastitis showed that while knockout mice had significantly lower serum 
cytokines CXCL1, IL1-ß, IL-6, IL-10, TNF-α, CCL2 and IP10, they also experienced a 
lower degree of mammary gland involution while maintaining increased capacity for 
milk production compared to wild-type littermates (Glynn et al., 2014). In agreement 
with the aforementioned studies, our lab has shown that high responding dairy animals, 
based on dermal fibroblast IL-8 production in response to TLR ligands, have greater 
tissue damage and neutrophil influx into the mammary gland post-infection and a slower 
return to pre-infection milk production levels in response to both Staphylococcus aureus 
(S. aureus) and E. coli mastitis, without any benefit to their ability to clear bacteria 
(Kandasamy et al., 2011, Benjamin et al., 2015b).  
Several factors, including genetic differences, may contribute to variation within 
an animal’s infection response phenotype. In one example, single nucleotide 
polymorphisms in the TLR4 gene have been linked to increased susceptibility to 
Mycobacterium avium subspecies tuberculosis, or Johne’s disease, in Canadian Holsteins 
(Sharma et al., 2015). However, a recent study between 3 breeds indicated an estimated 
heritability of clinical mastitis to be between 2% and 4%, suggesting a very large role for 
non-genetic factors (Govignon-Gion et al., 2015). Epigenetic modifications, such as DNA 
methylation, may help to explain discrepancies measured between large phenotypic 
differences with little genetic basis. In agreement with this, DNA methylation in two 
breeds of chicken has been shown to contribute to differential susceptibility to infectious 
diseases such as avian flu and Salmonella infection. Whole genome bisulfite sequencing 
(WGBS) revealed greater than 5,000 differentially methylated regions (DMRs) in lung 
tissue between the two breeds, with a portion of DMRs falling within gene regions. The 
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methylation data generated by WGBS together with mRNA expression data generated by 
RNA-seq, also identified genes with both differential methylation and expression, most 
notably TLR4 and PIK3CD (Li et al., 2015).  
In support of epigenetic regulation of the bovine innate immune response, data 
generated in our lab has shown that an age-dependent increase in dermal fibroblast 
response to LPS is ameliorated following treatment with a DNA methylation and histone 
deacetylase inhibitor, AZA-TSA (Green and Kerr, 2014). A subsequent study was 
performed to identify methylation and gene expression differences in fibroblast cultures 
isolated from female calves at 5- and 16-months of age. Transcriptome-wide analysis of 
these two sets of cultures identified numerous genes within the TLR4 response pathway 
that were up-regulated in older, more responsive cultures, including TLR4, CD14, IL-8 
and TNF-α (Green et al., 2015). In the same study, we sought to identify changes in DNA 
methylation between the young and old cultures that contribute to age-related differences 
in innate immunity, however, the MIRA (methylated CpG island recovery assay)-seq 
technique that was utilized does not have the resolution required to determine 
methylation differences at the base pair level. As such, very little difference in 
methylation was found between the two sets of cultures.  
Another phenotypic difference we have identified is the differential response 
between Holstein and Angus breeds, in which Holstein cattle exhibit a much higher 
fibroblast response to LPS than Angus cattle. The few reports of mastitis in beef cows 
have also suggested beef breeds are less susceptible to coliform mastitis, with no cases of 
E. coli mastitis cases detected in several studies (Lents et al., 2002, Persson Waller et al., 
2014). In this case, genetic differences between breeds are likely to have an influence. 
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However, calves from these two breeds experience highly disparate upbringing. In 
contrast with Angus and other beef breeds, Holstein calves are immediately separated 
from their dam, allowing for little to no maternal care, which has been shown to 
contribute to differential methylation of hormone receptors in rats (Pena et al., 2013).  
Again, transcriptome analysis of age-matched fibroblasts isolated from the two breeds 
revealed a number of pro-inflammatory genes with differential expression, with Holstein 
cultures exhibiting significant up-regulation as compared to Angus cultures. However, 
little to no difference in DNA methylation was found using the MIRA-seq technique 
(Benjamin et al., 2016a).  
Knowledge of epigenetic regulation of the immune response in dairy cattle is 
currently lacking, and will be important to understanding differences in mastitis 
susceptibility. From the previous studies, it is clear that methylation differences at a base 
pair resolution are required. As such, the aim of the current study was to identify base-
pair specific DNA methylation differences in fibroblasts taken from Holstein heifers at 5- 
and 16-months of age, using reduced representation bisulfite sequencing (RRBS). Once 
candidate differentially methylated genes were identified, we determined whether 
methylation affects gene expression by measuring fibroblast gene expression at various 
time points post-LPS treatment. Furthermore, we determined whether genes regulated by 
methylation in young and old cultures also differed in gene expression between Angus 
and Holstein cultures. Overall, the current study contributes to our knowledge of 
candidate immune response genes that are subject to regulation by DNA methylation 
within the genome of dairy cattle and may lead to a better understanding of the 
mechanisms that regulate inter-animal variation in susceptibility to severe mastitis. 
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2.3. Materials and Methods 
2.3.1 Experimental Animals 
Six pairs of dermal fibroblast samples, collected from Holstein heifers at 5 and 
16 months of age, were used from a previously characterized cohort of 15 heifer 
fibroblast samples (Green et al., 2011a). Primary dermal fibroblast collection and ranking 
based on IL-8 production following in vitro LPS stimulation was previously described 
(Green et al., 2011a). The six pairs of fibroblast samples chosen for DNA methylation 
analysis were all selected from mid-responding animals to reduce inter-animal variation 
within the two groups that could potentially interfere with any true age effects.  
A second set of dermal fibroblasts was collected for the breed difference experiments. 
Fibroblasts were isolated from four 19-month Holstein and four 19-month Black Angus 
cows. Fibroblast collection, isolation and LPS response are described elsewhere 
(Benjamin et al., 2016a).  
In both the age and breed experiments, fibroblasts were stimulated with 100 
ng/ml of LPS and RNA isolation was performed side-by-side in neighboring wells. From 
the same vial of cryopreserved cells used in the LPS challenge, some cells were cultured 
in a T-75 cm2 culture flask for DNA isolation. Cells were again cultured side-by-side and 
untreated cultures were used for DNA extraction. 
All experiments were approved by the Institutional Animal Care and Use 
Committee at the University of Vermont.  
2.3.2 Fibroblast Culturing and LPS Challenge  
Growth media for fibroblast cultures was Dulbecco’s Modified Eagle Media 
(DMEM; Hyclone Laboratories, Logan, UT) supplemented with 5% fetal bovine serum 
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(FBS; Hyclone Laboratories), 1% penicillin-streptomycin (Hyclone Laboratories) and 1% 
insulin-transferrin-selenium (ITS; Mediatech Inc., Herndon, VA).  Fibroblasts were 
revived from cryopreservation and expanded in a T-75 cm2 culture flask at 37°C 5% CO2 
in a humidified incubator. Confluent flasks were then treated with 0.25% trypsin (MP 
Biomedical, Santa Ana, CA) and cells were transferred to a 6-well plate at 1.25 x 105 
cells/ml in a total volume of 2 ml, or 2.5 x 105 total cells and cultured for 24 hours for the 
LPS challenge experiments. Remaining cells were transferred to a T-75 cm2 culture flask 
and allowed to grow to confluency for subsequent DNA isolation.  
After 24 hours, cells in the 6-well plates were treated with 100 ng/ml of ultra-
pure LPS isolated from Escherichia coli O111:B4 (Sigma-Aldrich, St. Louis, MO) for 
either 0, 2, 8 or 36 hours. At 0 and 36 hours, media was collected for protein production 
analysis. After removal from the wells, media was centrifuged at 10,000 x g for 1 minute 
to remove cellular debris and stored at -20°C until further analysis. At every time point, 
cells were rinsed gently with Dulbecco’s Phosphate Buffered Saline (DPBS; Hyclone 
Laboratories) and cell lysate was collected by adding 500 µl cell lysis buffer (5 Prime, 
Hamburg, Germany) to the well. Cell lysate was stored at -20°C until RNA isolation.  
Cells that were grown in a T-75 cm2 culture flask for DNA isolation were treated with 
trypsin at confluency and centrifuged at 400 x g. The cell pellet was then lysed with 300 
µl cell lysis buffer (5 Prime) by adding the lysis buffer and vortexing for 15 seconds. The 
cell lysate was stored at -20°C until DNA isolation. 
2.3.3 Quantification of IL-8 and IL-6 Protein 
Interleukin-8 production in media from LPS stimulated dermal fibroblasts was 
determined with a sandwich ELISA (Mabtech Inc., Cincinnati, OH) per manufacturer’s 
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protocol with slight modifications. Capture antibody was diluted 1:500 to 1 µg/ml in 0.05 
M bi-carbonate buffer. Recombinant bovine IL-8 (Thermo Scientific, Rockford, IL) was 
used as the assay standard with a detection limit of 156.25 pg/ml. Capture antibody was 
diluted 1:20,000 in PBS-0.05% Tween-20 to a concentration of 0.025 µg/ml. 
Streptavidin-horseradish peroxidase was diluted 1:15,000 in PBS-0.05% Tween-20 to a 
concentration of 0.07 µg/ml.  
Interleukin-6 production was also determined by a sandwich ELISA (Thermo 
Scientific) per manufacturer’s instructions. Briefly, capture antibody was diluted 1:100 in 
0.05 M bi-carbonate buffer. Recombinant bovine IL-6 (Thermo Scientific) was used as 
the assay standard with a detection limit of 156.25 pg/ml. Detection antibody was diluted 
1:100 in PBS-0.1% BSA. Streptavidin-horseradish peroxidase (Sigma-Aldrich) was 
diluted 1:2000 in PBS-0.1% BSA to a concentration of 0.5 µg/ml. Development of IL-8 
and IL-6 ELISA plates was done by adding 3,3’,5,5’-tetramethylbenzidine substrate 
(TMB; Thermo Scientific) to the wells and the reaction stopped with 1 M H2SO4.  
2.3.4 DNA extraction and preparation for RRBS  
DNA was extracted from 5- and 16- month dermal fibroblasts using a 5-Prime 
PerfectPureTM Archive DNA Extraction Kit (5 Prime) per manufacturer’s protocol. DNA 
concentrations were then determined using a QubitTM 2.0 Spectrofluorometer (Life 
Technologies, Carlsbad, CA). DNA was diluted to 40 ng/µl and a total of 2 µg was sent 
to Zymo Research (Irvine, CA) for Methyl-MiniSeqTM RRBS library preparation. 
Libraries were generated with 200-500 ng of DNA as previously described (Kanzleiter et 
al., 2015). Briefly, DNA was sequentially digested with 60 units of TaqαI and 30 units of 
MSPI (NEB, Ipswich, MA), which recognizes CCGG as a cut site and cleaves after the 
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first cytosine, creating DNA products with CG dinucleotides on both ends of the DNA 
and enriching for CG rich regions. Following enzymatic digestion, DNA products were 
end-repaired, A-tailed, and extracted with DNA Clean and Concentrator KitTM (Zymo 
Research). The extracted DNA was then ligated to methylated Illumina primers using the 
Illumina DNA preparation kit and protocol (Illumina, San Diego, CA). Adaptor ligated 
DNA was then size selected for desired input fragments (150-250 bp and 250-350 bp) 
with a 2.5% NuSieve 3:1 agarose gel and extracted using the ZymocleanTM Gel DNA 
Recovery Kit (Zymo Research). Successfully ligated and purified DNA was then bisulfite 
converted using the EZ DNA Methylation-LightningTM Kit (Zymo Research). Control 
DNA was similarly bisulfite converted to assess conversion rates, which were 99% for all 
samples. Following conversion, preparative-scale PCR was performed with a total of 16 
cycles and PCR products were purified with the DNA Clean and Concentrator KitTM 
(Zymo Research). Individual DNA libraries were then sequenced on the Illumina 
HiSeq2000 (Illumina), generating 50 bp paired-end reads and base-calling was performed 
using standard Illumina base-calling software. 
2.3.5 DNA Sequence Processing and Alignment  
Following sequencing, bioinformatics analysis was performed at Zymo 
Research using a proprietary analysis pipeline written in Python. Prior to alignment, reads 
were assessed for quality using FastQC (v0.11.1, Babraham Bioinformatics, UK) and 
Trim Galore (v0.3.7, Babraham Bioinformatics, UK). Bases with a Phred score greater 
than 20 were kept for downstream analysis (--paired --phred33 -q 20). Illumina adaptor 
trimming was done using Trim Galore with the default settings which are automatically 
set to standard Illumina adaptors unless otherwise specified. Trim Galore also contains a 
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setting specifically for trimming RRBS data (--rrbs), which was used to further modify 
our reads. RRBS introduces artificial CpG sites which require trimming in order to avoid 
them being used in methylation calling. To do so, Trim Galore trims the first 2 bases 
from the 3’ end of the sequence so the C closest to the second enzyme cut site is not 
included in methylation calling. Reads were then mapped to an in-silico bisulfite 
converted reference genome (BosTau8/BTau_4.6.1) with the Babraham Bismark 
software (v0.13.1, Babraham Bioinformatics, UK) using the 
bismark_genome_preparation command, the entire reference genome and with the --
non_directional parameter applied. Babraham Bismark is designed for aligning bisulfite 
sequencing data while simultaneously making methylation calls. In the process of 
bisulfite sequencing, un-methylated cytosines are converted to uracil, while methylated 
cytosines are unaffected. The result of this is four sets of potential sequences at any given 
locus. To determine which of these four potential sequences is correct, Bismark creates 
two bisulfite converted reference genomes, one that is a C  T conversion and one that is 
a G  A conversion to account for conversion on the reverse strand. Each sequence read 
is also bisulfite converted in silico and is aligned to the pre-converted version of the 
reference genome. The best alignment is then identified and used to make a methylation 
call. Alignments that are uniquely mapped were kept for analysis. Alignments that 
mapped to multiple regions were discarded. Due to enrichment-constraints of RRBS 
libraries, duplicates measured as a result of shorter, overlapping paired end inserts were 
not removed in the sequence data and were counted as two reads.  
On average, mapping efficiencies were 25% and ranged between 23-27% and 
the average number of unique CpGs identified were 6.0 million and ranged between 4.8 
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and 6.6 million. Differentially methylated CpGs falling within -2.5 kb, +1.0 kb of an 
annotated transcription start site (TSS) were defined as being within the promoter region 
of a gene. Methylation ratios were used as the comparison parameter to test statistical 
differences in DNA methylation and these were defined as the number of reads 
overlapping a particular CpG site, which contained either a cytosine or thymine 
nucleotide. Ratios were then calculated as Methylation Ratio (Mr) = (C)/(C + T).  
2.3.6 Functional Analysis 
KEGG (Kyoto Encyclopedia for Genes and Genomes) pathway, GO (Gene 
Ontology) and UCSC (University of California Santa Cruz) Transcription Factor Binding 
Site (TFBS) analyses were performed using the DAVID (the Database for Annotation, 
Visualization, and Integrated Discovery) 6.8 platform (Huang da et al., 2009b, a). Four 
lists of official gene IDs (all IDs or promoter only with ≥5X or ≥10X coverage) were 
generated for sites located within annotated genes that were hyper-methylated in either 
young or old cultures (Additional Files 1 and 2). A suggestive analysis was performed on 
all differentially methylated genes with ≥5X coverage and a conserved analysis was 
performed with only genes that had ≥10X coverage. Gene IDs from all three gene regions 
(exon, intron and promoter) were inputted into DAVID, converted to Entrez gene IDs, 
and default parameters were used for KEGG and GO analyses. Only those genes that 
were covered by RRBS, either at the 5X or 10X level, were set as the background. 
Promoter gene IDs were used in transcription factor enrichment analysis and TFBS 
analysis was similarly run with default parameters and Homo sapiens as the background 
due to a lack of support for Bos taurus within the UCSC_TFBS tool.  
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2.3.7 Gene Expression of Selected Genes 
Selected differentially methylated genes and LPS response genes were measured 
in all fibroblast cultures exposed to LPS for 0, 2 and 8 hours. RNA was isolated using the 
5 Prime PerfectPureTM RNA Cultured Cell Kit (5 Prime) per manufacturer’s instructions 
and quantified using a QubitTM 2.0 Fluorometer (Life Technologies, Carlsbad, CA). First 
strand cDNA synthesis was done using the ImpromIITM Reverse Transcriptase Kit 
(Promega, Madison, WI). To determine gene expression, quantitative reverse 
transcriptase PCR (RT-qPCR) was performed using Thermo Scientific™ Maxima™ 
SYBR™ Green/Fluorescein 2X qPCR Master Mix (Thermo Fisher) on a CFX96 
Touch™ Real-Time PCR machine (Biorad, Hercules, CA) on the selected genes. The 
gene β-Actin was used as a housekeeping gene control. Cycling conditions were as 
follows: 95°C for 2 minutes followed by 40 cycles of 95°C for 15 seconds, 60°C for 1 
minute and 72°C for 1 minute after which a melt curve was inserted. All oligonucleotide 
primer sequences are shown in Table 2.1. Unless already published primers were 
available, all primers were designed using Primer 3 on NCBI. An amplicon of 200 – 300 
base pairs was designed and the primer binding site could not contain any known SNP. 
Each primer sequence was then analyzed with an NCBI nucleotide BLAST search to 
ensure only the intended Bos taurus gene was detected. Melt curve analysis was 
performed on each primer pair and included a negative control reaction (no cDNA). Melt 
curve analysis revealed only one peak, indicative of a single product, with no peaks 
associated with the negative control.  
 41
2.3.8 Statistical Analysis  
To assess differences in cytokine protein production, a paired Student’s t test 
was performed using GraphPad Prism Version 6.0 for Windows (GraphPad Software, La 
Jolla, CA). Differences in DNA methylation at adequately covered (≥5X coverage based 
on similar RRBS studies (Pan et al., 2012, Begue et al., 2017)) CpG sites was performed 
at Zymo Research and determined using a paired Student’s t test comparing methylation 
ratios (i.e. percent methylation of each fibroblast sample) at each site. Since all young 
and old cultures were individually sequenced, statistical analysis to determine significant 
differences in methylation were determined at a per individual basis taking into account 
variation within a sample and comparing each animal’s young sample versus their old 
sample. A p-value of <0.05 was applied to assess significance. In addition, a cut-off of at 
least 25% difference in methylation was included when assessing gene expression levels 
as these regions are much more likely to have an influence on expression.  
A clustering dendogram was made according to methylation ratio on the top 100 
differentially methylated sites, based on p-value. The clustering analysis was performed 
at Zymo Research using a standard data analysis algorithm with a “complete” linkage 
method and a “Euclidean Distance” metric. Significance for GO, KEGG and TFBS were 
determined by a modified Fisher’s Exact test in DAVID as previously described (Huang 
da et al., 2009b) and multiple comparisons correction were done using the Benjamini-
Hochberg method. Gene expression differences were determined using either a paired 
(young vs. old) or unpaired (Angus vs. Holstein) Student’s t test at each time point in 
GraphPad. Protein concentrations and delta Ct values are expressed as the mean +/- 
standard error (SEM). 
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2.4. Results  
2.4.1 Fibroblast Cytokine Response to LPS  
Dermal fibroblasts from the same six animals taken at 5 and 16 months of age 
were revived from cryopreservation for a total of 12 cultures (6 young vs. 6 old). Cultures 
were subsequently stimulated with LPS (100 ng/ml) for 36 hours to determine cytokine 
protein concentration in the media. Media from unstimulated cultures was used as a 
negative control. Protein concentrations of interleukin-8 (IL-8) are shown in figure 2.1, 
panel A. As expected, the 16-month cultures produced significantly more IL-8 (P<0.01) 
than the 5-month cultures. At 36 hours, older cultures had an approximately 5-fold higher 
concentration of IL-8 than young cultures. No detectable IL-8 was produced in media 
only controls. Interleukin-6 (IL-6) was also measured in media post 36-hour LPS 
stimulation. In line with IL-8 protein, 16-month cultures produced significantly more IL-
6 (P<0.01) than 5-month cultures (Figure 2.1, panel B). This difference in older cultures 
was about 2.5-fold more IL-6 than young cultures. Again, control media IL-6 levels fell 
below detection limits of this assay.  
Next, to determine if cytokine gene expression was also different between the 
young and old cultures, RT-qPCR was performed on fibroblasts at 0, 2 and 8 hours post 
LPS stimulation. In line with protein production, IL8 and IL6 gene expression levels were 
upregulated (P<0.01) in old versus young cultures (figure 2.1, panels C and D).  Older 
fibroblast cultures had a 15.9 and 10.9-fold increase in IL8 gene expression and a 7.3 and 
13.4-fold increase in IL6 gene expression over younger cultures at 2 and 8 hours post 
LPS stimulation, respectively. 
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Cytokine protein and expression analyses confirmed that the older dermal 
fibroblast cultures were much more responsive to LPS than younger cultures. Genomic 
DNA was then isolated from unstimulated cultures, grown from the same cryopreserved 
stock used to assess LPS response, and analyzed by RRBS to determine whether 
methylation differences may contribute to differences in the LPS-induced response.  
2.4.2 Reduced Representation Bisulfite Sequencing in 5-month and 16-month 
Dermal Fibroblasts 
As outlined in the RRBS project workflow in figure 2.2, genomic DNA from all 
the cultures were treated with a methylation insensitive restriction enzyme MSPI. The 
restriction enzyme cuts at CCGG sites, following the first cytosine, yielding CG sites on 
both ends of the resulting DNA fragments. This results in enrichment of fragments from 
regions in the genomic DNA with many CpG sites, such as CpG islands, that are 
typically associated with promoter regions of DNA (Deaton and Bird, 2011). In our 
analysis, 65% of annotated promoter regions, defined as -2500 to +1000 bp from the 
transcription start site (TSS), had greater than 50X coverage, 8% had less than 50X but 
greater than 10X coverage, 4% had less than 10X coverage, and 23% were not 
represented. 
Following bisulfite conversion, sequencing, and post-sequencing bioinformatics, 
a paired T-test was performed on the methylation ratios between young and old cultures 
at each sequenced CpG site that met coverage requirements. Methylation analysis 
revealed 14,094 differentially methylated CpG sites with P<0.05 and at least 5X 
coverage. Of these, 9,351 (67%) were more methylated in young cultures and 4,743 
(33%) were more methylated in old cultures. Clustering analysis was performed on the 
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top 100 differentially methylated sites (i.e. sites with the greatest significant difference in 
methylation ratios). The old cultures and young cultures clustered separately, indicating 
that two distinct methylation profiles exist, where young cultures form one profile and 
old cultures form a second (Additional File 3).  
2.4.3 Suggestive Analysis of Differentially Methylated Genes  
Next, we performed a comprehensive, but suggestive functional analysis of all 
the sites that fell within gene regions and had ≥5X coverage. Of the 9,351 sites more 
methylated in young cultures, 752 regions were located in annotated promoters, 720 in 
gene exons, and 1926 in gene introns. Of the 4,743 sites more methylated in old cultures, 
365 were located in annotated promoters, 337 in gene exons, and 965 in gene introns. 
Sites that fell within annotated genes were used to generate lists of gene IDs with greater 
methylation in either young or old cultures and functional analysis was performed using 
DAVID. KEGG pathway analysis on genes more methylated in young cultures identified 
5 significantly enriched pathways. These included the “Adherens Junction”, 
“Proteoglycans in Cancer”, “Rap1 Signaling Pathway”, “Pathways in Cancer” and 
“Melanogenesis”. It is worth noting that the “PI3K-Akt Signaling Pathway” was also 
enriched with P=0.06 after multiple comparisons correction. In older cultures, 16 
pathways were significantly enriched, with the “Cholinergic Synapse” pathway as the top 
result. A number of secretory pathways and hormone synthesis pathways were also 
significantly enriched. Among the 16 pathways, those that were of most interest to the 
current study were the “Calcium Signaling Pathway”, “Inflammatory Mediator 
Regulation of TRP Channels” and “cAMP Signaling Pathway”. Among the top 
significantly enriched GO terms in genes with greater methylation in young cultures were 
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“Transcription Repressor Activity”, “Sequence Specific DNA Binding”, and “RNA 
Polymerase II Regulatory Region Sequence-Specific DNA Binding”. Interestingly, in 
older cultures, only one GO term, “Plasma Membrane” was significant and, in contrast to 
young cultures, lacked terms related to regulation of gene transcription. 
Using the annotated genes from only the promoter sites with greater methylation 
in either young or old cultures, a transcription factor enrichment analysis was performed 
using DAVID and Homo sapiens as the background species, because Bos taurus is not 
yet supported in the UCSC_TFBS function. Table 2.2 shows the top 15 most significantly 
enriched transcription factors that regulate the inputted gene promoters more methylated 
in young cultures and Table 2.3 shows transcription factors enriched in gene promoters 
more methylated in old cultures. A number of transcription factors associated with 
immune system regulation and the inflammatory response were associated with 
promoters more methylated in both young and old cultures. Most noteworthy in young 
cultures was greater methylation in NF-κB associated genes. Also, significantly more 
methylated in young cultures were genes regulated by PAX5 (also known as B-cell 
activating protein), and CREB (cAMP-regulated binding protein), a phosphorylation 
responsive transcription factor that binds to cAMP responsive elements.  
In old cultures, PAX5 was similarly enriched along with SP.1, p300 (a CREB 
co-activator), and ATF or activating transcription factors, which are diverse members of 
the ATF/CREB family of transcription factors with a range of physiological functions.  
2.4.4 Conserved Analysis of Differentially Methylated Genes  
In a second, conserved analysis we focused solely on sites with ≥10X coverage, 
which is the minimum coverage that is necessary to accurately determine differentially 
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methylated sites in an RRBS analysis. The additional filtering left 2,865 differentially 
methylated sites. Of these, 1,922 were more methylated in young cultures and 943 were 
more methylated in old cultures. In young cultures, 134 gene promoters, 98 exons, and 
354 introns were hyper-methylated, and in old cultures only 42 gene promoters, 45 exons, 
and 150 introns were hyper-methylated in comparison to young cultures. The genes 
associated with these regions were used to conduct a conserved GO, KEGG and TFBS 
analysis. Interestingly, with the additional filtering we found no significant GO terms 
associated with either young or old cultures, although “Semaphorin Receptor Activity” 
trended (P<0.10) towards significance in old cultures. Two KEGG pathways, “Adherens 
Junction” and “Proteoglycans in Cancer” remained significantly associated with young 
cultures and no KEGG pathways were found to be associated with old cultures. Finally, 
21 transcription factors were identified as significantly enriched in hyper-methylated 
promoter regions in young cultures, the top 10 of which are listed in table 2.4. We did not 
identify any transcription factors enriched in our assessment of hyper-methylated 
promoters in old cultures. Many of the transcription factors that were identified in the 
suggestive analysis in young cultures remained significant, including PAX5 and most 
notably, NF-κB that was found to be associated with 56 out of 134 gene promoters more 
methylated in young cultures.    
2.4.5 Fibroblast Gene Expression of Differentially Methylated Genes 
Selected differentially methylated genes were analyzed by RT-qPCR to 
determine whether changes in methylation resulted in differences in gene expression. The 
rationale for choosing the analyzed genes was that there was a greater than 25% 
methylation difference in at least one region in young versus old cultures, the sites had on 
 47
average greater than 10X coverage across the 12 animals, methylation was greater in 
young versus old cultures and, there was some evidence in the literature that the genes are 
involved in immune response regulation. The six selected genes, and number and location 
of differentially methylated regions, are listed in Table 2.5, along with a summary of 
expression differences.  
Gene expression analysis of the LPS responsiveness of the six selected genes 
hyper-methylated in young versus old cultures is shown in Figure 2.3. Overall, 5 of the 6 
selected genes showed a reduced expression in cultures established from the animals at 5 
vs. 16 months of age. Two of the 6 genes, FES and PIK3R1, had reduced expression in 
the younger cultures at all 3 time points, with a 5.7, 4.3, and 6.3-fold (P<0.01) lower 
expression in FES and 3.0, 2.6, and 2.5-fold (P<0.01) lower expression in PIK3R1 at 0, 2, 
and 8 hours post LPS stimulation, respectively. Both genes had differentially methylated 
sites located in the promoter region, a single site located 23 base pairs upstream from the 
transcription start site (TSS) of PIK3R1 and two sites, 4 and 6 base pairs, downstream of 
the TSS in FES. Additionally, FES had two differentially methylated sites located within 
exon regions and, PIK3R1 had one site located within the first intron of the gene. 
Expression of these genes was not affected by LPS stimulation. 
A gene that encodes a TNF superfamily member ligand, TNFSF13 also known 
as APRIL, also showed significantly lower expression in young cultures at 0 and 8 hours 
post LPS stimulation (2.0 and 2.8-fold, P<0.05), with a trend towards significantly lower 
expression at 2 hours (1.6-fold, P<0.10), but was not affected by LPS stimulation. 
TNFSF13 had one differentially methylated site in the gene promoter region, 145 bases 
upstream from the TSS in the anti-sense position and directly downstream from a site on 
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the positive strand with 93% sequence similarity to the consensus NF-κB binding site. 
The gene, NFATC1, which encodes an LPS responsive transcription factor, had 
significantly lower expression in young versus old cultures at 0 and 2 hours post LPS 
stimulation, with both time points showing a 1.8-fold (P<0.05) lower expression in young 
cultures. Expression of NFATc1 also increased 17.5 +/- 5.6-fold 2 hours post LPS 
stimulation, with no difference in fold change between young and old cultures. By 8 
hours post-challenge, expression returned to near basal levels. The NFATC1 gene had one 
differentially methylated site located within a CpG island in the promoter region, 
approximately 1000 bp upstream from the TSS and downstream of a potential Sp1 
binding site. Two additional differentially methylated sites were located within the last 
intron of the NFATC1 gene.  
The only selected gene that did not have differences in promoter methylation, 
RORA, had 6 differentially methylated sites located in the first intron of the gene. Gene 
expression analysis showed significantly lower levels of expression in young versus old 
cultures at 8 hours post LPS treatment (2.1-fold, P<0.001) with no change in response to 
LPS.  Finally, we measured TCF7, the gene that transcribes the transcription factor 
TCF7, that had 2 differentially methylated sites located within a CpG island in the 
promoter region. The first CpG was located approximately 1200 bp upstream from the 
TSS and near to a potential NFAT5 binding site, and the second CpG was approximately 
979 bp upstream from the TSS on the anti-sense strand. Interestingly, no significant 
expression differences were detected in young versus old cultures. However, there was a 
small increase in gene expression of TCF7 in response to LPS. Expression was increased 
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2.3 +/- 0.7-fold and 2.7 +/- 0.9-fold at 2 and 8 hours, respectively, with no difference 
between young and old cultures.  
2.4.6 Gene Expression of Differentially Methylated Genes in Angus vs. Holstein 
Fibroblast Cultures  
Finally, we wanted to determine whether differentially methylated genes 
identified in young versus old cultures would differ in expression in a second high vs. 
low LPS responsive cattle phenotype recently discovered in our laboratory. Just as with 
the age difference, we have shown that dermal fibroblasts collected from the Holstein 
breed are much more responsive to LPS than fibroblasts collected from the Angus breed 
(Benjamin et al., 2016a). To determine whether similar gene expression differences could 
be detected between breeds, RT-qPCR was performed on age-matched dermal fibroblast 
cultures at 0, 2 and 8 hours post-LPS treatment. Greater LPS-induced IL-8 and IL-6 
protein production and gene expression in Holstein vs. Angus cultures have been 
described elsewhere (Benjamin et al., 2016a). 
Gene expression analysis was performed on the same 6 genes that were 
differentially methylated in the young versus old fibroblast cultures, where young 
cultures had greater methylation and, with the exception of TCF7, lower expression. As 
shown in figure 2.4 and summarized in Table 2.5, the majority of the genes were 
similarly upregulated in Holstein cultures as they were in older cultures. Two notable 
exceptions to the pattern seen in our young versus old analysis were in TNFSF13, where 
no difference was measured in Angus versus Holstein cultures, and in TCF7, which was 
upregulated in Holstein cultures at 0 and 8 hours post LPS treatment. Under basal 
conditions, Holstein cultures expressed TCF7 4.5-fold (P<0.01) higher than Angus 
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cultures and at 8 hours post LPS TCF7 expression was 4.3-fold (P<0.05) higher in 
Holstein cultures. Interestingly, at 2 hours post LPS treatment, Angus cultures increased 
TCF7 gene expression 5-fold, while Holstein cultures only increased expression 2-fold. 
This fold increase at 2 hours was significantly higher in Angus cultures (P<0.05) as 
compared to Holstein cultures, although Holstein cultures did have a significantly 
(P<0.05) higher level of expression at 2 versus 0 hours. While Holstein cultures 
continued to maintain elevated expression of TCF7, Angus cultures had started to return 
to basal levels of expression at 8 hours post LPS, although expression was still 
significantly higher (P<0.05) than without treatment.  
 Similar to old cultures, Holstein cultures had significantly (P<0.05) higher 
expression of FES at 0 and 2 hours post LPS treatment, with expression levels being 3.7 
and 5.4-fold higher, respectively, and a trend (4.8-fold, P<0.10) towards higher 
expression in Holstein cultures at 8 hours post LPS. PIK3R1 also had higher levels of 
expression (P<0.01) 2 hours post-LPS treatment in Holstein cultures. This difference was 
due to a significant (P<0.01) 4-fold decrease in PIK3R1 gene expression in Angus 
cultures that was not detected in Holstein cultures. By 8 hours post LPS treatment, 
PIK3R1 expression returned to near-basal levels in Angus cultures.  
Most noteworthy was the gene NFATC1, which showed a very similar gene 
expression pattern between breeds as was seen in the age difference. Both Angus and 
Holstein cultures significantly increased their expression of NFATc1 at 2 hours post LPS 
treatment (30-fold and 12-fold respectively), with Holstein cultures having a 6.5-fold 
higher (P<0.01) level of expression over Angus cultures at 2 hours post LPS. Holstein 
cultures also trended towards greater expression (2.2 and 1.7-fold, P<0.10) at 0 and 8 
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hours post-LPS.  By 8 hours post LPS, both breeds returned to basal levels of expression. 
Finally, RORA had higher (P<0.01) levels of expression in Holstein cultures at 0 and 2 
hours post LPS treatment. At 0 hour, Holstein cultures had a 2.2-fold higher level of 
expression and at 2 hours they had a 2.0-fold higher level of expression. No LPS 
treatment effect was detected. 
2.5. Discussion 
An increase in the systemic production of pro-inflammatory mediators has been 
well characterized as a component of the aging process, heightening the risk of 
cardiovascular, neurodegenerative and other diseases in humans. This process, coined by 
Franceschi et al.,(Franceschi et al., 2000) as “inflamm-aging”, is highlighted by increased 
concentrations of serum TNF-α, IL1-ß and IL-6 along with acute phase proteins, such as 
C reactive protein (Franceschi et al., 2000, Baylis et al., 2013). To determine the potential 
mechanism behind an increase in chronic inflammation associated with age, both in 
healthy aging individuals and during the diseased state, regulation of pro-inflammatory 
gene expression by DNA methylation has been widely studied.  
A substantial decrease in methylation at a single CpG site in the promoter of the 
IL6 gene was measured in patients with rheumatoid arthritis versus healthy controls. In 
the same study, ranking of healthy control macrophages in response to LPS showed that 
an increase in LPS-induced IL-6 production was correlated with a decrease in IL6 
promoter methylation (Nile et al., 2008). Epigenetic regulation of another pleiotropic pro-
inflammatory cytokine gene, TNF, has been similarly described. In comparison to healthy 
controls, patients with previous exposure to the Dengue virus have higher blood TNF-α 
expression with a concomitant decrease in promoter methylation (Gomes et al., 2016). 
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DNA methylation changes have also been reported to occur in TNF in humans as part of 
the natural aging process. Macrophages obtained from 78 healthy individuals showed a 
1.4% per decade decrease in three 5’ CpG motifs located within the TNF promoter 
(Gowers et al., 2011). Increased methylation of TLR4, the key TLR in response to LPS, 
has also been shown in the context of intestinal epithelial homeostasis, whereby intestinal 
epithelial cells are made tolerant to stimulation by commensal microbiota through down-
regulation of TLR4 to avoid continuous inflammation (Takahashi et al., 2009). In that 
study, a comparison between a high responding and a low responding intestinal epithelial 
cell line showed that the lower responding cells not only exhibit decreased expression but 
also enhanced methylation in 11 CpG sites in the gene promoter of the TLR4 gene. 
Furthermore, inhibition of DNA methylation with AZA treatment in these two cell lines 
abolished the difference in TLR4 expression, further establishing a causal role for DNA 
methylation in the regulation of TLR4 (Takahashi et al., 2009). 
Research on epigenetic regulation of the immune response in livestock species 
has been somewhat more limited. However, it has been shown that in response to LPS 
treatment, bovine PBMCs decrease expression of methylation and histone deacetylation 
enzymes, suggesting LPS treatment may result in lower gene methylation and increased 
histone acetylation (Doherty et al., 2013). The effects of Mycobacterium bovis infection 
on global DNA methylation and gene expression have also been reported in bovine CD4+ 
T-cells, whereby, DNA methylation was negatively correlated with expression of 
interferon-γ (IFNG) and a gene that encodes the OX-40 receptor (TNFRSF4). The two 
genes, IFNG and TNFRSF4, are involved in T-cell response and proliferation, 
respectively, and provide one potential mechanism that contributes to the shift from Th1 
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to Th2 T-cell response following bovine tuberculosis infection (Doherty et al., 2016). 
Epigenetic mechanisms have also been shown to play a role in the hepatic expression of 
TLR4, lipopolysaccharide binding protein (LBP) and haptoglobin in response to E. coli 
mastitis. Chromatin de-compaction and increased expression of key innate response 
genes, LBP, HP, TLR2 and TLR4 occurs in liver biopsies following an intra-mammary 
challenge with E. coli. In TLR4, the chromatin changes are also correlated with promoter 
de-methylation (Chang et al., 2015a). In a similar study that assessed the effects of 
feeding a high concentrate diet to induce sub-acute ruminal acidosis (SARA), chromatin 
de-compaction and expression of these innate response genes was again increased in liver 
biopsies with subsequent DNA de-methylation seen in all four genes. Presumably, these 
changes were a result of greater concentrations of LPS found in the rumen, and hepatic 
and portal veins of cows experiencing SARA (Chang et al., 2015b).  
To elucidate the underlying causes of differences in innate response to mastitis 
causing pathogens, we have taken advantage of two phenotypes with clear response 
differences, age and breed, where fibroblasts from older versus younger animals (Green 
et al., 2015), and Holstein versus Angus animals (Benjamin et al., 2016a), have much 
higher in vitro responses. The age-dependent difference in response has also been shown 
to be at least partially mediated by epigenetic mechanisms. Inhibition of DNA 
methylation and histone deacetylation in fibroblasts isolated from the same animal at 5- 
and 16-months of age abolishes differences in in vitro cytokine production, suggesting 
methylation, chromatin modifications, or both contribute to the age-dependent increase in 
response (Green and Kerr, 2014). To determine which genes are regulated by DNA 
methylation, methylated CpG island recovery assay or MIRA-seq, was previously 
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performed on both the age and breed phenotypes following RNA-seq analysis. 
Unfortunately, this technique, which utilizes the protein complex MBD2b-MBD3L1 
complex to enrich for methylated regions within the genome, has only moderate 
resolution (~500 bp), and few differences were detected in both phenotypes that fell 
within gene regions, while none of these differences were detected in regions with a role 
in the innate response. Since it is known that small changes in methylation can be 
effective in changing gene expression, it was necessary to utilize a more sensitive 
technique, such as was performed in the current study.   
2.5.1 Methylation Differences in 5- versus 16-month Dermal Fibroblasts  
Reduced representation bisulfite sequencing was performed on fibroblasts taken 
from 5- and 16-month old heifers that had significantly different IL-8 and IL-6 protein 
production and gene expression. This analysis revealed 14,094 differentially methylated 
CpG sites. Approximately two-thirds of these sites were more methylated in younger 
cultures, consistent with previous data suggesting global hypo-methylation in older 
individuals (Bacalini et al., 2014, Marttila et al., 2015). The transcription factor, NF-κB, 
which is a major activator of pro-inflammatory gene expression downstream of a number 
of pattern recognition receptors and TNF-associated receptors (van Delft et al., 2015), 
was identified as significantly associated with hyper-methylated promoter regions in 
young cultures. This suggests that increased methylation in young cultures may block 
NF-κB binding sites, reducing transcription of pro-inflammatory genes. Blocking of NF- 
κB gene transcription by DNA methylation has been shown to occur in patients with 
secondary acute myeloid leukemia (sAML), where hematopoietic progenitor cells fail to 
express Fas receptor, an activator of apoptosis. The FAS gene was shown to contain 3 
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canonical NF-κB binding sites and increased methylation in bone marrow blast cells from 
patients with sAML as compared to those with low-risk myelodysplastic syndrome 
whose Fas expression remains intact. In addition, re-expression of Fas occurred in sAML 
patients upon de-methylation with AZA (Ettou et al., 2013). Although only identified in 
our suggestive (≥5X coverage) analysis, the transcription factor, cAMP regulated binding 
protein (CREB), was also associated with gene promoters more methylated in young 
cultures. Downstream of a wide variety of serine-threonine kinases (such as PKA, PKC, 
and p38 MAPK) CREB regulates a multitude of processes, including the innate immune 
response (Wen et al., 2010). Recently, CREB has been shown to mediate TNF-α 
dependent GM-CSF production in primary asthmatic lung fibroblasts and human fetal 
lung fibroblasts (Koga et al., 2016). CREB also increases LPS and TLR4 dependent IL-6 
production in vascular smooth muscle cells which may contribute to the vascular 
inflammation seen in atherosclerosis (Lee et al., 2016).  
In older cultures, transcription factor binding sites for Sp1, p300, and ATF were 
enriched in hyper-methylated genes. Numerous genes contain Sp1 binding sites, which 
are located in GC-rich regions often regulated by DNA methylation. Somewhat 
contradictory to our hypothesis, Sp1 does up-regulate expression of some innate response 
genes. In intestinal epithelial cells, basal expression of TLR5 is regulated by Sp1. 
Interestingly, inducible expression of TLR5 is also partially mediated by p300, in 
agreement with our results that both Sp1 and p300 regulated genes were hyper-
methylated in older cultures (Thakur et al., 2016). Alternatively, in response to LPS, Sp1 
enhances macrophage transcription of IL-10, a key anti-inflammatory cytokine (Wang et 
al., 2014). ATFs are members of the activating transcription factor/cAMP responsive 
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element binding protein (ATF/CREB) family of transcription factors. It was not clear 
with DAVID analysis which of the family members were enriched in regulation of the 
genes more methylated in older cultures, however, analysis of just the 106 genes 
regulated by ATF showed that 62 were regulated by ATF6. ATF6 is a key transcription 
factor that is activated under ER stress and mediates the unfolded protein response. 
Again, contrary to our data, ER stress contributes to inflammation during an infection 
with Brucella abortis in a NOD1/NOD2 dependent manner, and the unfolded protein 
response has been shown to strengthen NF-κB dependent inflammation (Mohammed-Ali 
et al., 2015, Keestra-Gounder et al., 2016). However, other ATFs, such as ATF3, have 
been shown to have the opposite effect and reduce inflammatory gene expression (Labzin 
et al., 2015).  Furthermore, when additional stringency was applied to the TFBS analysis 
to include only genes that contained differentially methylated sites with ≥10X coverage, 
we failed to identify any transcription factors associated with genes hyper-methylated in 
old cultures, unlike what was found in young cultures. An additional caveat to the 
transcription factor binding data used in the current study is that conclusions were drawn 
on sequence conservation found between human and rodent alignments. Sequence 
conservation does not necessarily result in transcription factor binding and regulation and 
whether enrichment of the identified transcription factors regulate cellular response 
differences to LPS in a methylation-dependent manner would need to be validated in our 
model.  
2.5.2 Gene Expression Analysis of Differentially Methylated Genes  
Methylation of DNA is most known for its role in repressing gene transcription. 
To determine if the measured methylation differences had any effect on gene expression, 
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we chose six genes that exhibited higher methylation in young cultures for RT-qPCR 
analysis. We hypothesized these six genes would have lower expression in the young 
cultures due to their increased methylation status. We chose the following six genes for 
their potential role in the innate response: TNFSF13, PIK3R1, NFATC1, FES, TCF7 and 
RORA. The TNF superfamily 13, or APRIL, protein is a surface or secreted ligand 
recognized by the transmembrane activator and calcium-modulating cyclophilin ligand 
interactor (TACI) and B-cell maturation antigen (BCMA) receptors and has been 
implicated in the pathogenesis of numerous pro-inflammatory conditions such as 
rheumatoid arthritis (Weldon et al., 2015), atherosclerosis (Sandberg et al., 2009), lupus 
(Salazar-Camarena et al., 2016) and psioriasis (Alexaki et al., 2012). Moreover, APRIL 
has been shown to activate NF-κB dependent cytokine production in macrophages (Lee et 
al., 2011) and keratinocytes (Alexaki et al., 2012). In our analysis, fibroblast expression 
was significantly up-regulated in older cultures at 0 and 8 hours post LPS treatment as we 
expected. The single site hyper-methylated in young cultures was located near to the 
consensus NF-κB binding sequence, 5′-GGGRNYY YCC-3′. However, since expression 
of the gene did not increase after LPS treatment and was already up-regulated under basal 
conditions, it is unlikely NF-κB regulates its transcription in response to LPS.  
The gene, PIK3R1, transcribes the p85α subunit of phosphoinositide 3-kinase 
(PI3K), a lipid kinase that phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) 
to phosphatidylinositol 3,4,5-trisphosphate (PIP3). The p85α subunit is a regulator of 
kinase activity, whereby it is thought to inhibit PI3K activity under most circumstances 
(Cheung et al., 2015). Interestingly, in a murine model of polymicrobial sepsis, inhibition 
of the PI3K pathway increased serum IL1-β, IL-6 and TNF-α levels, and decreased the 
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survival rate of septic mice (Williams et al., 2004). Alternatively, pharmacological 
activators of PI3K signaling have recently been suggested as anti-inflammatory drug 
candidates (Kok and Saez, 2014). However, the role of PI3K in inflammation is complex, 
since kinase activity can also activate leukocytes and is further complicated by the 
existence of multiple isoforms of PI3K with a variety of physiological functions 
(Hawkins and Stephens, 2015). In our model, PIK3R1 expression was up-regulated in 
older cultures at all 3 time points post LPS with a fairly consistent fold change of 2.5 – 
3.0-fold. A single CpG site in the promoter region was more highly methylated, only 23 
base pairs from start site of the gene, potentially interfering with the progression of the 
RNA polymerase enzyme complex. 
 Nuclear factor of activated T-cells, calcineurin dependent 1 (NFATc1), the gene 
product of NFATC1, is a calcium dependent transcription factor that is necessary for 
lymphocyte development and is expressed in a number of other cell types such as 
dendritic cells (Zanoni et al., 2009), macrophages (Yarilina et al., 2011) and endothelial 
cells (Suehiro et al., 2010), and is responsible for mediating TLR4 independent, CD14 
dependent pro-inflammatory gene expression in response to microbial agonists, such as 
LPS. Interestingly, the NFATC1 gene is less methylated and more expressed in 
individuals with lower socioeconomic status which is a known risk factor for increased 
inflammation that can lead to pathologies such as type II diabetes (Stringhini et al., 2015, 
Stringhini et al., 2016). In our study, NFATc1 was induced following LPS stimulation in 
both young and old fibroblasts, further solidifying its role as an LPS-responsive 
transcription factor. In the promoter, the differentially methylated CpG was located 
directly downstream of a Sp1 binding site that has been shown in numerous recent studies 
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to bind at lower levels with increased DNA methylation status (Gopisetty et al., 2013, 
Zhang et al., 2014, Cai et al., 2016). In addition, two other sites were located in the last 
intron of the gene. This is of interest because an enhancer element within the last intron 
of the NFATc1 gene that activates transcription to an even greater extent than the 
promoter region of the gene has been identified using human lymphocytes (Rudolf et al., 
2014).  
Feline sarcoma oncogene (FES) is a non-receptor tyrosine kinase that, in 
humans, stimulates hematopoiesis, osteoclastogenesis, and mast cell activation (Hellwig 
et al., 2012). It is worth mentioning that both FES and PI3K activate mast cells through a 
similar SCF-c-Kit-integrin pathway, and the two proteins have been speculated to interact 
with one another through tyrosine phosphorylation of PI3K by FES (Tan et al., 2003, 
Smith et al., 2010). As with PIK3R1, FES kinase expression was also similarly up-
regulated at all time points in older cultures while younger cultures had two hyper-
methylated sites near to the transcriptional start site which again may interfere with 
transcriptional elongation by RNA polymerase.  
Transcription factor 7 (TCF7), transcribed from the gene TCF7, is a 
transcription factor that is crucial to the proper development of T-cells in the thymus, but 
has been shown to inhibit the development of regulatory T-cells, or Tregs, which 
suppress inflammation and aid in the resolution of infection (Barra et al., 2015). Although 
several methylation differences were detected within the promoter region of TCF7, no 
difference in expression was measured in fibroblasts either basally or post LPS. There are 
a couple of possible explanations for this discrepancy. Methylation itself may not be 
sufficient to repress expression and it is likely an over-simplification to assume 
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methylation always leads to repression. For example, in a study assessing the relationship 
between methylation and gene transcription in the blood of 148 healthy human subjects, 
the authors found that 276 of 798 local associations were actually positively associated, 
where less methylation led to less transcription or more methylation led to more 
transcription (van Eijk et al., 2012). Other factors, such as histone modifications and 
transcription factors that also have an effect on transcription should be taken into 
consideration as they can override any differences in methylation as has been shown in 
the differentially imprinted gene IGF2R (Vu et al., 2004). Lastly, it is possible that splice 
variants of TCF7 exist that exhibit differential expression in our samples but were not 
measured in our RT-qPCR analysis.    
Finally, RORA, or retinoic acid related (RAR) orphan receptor alpha, belongs to 
a family of nuclear receptor transcription factors (RORs) that have known roles in the 
innate and adaptive immune response, circadian rhythm, and metabolic regulation, 
among others (Cook et al., 2015). Specifically, RORA is required for the development of 
type II innate lymphoid cells and mice lacking the gene experience reduced eosinophil-
mediated lung inflammation in response to allergens (Halim et al., 2012) and are less 
susceptible to obesity induced inflammation in response to a high fat diet (Kang et al., 
2011). We detected a small, but significant increase in RORA expression in older 
fibroblasts at 8-hours post LPS. In this case, we identified 6 methylation differences all 
within first intron of the gene, which can contain enhancer elements for gene activation 
(Blattler et al., 2014).  
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2.5.3 Expression of Differentially Methylated Genes in Angus versus Holstein 
Fibroblasts 
In our final experiment, we wanted to determine whether similar expression 
differences could be detected in another high-low response phenotype, a breed difference 
identified in our lab that shows the Holstein breed having a much higher in vitro response 
as compared to the Angus breed (Benjamin et al., 2016a). Genes similarly up-regulated in 
Holsteins might suggest a conserved mechanism of regulation, such as DNA methylation 
or other epigenetic modifications. This of particular interest in the breed difference as 
these two breeds are not only genetically selected for divergent purposes but also 
experience highly dissimilar neonatal environments, leaving room for possible 
environmental interventions. Many studies have shown that neonatal nutrition, maternal 
care, and exposure to immune agonists can shape an individual’s adult epi-genotype, and 
all three of these environmental influences differ between Holstein and Angus calves. 
Angus calves are maternally cared for in a pasture setting, drink milk from their dam, and 
are exposed to a variety of maternally-derived commensal and environmental microbes in 
contrast to Holstein calves that are raised individually without maternal contact, fed milk 
replacer, and are housed in a considerably more defined environment.  
Expression analysis of fibroblasts isolated from the two breeds showed some 
similar differences to our age-dependent differences. In the high responding Holstein 
breed, FES, NFATC1, RORA, and to a lesser extent PIK3R1, were up-regulated. 
Additionally, TCF7 was up-regulated, a difference not detected in the young-old culture 
comparison. This discrepancy may indicate a genetic difference as a result of selection 
for different traits (beef versus dairy) between Angus and Holstein breeds. No difference 
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was measured in TNFSF13, suggesting the loss of methylation is unique to the aging 
process. Most noteworthy of the differentially expressed genes were FES and NFATC1. 
These two genes showed an identical pattern of up-regulation in Holstein cells as was 
seen in older cells, indicating they may be similarly regulated. However, additional 
experiments with the Holstein and Angus cultures would be necessary to confirm whether 
expression differences are due to differences in methylation or other epigenetic factors, 
genetic differences, or a combination of factors. Expression of FES is up-regulated 
basally in both high response phenotypes, making it a candidate biomarker for selection 
strategies, which would require a rapid test without the need of culturing cells and 
treating with LPS. Additionally, NFATC1 is of interest due to its role in the response to 
LPS and as a known contributor to many pro-inflammatory pathologies. Future studies 
assessing methylation differences in Angus and Holstein breeds are underway and should 
provide insight into how this phenotype is regulated.  
One limitation of the current study was that the RRBS technique does not allow 
for a comprehensive methylation analysis and as a result many CpG sites are missed. 
This may be one reason why we failed to identify methylation differences in classic LPS 
response genes that show similar up-regulation of expression in both high responding 
phenotypes. Targeted bisulfite sequencing of candidate genes, such as TLR4 and IL8, will 
be the subject of future experiments to determine whether methylation may influence 
expression of genes that directly mediate LPS response.  
2.6. Conclusions  
Overall, the current study has shown that many sites differ in their methylation 
status in young versus old cultures, with the majority of sites becoming less methylated 
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as the animals increased in age. Candidate innate response genes that were hyper-
methylated in young cultures also exhibited lower expression in most instances, 
indicating methylation may suppress expression in younger cultures making them less 
responsive to TLR agonists, such as LPS. Expression analysis in a second high-low 
response phenotype, Angus versus Holstein fibroblasts, identified two genes (FES and 
NFATC1) that showed an identical response pattern as the young and old cultures. These 
two genes may be useful as candidate biomarkers for predicting whether an animal will 
have a high or low response phenotype, and subsequently, whether she is susceptible to 
severe mastitis. In conclusion, knowledge of critical changes in methylation that 
increases the magnitude of inflammatory response within an individual may allude to the 
mechanisms of between-individual variation in the innate response. This is particularly 
important in diseases where an unregulated innate response contributes to the pathology 
of the disease, such is the case in bovine mastitis.  
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Table 2.1: Suggestive Transcription Factor Enrichment of Gene Promoters More 
Methylated in Young Cultures. 
Category Term Count* Fold Enrichment** FDR***  
UCSC_TFBS PAX5 288 1.32 4.35E-09 
UCSC_TFBS LMO2COM 297 1.31 6.04E-09 
UCSC_TFBS P53 321 1.25 2.23E-08 
UCSC_TFBS EGR3 111 1.77 5.34E-08 
UCSC_TFBS AP2 148 1.57 1.04E-07 
UCSC_TFBS NMYC 174 1.48 1.57E-07 
UCSC_TFBS ARNT 243 1.33 2.26E-07 
UCSC_TFBS NRSF 265 1.29 3.42E-07 
UCSC_TFBS MYCMAX 302 1.23 8.19E-07 
UCSC_TFBS NFKB 246 1.30 1.43E-06 
UCSC_TFBS AHRARNT 259 1.28 1.49E-06 
UCSC_TFBS CREB 218 1.33 1.79E-06 
UCSC_TFBS E47 290 1.23 2.99E-06 
UCSC_TFBS COUP 209 1.33 5.73E-06 
UCSC_TFBS TAXCREB 262 1.25 6.31E-06 
*Number of inputted genes regulated by transcription factor listed.  
 **Fold enrichment as measured by Fisher’s Exact Test.  










Table 2.2: Suggestive Transcription Factor Enrichment of Gene Promoters More 
Methylated in Old Cultures. 
 
 
*Number of inputted genes regulated by transcription factor listed.  
 **Fold enrichment as measured by Fisher’s Exact Test.  















Category Term Count* Fold Enrichment** FDR*** 
UCSC_TFBS PAX5 187 1.43 8.40E-10 
UCSC_TFBS SP1 95 1.73 1.66E-06 
UCSC_TFBS ATF 113 1.58 3.02E-06 
UCSC_TFBS NRSF 165 1.35 9.59E-06 
UCSC_TFBS MIF1 136 1.43 1.06E-05 
UCSC_TFBS P300 124 1.47 1.09E-05 
UCSC_TFBS ZID 150 1.38 1.14E-05 
UCSC_TFBS SREBP1 178 1.28 4.10E-05 
UCSC_TFBS MYOGNF1 145 1.35 6.27E-05 
UCSC_TFBS TAXCREB 162 1.30 8.37E-05 
UCSC_TFBS ZIC3 123 1.41 8.80E-05 
UCSC_TFBS MZF1 147 1.33 9.46E-05 
UCSC_TFBS AHRARNT 158 1.31 9.57E-05 
UCSC_TFBS HMX1 139 1.34 1.39E-04 
UCSC_TFBS TAL1BETAITF2 158 1.29 1.50E-04 
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Table 2.3: Conserved Transcription Factor Enrichment of Gene Promoters More 












*Number of inputted genes regulated by transcription factor listed.  
 **Fold enrichment as measured by Fisher’s Exact Test.  























Category Term Count* Fold Enrichment** FDR*** 
UCSC_TFBS P300 49 1.67 0.007 
UCSC_TFBS TAL1BETAITF2 60 1.40 0.024 




UCSC_TFBS P53 69 1.29 0.028 
UCSC_TFBS COUP 48 1.46 0.031 
UCSC_TFBS NFKB 56 1.42 0.032 
UCSC_TFBS EGR3 25 1.92 0.032 
UCSC_TFBS AP2 35 1.78 0.032 
UCSC_TFBS AP2GAMMA 18 2.19 0.040 
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Table 2.4: Summary of Selected Innate Response Genes Hyper-Methylated in 
Young Cultures. 
 
*Number of differentially methylated CpGs (P<0.05, >25% meth diff). 
**Displayed as fold change at 0, 2 or 8 H post LPS. Positive values indicate (Old > 
Young) or (Holstein >Angus), negative values indicate (Young > Old) or (Angus > 
































at 0, 2, & 8 H 
post LPS**  
FES 2 Promoter, 
Exon 
5.7, 4.3, 6.3 3.7, 5.4, 4.8 
NFATc1 3 Promoter, 
Intron  
1.8, 1.8, --- 2.2, 6.5, 1.7 
PIK3R1 2 Promoter, 
Intron  
3.0, 2.6, 2.5 ---, 2.4, (-1.9)  
RORA 5 Intron  ---, ---, 2.1  2.0, 2.2, --- 
TNFSF13 1 Promoter 2.0, 1.6, 2.8 ---, ---, ---  
TCF7 2 Promoter  ---, ---, ---  4.5, ---, 4.3  
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Figure 2.1: Fibroblast Response to LPS in Young versus Old Cultures. 
 
Interleukin-8 (A & C) and Interleukin-6 (B & D) protein production and gene expression 
were measured in young and old dermal fibroblasts (n = 6 per group) at various time 
points post LPS. Protein production is presented in pg/ml following 36 hours of LPS 
stimulation. Gene expression was measured by RT-qPCR and is presented as the change 
in cycles to threshold (dCT) of gene expression at 0, 2 & 8 hours post LPS in comparison 
to β-actin. Fold change gene expression (Old>Young) is presented in parentheses above 
each significant time point. All values are displayed as mean (+/- SEM). Significance was 







Figure 2.2: RRBS Project Workflow 
Prior to methylation analysis, 6 pairs of fibroblasts isolated from the same animals at 5- 
and 16-months of age were selected and challenged with LPS for 0, 2, 8 and 36 hours to 
measure cytokine protein and gene expression. In preparation for RRBS, fibroblast DNA 
was digested with MSPI to enrich for CpG rich regions of the genome, followed by end-
repair and Poly-A tail addition. The digested DNA was then ligated to Illumina primers, 
size selected and bisulfite converted prior to sequencing. The subsequent reads were 
quality controlled by FastQC and Illumina adaptors were trimmed with TrimGalore. 
Those that passed quality control were then aligned to the BosTau8 genome and uniquely 
mapped reads were kept for analysis with a paired T test at each CpG site with greater 
than or equal to 5X coverage. Once differentially methylated sites were identified, 
clustering analysis was performed on the top 100 sites based on p-value. Functional 
analysis to identify enriched KEGG pathways, GO terms and transcription factors was 




Figure 2.3: Gene Expression post LPS treatment of Selected Differentially 
Methylated Genes in Young and Old Fibroblast Cultures. 
 
Expression of six genes more methylated in young cultures A) PIK3R1, B) FES, C) 
TNFSF13, D) NFATC1, E) TCF7 and F) RORA were measured in young and old 
fibroblasts (n = 6 per group) at 0, 2 and 8 hours post LPS. Expression was measured by 
RT-qPCR and values are presented as dCT in comparison to β-actin. Fold change gene 
expression (Old>Young) is displayed in parentheses above each significantly different 
time points. All values are displayed as mean (+/- SEM). Significance was determined 
using a paired Student’s t Test at each time point post LPS treatment and *** = P < 






Figure 2.4: Gene Expression post LPS Treatment of Selected Genes from RRBS 
Analysis in Angus and Holstein Fibroblast Cultures. 
 
Expression of six genes more methylated in young cultures, A) PIK3R1, B) FES, C) 
TNFSF13, D) NFATC1, E) TCF7 and F) RORA were measured in fibroblasts isolated 
from 19-month Angus and Holstein cows at 0, 2 and 8 hours post LPS. Expression was 
measured by RT-qPCR and values are presented as dCT in comparison to β-actin. Fold 
change gene expression is displayed in parentheses above each significantly different 
time point, whereby positive values indicate Holstein>Angus and negative values 
indicate Angus>Holstein. All values are displayed as mean (+/- SEM). Significance was 
determined using an unpaired Student’s t Test at each time point post LPS treatment and 
** = P<0.01, * = P < 0.05, † = P < 0.10.  
 
Additional files for Chapter 2 can be accessed on NCBI’s gene expression omnibus 
(GEO) website through GEO accession number GSE91088. 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE91088 
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CHAPTER 3: VARIATION IN FIBROBLAST EXPRESSION OF TLR4 AND 
LPS-INDUCED CYTOKINE PRODUCTION BETWEEN-ANIMALS PREDICTS 
CONTROL OF BACTERIAL GROWTH BUT NOT SEVERITY OF 
ESCHERICHIA COLI MASTITIS  
3.1 Abstract  
Mastitis cases caused by environmental pathogens, such as Escherichia coli (E. 
coli) are highly problematic to the dairy industry because milk producers incur substantial 
cost and the disease tends to be difficult to manage. An effective innate immune response 
by the host is key to controlling infection, but it should also limit collateral damage to the 
mammary gland. Between-animal differences in mastitis severity have been attributed to 
variability in the innate response. In the current study, the primary dermal fibroblast was 
used as a model to rank animals based on composite expression of toll-like receptor 4 
(TLR4) and lipopolysaccharide (LPS)-induced IL-8 and IL-6 protein production. Animals 
ranked as high and low were then infected in the mammary gland with the P4 strain of E. 
coli to determine how difference in rank would affect response to mastitis. All animals 
developed an acute response to the infection with varying degrees in severity, however, 
high responders had an elevated somatic cell count and fever response at 12-hrs. post 
infection and higher quantities of milk IL-8 at 24-hrs. post infection. High responding 
animals were also significantly more capable of limiting bacterial growth. No differences 
were measured in post-infection milk production or tissue damage. The current study 
indicates that high responding animals have an early up-regulation in their innate 
response that is beneficial for bacterial clearance, however they are still equally 
susceptible to tissue damage caused by an exuberant response to the infection. The 
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dermal fibroblast can be used in conjunction with other cell types to determine how the 
innate response is regulated to mitigate unnecessary injury to the mammary gland while 
still effectively clearing the pathogen.  
Keywords: LPS; experimental mastitis; dairy cow; innate immunity  
 
3.2 Introduction  
Infection of the mammary gland with Escherichia coli (E. coli), a common 
opportunistic pathogen found within the dairy cow environment, causes clinical mastitis 
that ranges from mild to severe.  Although infections are typically transient and self-
limiting, host response to the pathogen causes damage to milk-producing epithelial cells 
that results in a substantial decrease in milk production and quality. In addition to lower 
milk production and non-saleable milk, direct costs, such as veterinary care, and indirect 
costs, such as early culling, contribute to mastitis-related economic losses that altogether 
cost the producer approximately $450 per clinical case of mastitis occurring within the 
first 30 days of lactation (Rollin et al., 2015). Treatment of E. coli mastitis with 
antibiotics has shown very limited benefit (Lago et al., 2011b, a, Vasquez et al., 2017) 
and, within the United States, effective treatments are restricted to hetacillin potassium, a 
broad-spectrum ß-lactam antibiotic, and ceftiofur, a third generation cephalosporin and a 
high priority drug for human diseases (Suojala et al., 2013); thus their use in animal 
agriculture is not generally recommended. Use of the current J5 vaccine against E. coli 
has shown a modest benefit in reducing severity of mastitis (Wilson et al., 2007), 
however, it does not significantly reduce the incidence of disease. Both the desire to 
reduce antibiotic usage and a lack of an efficacious vaccine has led to increased interest 
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in the selection of animals based on natural disease resistance, however, genes that 
contribute to resistance and susceptibility have remained relatively elusive. 
Physiological state of the host is known to affect mastitis severity and 
susceptibility, whereby early lactation, older age and increased parity are risk factors for 
mastitis (Steeneveld et al., 2008, Taponen et al., 2017). Differences in strain of E. coli 
may also contribute to variation in mastitis severity (Blum et al., 2017). It has been 
suggested that strains adapted to the mammary gland, called mammary pathogenic strains 
(MPEC), express virulence factors and more efficiently utilize nutrient sources that allow 
for improved survival within the mammary gland environment (Blum et al., 2015). 
However, a recent analysis comparing the gene sequences of eight MPEC strains versus 
six fecal commensal strains did not reveal enrichment of virulence determinants or fitness 
factors in strains isolated from bovine mastitis cases versus commensal organisms. 
Instead, the authors suggest that each individual strain contains unique strain-specific 
traits that enhance fitness and are the result of competition for resources associated with 
commensalism rather than pathogenicity (Leimbach et al., 2017).  In addition, 
experimental infections controlling for host variables, such as stage of lactation and 
parity, and with the same strain of E. coli, have shown that the severity of clinical 
mastitis is quite variable between animals (Lee et al., 2006), albeit to a lesser extent in 
primiparous cows (Vangroenweghe et al., 2004, Vangroenweghe et al., 2005a). 
Additional host factors, such as the genetic or epigenetic regulation of immunity, may 
help to explain variation in mastitis severity between animals that is independent of 
bacteria and other host factors.  
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Genetic predisposition to infectious disease, including mastitis, has been widely 
studied, but is complicated by the likely polygenic nature of this trait. In one study, using 
the estimated breeding values (EBV) of bulls based on daughter somatic cell score (SCS) 
as the primary risk factor for mastitis susceptibility, genetic polymorphisms in the gene 
region of osteopontin (SPP1) were shown to have an effect on SCS and presumably 
mastitis risk (Alain et al., 2009). In addition, a quantitative trait loci (QTL) on 
chromosome 18 is associated with resistance or susceptibility to mastitis. Interestingly, 
mammary epithelial cells that are isolated from animals with either the resistant or 
susceptible QTL also exhibit differences in the up-regulation and kinetics of numerous 
innate immune response genes in response to E. coli and S. aureus in vitro stimulation 
(Brand et al., 2011). Furthermore, genes that exhibit differences in DNA methylation 
have been identified in peripheral blood leukocytes isolated from cows with subclinical S. 
aureus mastitis versus uninfected cattle, and include three inflammatory response genes 
that are hypo-methylated and up-regulated in infected cattle (Song et al., 2016). The three 
aforementioned studies, among many others, emphasize the importance of the innate 
immune response to mastitis and seem to suggest that differences in innate immunity may 
determine mastitis resistance or susceptibility.   
In response to infection, the innate immune response is rapidly activated through 
the interaction of germ-line encoded pattern recognition receptors (PRR) with conserved 
microbial components. Toll-like Receptor 4 (TLR4) is the main PRR that is activated in 
response to Gram-negative bacteria, such as E. coli, as a result of its interaction with 
bacterial endotoxin, or LPS (Chow et al., 1999). Following recognition of LPS facilitated 
by co-receptors CD14 and MD2, TLR4 activates both a MyD88-dependent and -
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independent signaling cascade that allows transcription factors NF-κB, AP-1 and IRFs to 
up-regulate the transcription of inflammatory response genes, such as IL-8, IL-6, TNF-α, 
IL-1ß, and IFN-γ, among many others (Lu et al., 2008). To determine how innate 
immunity contributes to between-animal differences in response to mastitis-causing 
pathogens, we have developed a primary bovine dermal fibroblast model to assess the 
immune response of a large number of animals in cell culture prior to testing the in vivo 
response of selected animals to intra-mammary infection. The dermal fibroblast was 
chosen as a model cell for its repeatability of response (Kandasamy et al., 2011), ease of 
isolation and cryopreservation, and low activation at baseline. Furthermore, a comparison 
of model cell types including primary bovine epithelial cells, fibroblasts and 
macrophages showed that while both fibroblasts and epithelial cells distinguished 
between pathogen-specific immune responses, macrophages fail to make the distinction 
(Gunther et al., 2016b).  
Using this approach, we have previously ranked cohorts of adult Holsteins on 
fibroblast IL-8 production in response to LPS or PAM2CSK4 to mimic E. coli and S. 
aureus mastitis, respectively. Animals that were designated as high responders and low 
responders, based on high or low fibroblast IL-8 production, were then infected with the 
pathogen of interest. Both experiments showed that high responders had elevated tissue 
damage and somatic cell count within the mammary gland in response to infection. High 
responders challenged with E. coli also had a slower return to pre-infection milk 
production levels, and high responders challenged with S. aureus had significantly 
elevated milk IL-8. In either case, no difference was measured in bacterial clearance, 
suggesting that high responders do not benefit from the enhanced response and that the 
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innate response contributes to mammary gland tissue damage and lower milk production 
(Kandasamy et al., 2011, Benjamin et al., 2015b).  
To further characterize the high response phenotype and potentially identify 
genetic markers for severe mastitis susceptibility, the current experiment utilizes a multi-
variable approach to rank a cohort of adult Holsteins on LPS-induced fibroblast 
production of IL-8 and IL-6 and gene expression of TLR4. High and low responders were 
subsequently infected with E. coli to determine if fibroblast phenotype would accurately 
reflect the immune response within the mammary gland.  
3.3 Materials and Methods  
3.3.1 Ethics Statement 
All animal procedures performed in this experiment were approved by the 
Institutional Animal Care and Use Committee at the University of Vermont. Animals 
enrolled in the study were handled by authorized personnel approved by the 
aforementioned committee and all efforts were made to minimize animal suffering in 
accordance with IACUC standards. In particular, Banamine® was administered to animals 
that developed a febrile response of greater than 105.7 ºF (40.9ºC).  
3.3.2 Experimental Animals 
Adult Holstein cows were housed at a large (1,400 lactating cows), local 
collaborating dairy farm and 60 early lactation animals were selected to be included in 
the study. At the time of the initial skin sampling, all animals were in early lactation (78 
± 10 DIM) and were in their second or greater (2.9 ± 1.1) lactation. The 12 animals 
selected for the intra-mammary treatment with E. coli were transported to the University 
of Vermont’s Miller Research farm when they were in late lactation (238 ± 6 DIM). They 
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were housed in a tie-stall barn, fed a standard total-mixed ration ad libitum, and allowed a 
seven-day acclimation period prior to challenge. Selected cows were in their 2nd – 4th 
lactation.  
3.3.3 Dermal Fibroblast Isolation and Culturing   
Ear notches from 60 animals were collected over a 4-week period with 15 
animals sampled per week. The section of the ear to be sampled was clipped and shaved 
to remove hair and scrubbed three times, alternating between povidone iodine and 70% 
ethanol. After the last ethanol wash, a large v-cut ear notch was taken using an aluminum 
ear notcher (Model# WI-0002433, Livestock Concepts, Hawarden, IA), while carefully 
avoiding main arteries and vein. Ear notch samples were transported to the laboratory on 
ice in Dulbecco’s PBS (DPBS; Hyclone Laboratories, Logan, UT) containing a 1x 
antibiotic-antimycotic solution (1x AB/AM; 100 U/ml penicillin, 100 µg/ml streptomycin 
and 0.25 ug/ml of amphotericin B; Hyclone Laboratories). Tissue samples were then 
minced into smaller pieces using opposing scalpel blades and washed 4 times with fresh 
DPBS containing 1x AB/AM. After the last wash, 10 ml of Dulbecco’s modified Eagle 
medium (DMEM; Hyclone) containing 1x AB/AM and 0.5% collagenase type I enzyme 
(Gibco, Gaithersburg, MD) was added to each sample and samples were incubated 
overnight at 37°C with orbital shaking. The collagenase-digested tissue was then filtered 
with a 70 µM nylon mesh filter (Thermo Fisher, Pittsburgh, PA) and centrifuged at 1100 
x g for 5 minutes at room temperature. Supernatant was discarded and the cell pellet was 
reconstituted in DMEM containing 10% fetal bovine serum (FBS; Omega Scientific, 
Tarzana, CA), 1x insulin-transferrin-selenium (ITS; Gibco), and 1x AB/AM. Cells were 
cultured in a 25 cm2 flask in a humidified incubator containing 5% CO2 at 37°C until 
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reaching approximately 70% confluency. Cells were then detached using 0.25% trypsin 
(MP Biomedical, Santa Ana, CA) and transferred to a 75-cm2 flask with DMEM 
containing 5% FBS, 1x ITS, and 1x antibiotic only (1x AB; 100 U/ml penicillin and 100 
µg/ml streptomycin). Upon confluency, cells were trypsinized and split into three 75-cm2 
flasks. Confluent third passage cells were then trypsinized and transferred to DMEM 
containing 20% FBS, 1x ITS, 1x AB/AM, and 10% dimethyl sulfoxide (DMSO; Thermo 
Fisher). Cells were cryopreserved in liquid nitrogen for future experiments.   
3.3.4 Treatment of Dermal Fibroblasts with LPS and Heat-Killed E. coli 
Two fibroblast challenges were performed within the study. First, we challenged 
all 60 cultures with LPS to determine the initial ranking. Second, to compare the side-by-
side response of the animals that were selected for the intra-mammary E. coli treatment, 
we challenged fibroblasts from the 6 high-ranked and 6 low-ranked animals (see below) 
with LPS and heat-killed E. coli. In both challenges, cells were revived from 
cryopreservation into pre-warmed DMEM containing 5% FBS, 1x ITS, and 1x AB/AM, 
and cultured to confluency. Fourth passage cells were detached with trypsin and seeded 
in 6-well plates at a concentration of 7.5 x 104 cells/ml (challenge 1) or 1.25 x 105 
cells/ml (challenge 2) in a total volume of 2.0 ml. After a 24-hour incubation, media was 
removed and replaced with fresh media only (negative control), or with media containing 
either 100 ng/ml of ultra-pure LPS isolated from E. coli O111:B4 (Millipore Sigma, St. 
Louis, MO) or heat-killed E. coli strain P4 at an MOI of 10.  
To rank the whole cohort of 60 animals, cells were incubated for 24-hours in 
LPS and negative control media. To compare the 6 highs and 6 lows, cells were 
incubated for 0, 2, 8, and 24-hours with LPS and for 24-hours with heat-killed E. coli. 
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Media was collected from 0 hour cultures as the negative control. After 24-hours, 
challenge media was removed from all cells and stored at -20°C until further analysis. 
Cell lysate was also obtained by applying 800 µl of lysis buffer (PureLink™ RNA Mini 
Kit, Thermo Fisher) directly to the wells and stored at -80ºC until RNA extraction.  
3.3.5 Quantification of IL-8 and IL-6 Protein in Challenge Media  
Production of IL-8 in conditioned media was measured using a commercially 
available sandwich ELISA per manufacturer’s instructions with slight modifications 
(Mabtech, Cincinnati, OH). Capture antibody was diluted to a concentration of 1 µg/ml in 
0.05 M bi-carbonate buffer. Biotinylated detection antibody was diluted to 0.025 µg/ml in 
PBS-0.05% Tween-20. Streptavidin-horseradish peroxidase (Strep-HRP; Millipore 
Sigma) was diluted to a concentration of 0.07 µg/ml in PBS-0.05% Tween-20.  
Recombinant bovine IL-8 (Thermo Fisher) was used as the assay standard with a 
detection limit of 78.125 pg/ml.  
Production of IL-6 was similarly measured by sandwich ELISA per 
manufacturer’s instructions (R&D Systems, Minneapolis, MN). Recombinant bovine IL-
6 (R&D Systems) was used as the assay standard with a detection limit of 156.25 pg/ml.  
For both assays, plate washing was performed 3 times with PBS-0.05% Tween-20 
between each step. After the final plate wash, development of IL-8 and IL-6 assays was 
done by adding 3,3’,5,5’-tetramethylbenzidine substrate (TMB; Thermo Scientific) and 
the reaction was stopped with 1 M H2SO4 after 3-5 minutes. Absorbance was measured at 
450 nm with a plate reader (Synergy-HT, Bio-Tek, Winooski, VT) to quantify protein 
levels using a 4-parameter analysis with optical density corrected against blank wells. 
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3.3.6 Fibroblast Gene Expression  
Extraction of RNA from cell lysate was done using the PureLink™ RNA Mini 
Kit (Thermo Fisher), which included a 15-minute DNase treatment that was performed 
using the PureLink™ DNase Set (Thermo Fisher). Concentration of RNA was 
determined using a Qubit™ 2.0 Fluorometer (Life Technologies, Carlsbad, CA) and first-
strand cDNA synthesis was done using the Improm-II™ Reverse Transcriptase Kit 
(Promega, Madison, WI) on 400 – 600 ng of RNA. Gene expression analysis of select 
immune response genes was measured by real-time quantitative PCR (RT-qPCR) on a 
CFX96 Touch™ Real-Time PCR Detection System (BioRad, Hercules, CA) using 
Thermo Scientific™ Maxima™ SYBR™ Green/Fluorescein qPCR Master Mix (Thermo 
Fisher). Cycling conditions were as follows: 95°C for 2 min followed by 40 cycles of 95 
°C for 15 s, 60 °C for 1 min and 72 °C for 1 min after which a melt curve was inserted.  
All oligonucleotide primer sequences are listed in Table 3.1. Unless already validated and 
published, primers were designed using the Primer 3 program on NCBI. Primers were 
designed to amplify a 100-300 base pair region without any known SNPs and if possible, 
to span an exon-intron junction and include a GC clamp. Primer sequences were then 
analyzed by the NCBI nucleotide BLAST program to ensure only the target Bos taurus 
gene was detected. Melt curve analysis of all primer sets was analyzed and only one peak 
could be detected, indicating a single amplicon without primer-dimer contamination. No 
amplification was detected in negative (no cDNA controls).  
3.3.7 Preparation of E. coli for Intra-mammary Infection    
An aliquot of cryopreserved E. coli strain P4, originally isolated from an acute 
case of clinical mastitis (Bramley, 1976) and classified as O32:H37, ECOR phylogenetic 
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group A and multilocus sequence type ST10 (Blum et al., 2012) was initially grown 
overnight on trypticase soy agar containing 5% sheep’s blood (SBA; Northeast 
Laboratory Services, Waterville, ME) at 37ºC to isolate a single colony. One colony was 
then inoculated into 3 mL of trypticase soy broth (TSB; Thermo Fisher) and incubated at 
37ºC with shaking for 6 hours. One mL of the 6-hour culture was then inoculated into 99 
mL of TSB and incubated for 16 hours at 37ºC with shaking. The stock culture was kept 
at 4ºC until concentration of bacteria was determined by serial dilution and plating. Once 
determined, stock culture was diluted to 40 cfu/ml in sterile, endotoxin free, isotonic 
saline (Phoenix, St. Louis, MO) in preparation for intra-mammary challenge.  
3.3.8 Experimental Mastitis Challenge  
Twelve animals, determined to be either high (n=6) or low (n=6) responders based 
on their fibroblast phenotype, were chosen for an experimental mastitis challenge with E. 
coli.  Fibroblast ranking was based primarily on baseline expression of TLR4 followed by 
cytokine response to LPS. Using this ranking strategy, 4 high responders (HR) and 4 low 
responders (LR) were within the top and bottom 20% of TLR4 expression, respectively. 
The 2 HR and 2 LR that were not within the 20% cutoff were chosen based on their ranking 
within the top or bottom 20% of IL-8 or IL-6 response and on their mastitis free status and 
availability from the collaborating farm.  
All 12 animals were transported to the UVM Miller Research Farm and allowed 
to acclimate for 7 days before the infusion. Ten of the animals were pregnant and the 2 
non-pregnant animals were maintained in diestrus using controlled internal drug release 
inserts containing progesterone (Eazi-Breed™ CIDR®, Zoetis US, Parsippany, NJ). 
Cows were milked twice daily at 12-hour intervals using individual milking units. 
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Quarter milk samples were taken prior to the challenge to ensure quarters were free of 
mastitis-causing pathogens and composite SCC was below 200,000 cells/ml. Following 
morning milking on the day of the challenge, teat ends were disinfected with 70% ethanol 
and 5 mL of the bacterial solution was infused into the right hind quarter using a teat 
cannula. The infusion solution was plated in triplicate and plate counting was done to 
determine the actual infusion dose, which was 37 cfu/ml and 185 cfu total. Following the 
intra-mammary challenge, rectal temperature was monitored for 96 hours. Blood samples 
were taken by venipuncture of the tail vein at 0, 12, 24 and 36 hours post-infection for 
serum cytokine analysis and at 7 and 14 days post infection to measure antibody 
response. Blood samples were collected in vacutainer tubes containing sodium-heparin 
(BD, Franklin Lakes, NJ) and transported to the lab on ice. Blood was centrifuged at 
1,000 x g for 15 minutes at 4ºC. Plasma layer was removed and stored at -20ºC for 
downstream experiments.  
Aseptic milk samples were taken at 12-hour intervals for 5 days, at 24-hour 
intervals for an additional 5 days and at 48-hour intervals for the remainder of the study. 
Bacterial clearance was measured from infected quarters by plating 10 µl of undiluted 
milk or milk diluted in sterile PBS onto SBA, incubating overnight at 37ºC, and counting 
colonies. Infected quarter SCC was measured using a portable cells counter (DCC, 
DeLaval, Tumba, Sweden). Infected quarter milk was collected using a separate quarter 
milker at each milk sampling time-point to measure infected quarter production.  
3.3.9 Whey Preparation 
Whole milk samples were centrifuged at 16,000 x g at 4°C for 30 minutes. Top 
cream layer was removed and skim milk samples were centrifuged again at 16,000 x g at 
 93
4°C for 30 minutes. The whey supernatant was removed and stored at -20°C for 
downstream analysis.  
3.3.10 Measurement of Proteins in Whey   
Concentrations of IL-8 and IL-6 in whey were measured as previously 
described. Whey was diluted 1:5 in PBS-0.05% Tween-20 for IL-8 assays and 1:10 in 
PBS-0.05% Tween-20 for IL-6 assays.  
Bovine serum albumin (BSA) concentrations were measured per manufacturer’s 
instructions using a commercially available ELISA kit (Bethyl Laboratories, 
Montgomery, TX) with slight modifications. Briefly, capture antibody was diluted 1:100 
in 0.05 M bi-carbonate buffer to a concentration of 10 µg/ml and incubated at room 
temperature for 1 hour. Plates were blocked overnight at 4ºC with PBS-0.05% Tween-20. 
Whey samples were diluted 1:40,000 in PBS-0.05% Tween-20. Samples and standards 
were incubated at room temperature for 1 hour. Horseradish peroxidase-conjugated 
secondary antibody was diluted 1:50,000 in PBS-0.05% Tween-20 to a concentration of 
20 ng/ml and incubated at room temperature for 1 hour. Plates were washed between 
each step 3 times with PBS-0.05% Tween-20. After the last wash step, plates were 
developed by adding TMB and allowed to develop for 5-7 minutes. The reaction was 
stopped by adding 1 M H2SO4 and absorbance was read at 450 nm with a plate reader as 
previously described. Detection limit of the BSA assay was 6.25 ng/ml. 
3.3.11 Circulating Cytokine Response 
Serum TNF-α levels were measured by radioimmunoassay (RIA) as previously 
described (Elsasser et al., 2005) and serum IL-6 was measured by ELISA as previously 
described.  
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3.3.12 Heat Killing Bacteria   
A cryopreserved stock of the same E. coli P4 challenge strain was grown as 
described earlier for the intra-mammary challenge preparation. A plate dilution was set 
up to determine concentration of stock bacteria. Stock bacteria was then subjected to heat 
killing by incubating in a water bath at 70ºC for 45 minutes with shaking every 10 
minutes. Heat killed bacteria was then stored at 4ºC overnight while 100 μl of heat killed 
bacteria was plated onto SBA and incubated overnight to ensure bacteria were killed. The 
following day, heat killed bacteria was spun at 3600 x g for 15 minutes at 4ºC and re-
suspended in 50 mL of double distilled water. Heat killed bacteria was then aliquoted and 
stored at -20ºC for downstream applications.  
3.3.13 Antibody Response to challenge strain 
Total anti-E. coli IgG levels were measured in plasma at 0, 7 and 14 days post 
infection using a custom indirect ELISA. Heat killed E. coli was diluted 1:100 in 0.05 M 
bi-carbonate buffer to a concentration of 1 x 107 heat-killed bacteria. Diluted E. coli and 
bi-carbonate buffer only (blank wells) were incubated overnight at 4ºC. Blocking was 
then performed for 1 hour at room temperature with PBS-2% non-fat milk (Lab 
Scientific, Highlands, NJ). Plasma was plated at a dilution of 1:1000 in PBS-0.05% 
Tween-20 and incubated at room temperature for 1 hour. Horseradish peroxidase-
conjugated goat anti-bovine IgG was diluted 1:20,000 in PBS-0.05% Tween-20 to a 
concentration of 0.025 μg/ml and incubated at room temperature for 1 hour. Plates were 
washed three times with PBS-0.05% Tween-20 between each step. After the final plate 
wash, TMB was added and the reaction was allowed to develop for approximately 5 
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minutes. The reaction was stopped with 1 M H2SO4. Optical density at 450 nm was 
measured as previously described.  
3.3.14 Statistical Analysis  
An unpaired Mann-Whitney U test in GraphPad Prism 7.0 (GraphPad Software 
Inc., La Jolla, CA) was performed to compare concentrations of IL-8 and IL-6 in dermal 
fibroblast challenge media and to compare 12-hr. SCC response. Spearman rank 
correlation and linear regression analysis of IL-8 and IL-6 production in challenge media 
from LPS vs. heat-killed E. coli cultures was also performed in GraphPad. Analysis of 
dermal fibroblast gene expression, serum cytokine response and humoral response was 
done using a 2-way repeated measures ANOVA in GraphPad with time as the repeated 
measure to determine time x fibroblast response significance. A post-hoc Bonferroni’s 
multiple comparisons test was then done to determine significance at each time point. 
Finally, comparison of phenotype (LR vs HR) on concentrations of whey IL-6, IL-8 and 
BSA, infected quarter milk production, rectal temperature and infected quarter SCC and 
bacteria counts, both transformed for normal distribution, were analyzed using a linear 
regression model assuming a first order auto-regressive covariance structure with time 
post-infection as the repeated measure. A least square means test was performed to 
determine effect of time, time x fibroblast response and to compare fibroblast response at 
each time point. This analysis was performed using the MIXED procedure in SAS 
version 9.4 (SAS Institute Inc., Cary, NC). All values are presented as the mean of each 
group ± SEM. Statistical significance is defined as P<0.05 and a trend as P<0.10.  
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3.4 Results 
3.4.1 Dermal Fibroblast Response to LPS  
The sixty fibroblast cultures were revived from cryopreservation in five separate 
batches of twelve cultures. The cells were mixed by sampling date, such that each 
challenge batch contained fibroblasts that were isolated on all four sampling dates. 
Unfortunately, 2 of the 60 cultures did not survive cryopreservation, leaving 58 LPS-
challenged cultures.  
Fibroblasts were treated with either media alone or media supplemented with 
100 ng/ml of LPS for 24 hours. Fibroblast production of IL-8 and IL-6 were measured in 
all media samples following the challenge and were adjusted for final cell number. Levels 
of IL-8 and IL-6 in negative controls were minimal but were subtracted from the 
challenge values. In addition, to normalize for batch-to-batch variation between 
challenges, protein amounts were adjusted for batch mean and standard deviation. 
Adjusted rank, ranging from -1.50 to 2.33 for IL-8 and from -1.65 to 2.54 for IL-6, were 
used as response variables. As with previous experiments (Kandasamy et al., 2011, 
Benjamin et al., 2015b), a large range in response to LPS was measured in conditioned 
media, with a significant correlation between LPS-induced IL-6 and IL-8 production 
(data not shown) (R2 = 0.28, P<0.0001).  
3.4.2 Dermal Fibroblast Expression of TLR4 and Ranking   
Expression of TLR4 was measured in cultures from negative, media-only control 
wells. Of the 58 challenged cultures, three cultures had very low RNA yield and were 
excluded from further ranking. Expression of TLR4 was measured in the remaining 55 
cultures using two primer sets that showed a 40- and 70-fold difference in expression 
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between the lowest and highest cultures. The two primer sets also exhibited a significant 
correlation in ranking of TLR4 expression (data not shown) (R2 = 0.77, P<0.0001). As 
such, measurement of TLR4 will be presented using one of the two primer sets for the 
remainder of experiments.  
Fibroblast phenotype was determined by sorting and ranking on all three 
variables as shown in figure 3.1. Selection was then based on identifying the tail ends of 
TLR4 expression and whenever possible, choosing animals with a positive or negative 
rank for both IL-8 and IL-6 as our high and low responders, respectively. Using this 
strategy, 6 selected high responders (figure 3.1, red dots) and 6 selected low responders 
(figure 3.1, blue dots) were selected for subsequent in vitro and in vivo experiments.  
3.4.3 Phenotype Confirmation of 12 Selected Animals  
To confirm that our ranking strategy accurately predicts fibroblast response to 
LPS and to compare whether LPS and heat-killed E. coli would elicit a similar response, 
fibroblasts from the 12 selected highs and lows were revived a second time from 
cryopreservation and treated for 24 hours with media alone, media supplemented with 
100 ng/ml of LPS, and media supplemented with heat-killed E. coli at an MOI of 10.  
As predicted, LPS-induced production of IL-6 protein was higher in animals 
ranked as high responders versus those ranked as low responders (figure 3.2, panel A). 
High responding fibroblasts produced 32.5 ± 3.3 fg/cell of IL-6 as compared to low 
responders that produced 20.2 ± 3.9 fg/cell. Interestingly, this difference did not extend to 
fibroblast response to heat-killed E. coli, even though LPS and heat-killed E. coli 
production of IL-6 was significantly correlated (R2=0.76, P<0.01) within animals (figure 
3.2, panel C). No detectable IL-6 was measured in fibroblasts cultured with media alone.  
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Similar results were measured in LPS-induced production of IL-8. High 
responding cultures produced significantly more IL-8 in response to LPS in comparison 
to low responding cultures (2.51 ± 0.2 vs 1.4 ± 0.1 fg/cell, P<0.001, figure 3.2, panel B). 
However, IL-8 production was also significantly elevated in high responding cultures in 
response to heat-killed E. coli (1.8 ± 0.1 vs 1.0 ± 0.1 fg/cell, P<0.05, figure 3.2, panel B). 
Fibroblast cultures that were treated with media alone did have low background levels of 
IL-8 and notably, these levels were significantly elevated (0.25 ± 0.1 vs. 0.1 ± 0.04 
fg/cell, P<0.001) in high responding cultures but did not affect differences in response to 
LPS or heat-killed E. coli (figure 3.2, panel B). As with IL-6 production, fibroblast 
production of IL-8 is significantly correlated (R2=0.61, P<0.01) within-animals when 
comparing response to LPS and to heat-killed E. coli (figure 3.2, panel D). Fibroblasts 
also produce more IL-8 in response to LPS than to heat-killed E. coli, the opposite of 
which is true for fibroblast production of IL-6.  
3.4.4 Fibroblast Gene Expression in Response to LPS  
To determine whether protein differences would also be reflected at the mRNA 
level and to measure the expression of other innate response genes, gene expression 
analysis was performed on high and low responding fibroblasts at 0 (control), 2, and 8 
hours post LPS treatment. Expression of both IL-8 and IL-6 were up-regulated by 2 hours 
post LPS treatment and were significantly higher (P<0.05, figure 4.3, panels A & B) in 
high responding cultures, confirming the protein response difference. The largest 
difference in IL-8 and IL-6 expression between the two sets of cultures was measured at 
2-hrs post LPS at which time high responding cultures exhibited a 4.6- and 4.8-fold 
higher level of expression, respectively. Interestingly, difference in TLR4 expression was 
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not as high as expected based on our initial ranking, perhaps due to technical variation of 
the RT-qPCR assay. However, expression of TLR4 was higher in high responding 
cultures with a time x response difference that trended towards significance (P<0.10, 
figure 3.3 panel C). Again, the greatest difference between the two sets of cultures was 
measured at 2-hrs. post LPS treatment, at which time a significant (P<0.05) 2-fold higher 
level of expression was seen in high responding cultures. There was also a small (3.5-
fold), but significant increase in TLR4 expression by 8-hrs post-LPS treatment.  
The expression of three other innate immune response genes were also measured 
to determine whether the high and low phenotype was unique to our ranking variables. 
The expression of TNF-α was measured as this is a crucial early-response cytokine with a 
similar, but not identical role in the innate response as IL-6. As expected, a large increase 
in TNF-α expression was measured by 2-hrs. post LPS treatment that returned close to 
baseline by 8 hrs (figure 3.3, panel D). Overall, there was a time x response trend towards 
significance (P<0.10) for higher expression in high responding cultures. As with the 
previously measured genes, the greatest difference was measured at 2-hrs. post LPS at 
which time high responding cultures exhibited a 2-fold higher level of TNF-α expression. 
Expression of serum amyloid A-3, a member of the SAA family of acute phase proteins, 
was also measured in response to LPS treatment. Although expression was higher in high 
responding cultures at all time points, no significant differences were measured between 
the two groups of animals (figure 3.3, panel E). Finally, a large increase in expression of 
CCL20, a CC-family chemokine, was measured in response to LPS treatment, with no 
differences observed between high and low responding cultures (figure 3.3, panel F).  
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3.4.5 Intra-mammary Infection with E. coli  
To determine how dermal fibroblast phenotype relates to in vivo response, the 6 
high responders and 6 low responders were given an infusion of 185 cfu of E. coli in their 
right-hind quarter following morning milking. Clinical signs of coliform mastitis, such as 
lethargy, fever and anorexia, were evident by 12-hrs. post infection. One high responding 
animal developed acute toxic mastitis and was humanely euthanized at 48 hrs. post 
infection. Her data was utilized for milk samples up to 12-hrs. post infection and rectal 
temperatures and blood samples up to 36-hrs. post infection. Rectal temperatures were 
monitored for 96-hrs. post-infection and peaked at 15-hrs. in all animals (figure 3.4), 
indicative of an acute case of mastitis, and returned to baseline by 21-hrs. post-infection. 
Overall, there was no difference in febrile response between high and low responders, 
however, high responders had an early and significant increase (39.4 ± 0.2 vs 38.7 ± 
0.2ºC, P<0.05) in temperature by 12-hrs. post-infection in comparison to low responding 
animals, suggesting that high responders may react more quickly to E. coli infection. In 
contrast, low responders had a significantly elevated temperature at 18-hrs. post-infection 
(39.4 ± 0.4 vs 38.8 ± 0.3ºC, P<0.05). This result should be taken with caution, however, 
as a non-steroidal anti-inflammatory (Banamine®, flunixin meglumine) was administered 
to half of the animals (4 HR and 2 LR) at 15-hrs. post-infection per IACUC requirements. 
All temperatures returned to baseline by 21-hrs. post-infection.  
A notable drop in infected (figure 3.5) and uninfected (data not shown) quarter 
milk production was measured by 24-hrs. post infection. No difference in post-infection 
milk production was measured in the high versus low responding animals. All animals 
recovered to pre-infection milk production levels by the end of the study, with the 
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exception of one low responder that stayed close to dry-off from 144-hrs post-infection 
until the end of the study and one high responder that had very low production on the last 
day of sampling due to re-infection in her right hind quarter.  
Leukocyte influx into the mammary gland was assessed by measuring increase 
in infected quarter somatic cell count (SCC) for 14 days following E. coli infection 
(figure 3.6, panel A). Using a linear regression model, there was no difference in SCC 
between high and low responders, with the exception of a trend towards elevated SCC in 
high responders at 60 and 108-hrs. post infection. Interestingly, it was noted that at 12-
hrs. post infection high responders had already increased their SCC above baseline, 
whereas low responders remained near pre-infection levels. In light of this observation, 
we performed an assessment of just the increase in SCC at 12-hrs. post infection (figure 
3.6, panel B) that showed that high responders had an up-regulated SCC that was 
significantly (183,000 ± 98,000 vs. 26,000 ± 11,000 SCC/ml, P<0.05) higher than low 
responders at this early time point post-infection. The difference in SCC was gone by 24-
hrs. post infection, but in conjunction with their elevated febrile response, may indicate 
that high responding animals respond more quickly to infection. Somatic cell count 
remained elevated in all animals through the end of the study.  
Recovery of E. coli from the infected gland was similarly measured for 14 days 
post-infection to determine how phenotype impacts bacterial clearance. As shown in 
figure 3.6 panel C, bacteria quickly multiply post-infection, reaching maximal levels at 
12-24-hrs. post-infection. Interestingly, while high responding animals peak at 12-hrs 
post-infection, levels of bacteria keep increasing in low responding animals until 24-hrs. 
post infection. Over the entire course of infection, high responding animals trended 
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(P=0.10) towards lower bacterial levels and enhanced bacterial clearance which reached 
significance (P<0.05) at 24, 72, and 84 hours post infection. All animals were clear of 
infection by 12 days post infection, however, one high responding animal became re-
infected with E. coli at 14 days post infection.  
3.4.6 Infected Quarter Cytokine Response and Tissue Damage   
Infected quarter whey concentrations of IL-8, IL-6 and bovine serum albumin 
(BSA) were measured to determine how phenotype affects local inflammatory response 
and tissue damage. A dramatic increase in IL-8 was measured by 24-hrs. post infection 
(figure 3.7, panel A) that returned to baseline by 96-hrs. post infection. Overall, there was 
no difference between high and low responders in infected quarter levels of IL-8, 
however, high responding animals had significantly (27.8 ± 5.9 vs. 18.5 ± 3.5 ng/ml, 
P<0.05) higher concentrations of IL-8 at 24-hrs. post-infection. This difference at 24-hrs. 
may partially contribute to the higher SCC levels measured at 12-hrs. post-infection in 
high responding animals as IL-8 is the primary chemokine resulting in neutrophil 
chemotaxis.  
Whey concentrations of IL-6 also peaked at 24-hrs. post-infection, however no 
differences were measured between high and low responders at any time point post-
infection (figure 3.7, panel B). Levels of IL-6 returned to baseline by 144-hrs. post-
infection, indicating IL-6 has a prolonged role in response to E. coli infection in 
comparison to IL-8. Whey concentrations of BSA, an indicator of blood-milk barrier 
damage, were again significantly elevated in all animals by 24-hrs. post-infection and, 
with the exception of one animal, returned to baseline by 144-hrs. post-infection (figure 
3.7, panel C). One low responder had elevated levels of BSA and very low milk yield 
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until 216-hrs. post-infection due to persistence of the E. coli infection. No significant 
differences in BSA levels were measured between high and low responders at any time 
point post-infection.  
3.4.7 Systemic Response to E. coli Infection  
  Concentrations of plasma TNF-α and IL-6 were measured every 12 hrs. for 36 
hrs. following the infection as markers of systemic response to E. coli. Peak TNF-α levels 
were detected at 24-hrs. post-infection, with no significant difference between low and 
high responders, overall.  A trend towards higher levels of TNF-α in low responders was 
detected at 24-hrs. post-infection (0.13 ± 0.03 vs 0.09 ± 0.02 ng/ml, P<0.10) (figure 3.8, 
panel A). Concentrations of plasma IL-6 was also highest at 24-hrs, with no significant 
differences measured between high and low responding animals (figure 3.8, panel B).  
3.4.8 Humoral Response to E. coli Infection  
Finally, to determine if levels of total anti-E. coli serum IgG would differ by 
fibroblast phenotype following infection, blood samples were taken to measure antibody 
response at 0, 7 and 14 days post-infection. A significant increase in E. coli-specific IgG 
was measured by day 7 that remained elevated through day 14, however, no difference 
was measured between the high and low responding animals (figure 3.9).  
3.5 Discussion 
In the current analysis, we aimed to refine the high and low fibroblast phenotype 
based on earlier, promising results that animals whose fibroblasts produce more IL-8 in 
response to synthetic TLR agonists, LPS and PAM2CSK4, have a more severe response 
to E. coli and S. aureus mastitis, respectively. If able to accurately predict cow response 
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to infection, the dermal fibroblast could be used as a valuable tool to discover genetic or 
epigenetic markers that cause resistance or susceptibility to severe mastitis.  
In addition to increased profitability for the dairy producer, selection of 
replacement heifers based on genetic resistance to mastitis has shown increased interest 
due to an effort to reduce antibiotic usage in food-producing animals and to improve 
animal welfare. Genetic variability that results in increased susceptibility or severity of 
infection has already been observed in various species in response to a wide range of 
pathogens. In one report, a polymorphism in the IL17A gene was shown to lead to 
increased susceptibility to Gram-positive infection and sepsis mortality (Nakada et al., 
2011). Copy number variants are another, less common type of gene variant that have 
been shown to contribute to differences in susceptibility to malaria and HIV infection in 
humans (Hollox and Hoh, 2014) and are also gaining attention in agriculture species as 
another potential source of variation in mastitis susceptibility (Duran Aguilar et al., 
2017).  Genetic differences in CXCR1, the main receptor for IL-8 signaling, was also 
recently shown to impact severity of experimental intra-mammary infection with 
Streptococcus uberis, whereby a haplotype was discovered to be protective against both 
inflammation and bacterial growth (Siebert et al., 2017).  
Using a slightly different approach, our hypothesis was that mastitis severity 
would be reflected in the fibroblast innate response phenotype, such that fibroblasts could 
be utilized in the future to identify the genetic or epigenetic basis of severe mastitis 
resistance and/or susceptibility using genome-wide sequencing techniques. The decision 
to use dermal fibroblasts over other cell culture models was based on their ease of 
isolation, ability to cryopreserve, responsiveness to TLR agonists, low baseline 
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activation, and on previous research suggesting that the primary fibroblast accurately 
reflects progression of natural infection. Primary dermal fibroblasts have been used as a 
model cell to identify strain-specific differences in the virulence of Herpesvirus sub-
species in infections of non-natural hosts (Rogers et al., 2007) and in cattle to mimic 
pathogen-specific differences in mammary gland response to mastitis (Gunther et al., 
2016b). Furthermore, mammary-derived stromal fibroblasts (BMFs) isolated from E. 
coli-infected versus healthy cows exhibit a pro-inflammatory phenotype at isolation and 
are able to induce epithelial cell expression of TNF-α and IL-8 in a co-culture system 
(Chen et al., 2016). Conversely, epithelial cells pre-treated with LPS or lipoteichoic acid 
(LTA) are able to induce pro-inflammatory gene expression in BMFs isolated from 
healthy cattle (Zhang et al., 2016). Both studies are evidence of the cross-talk that occurs 
between the epithelial cell and fibroblast within the mammary gland and the importance 
of the fibroblast in initial response to infection.  
In the current study, primary bovine dermal fibroblasts were isolated from ear 
notch biopsies and used to study the cow-to-cow variation in mastitis severity that exists 
independent of pathogen type and host physiological state. Fibroblasts were initially 
isolated from a cohort of 60 multiparous, adult Holsteins at the same stage in lactation, 
and their fibroblast phenotype was ranked from high to low innate response based on 
LPS-induced IL-8 and IL-6 protein production and TLR4 gene expression. Six high 
responders and six low responders were then chosen, primarily on differences in TLR4 
gene expression and subsequently on their high or low production of both IL-8 and IL-6, 
for additional experiments. Since fibroblast response was measured in different batches, 
high and low cultures were re-challenged side-by-side and their difference in LPS-
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induced production of IL-8 and IL-6 was confirmed. Bacterial endotoxin, or LPS, has 
been used in countless studies to mimic the response to E. coli and other Gram-negative 
bacteria, however, E. coli can also activate the innate response through receptors other 
than TLR4, such as TLR5 that is activated by flagellin (Andersen-Nissen et al., 2007), 
TLR9 that is activated by bacterial DNA (Magnusson et al., 2007), and DAP (D-
glutamyl-meso-diaminopimelic acid)-dependent NOD1 activation (Kumar et al., 2011). 
As such, in the second challenge, we stimulated fibroblasts isolated from high and low 
responders with heat-killed E. coli along with LPS and showed that LPS-induced IL-8 
production, and to a lesser extent IL-6 production, corresponds to response to E. coli. 
Fibroblast IL-8 production is also higher in response to LPS than to E. coli, the opposite 
of which is true for IL-6 that is produced in higher quantities in response to E. coli. The 
IL-8/IL-6 discrepancy could be due to increased signaling pathways that induce IL-6 
production following E. coli stimulation or in differential post-transcriptional regulatory 
mechanisms such as mRNA stabilization that is shown to occur through interaction with 
Arid5a for IL-6 transcripts (Nyati et al., 2017) and through p38 MAPK kinase and MK2 
for IL-8 transcripts (Bhattacharyya et al., 2011, Moretto et al., 2012).  
LPS-induced gene expression was then measured in high and low responding 
fibroblasts to confirm that mRNA also reflects protein level differences and to measure 
the expression of other important innate response genes. As expected, mRNA levels of 
IL-8, IL-6, and TLR4 were significantly higher in high responding cultures at 2-hrs. post 
LPS stimulation. We were, however, surprised that baseline (0-hr.) TLR4 expression only 
trended towards significance with a 1.9-fold higher level of expression in high 
responders, when in our initial ranking high responders exhibited a significant 6.9-fold 
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higher level of expression using identical primer sets. In addition to inherent between-
assay variation, this discrepancy could be explained by length of cryopreservation and by 
differences in initial cell density between the two sets of experiments. Expression of 
TNF-α also trended towards higher levels in high responding cultures. This difference is 
somewhat expected based on the role of TNF-α as a canonical pro-inflammatory and 
pleiotropic cytokine with similar regulatory mechanisms to IL-6.  Serum amyloid a3 
(SAA3), an acute-phase protein that is induced by pro-inflammatory cytokines TNF-α, IL-
1ß and IL-6 following infection (Ye and Sun, 2015), was also measured post-LPS 
treatment to determine if differences in fibroblast IL-6 production would be reflected in 
SAA3 expression. Although expression of SAA3 was higher in high responders at all three 
time points, no significant differences were measured, and the weak induction of SAA3 
post-LPS stimulation suggests that more time may be required following LPS treatment 
for IL-6 to elicit its effect on SAA3 expression. Finally, expression of CCL20, a CC-motif 
chemokine that is induced in response to E. coli mastitis (Petzl et al., 2012) and has also 
been shown to differ in expression in two other groups of high and low responding 
fibroblasts (Green et al., 2015, Benjamin et al., 2016a), was measured. The chemokine 
was highly up-regulated by 2-hrs. post LPS-treatment and overall, expression was higher 
in high responding cells, but again the difference did not reach significance.  
With the high and low fibroblast phenotype established, all 12 animals were 
infected with the P4 strain of E. coli in their right-hind quarter to test their immune 
response to infection. Overall, the response to intra-mammary challenge with E. coli 
followed a similar magnitude and kinetics as has been noted in previous challenges with 
E. coli (Bannerman et al., 2008, Kandasamy et al., 2011) and were reflective of acute, 
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clinical mastitis. Unfortunately, very few differences were measured between the high 
and low responding animals and in general, the responses were extremely variable 
between all 12 animals. At the most severe, one high responder developed acute toxic 
mastitis first evidenced by dysstasia at 24-hrs post-infection, which resulted in our 
decision to humanely euthanize the animal at 48-hrs post-infection, as she did not 
respond to treatment with Banamine® and systemic antibiotic therapy. Another low 
responding animal completely dried off in her infected quarter at 192-hrs. post-infection 
and remained very low in infected quarter milk production until the end of the study. In 
general, milk production was drastically reduced by 24-hrs. post-infection in all animals 
with no differences measured between high and low responders. Again, there was 
significant animal-to-animal variation in their time to recovery to pre-infection milk 
production, ranging from 5 to >14 days post-infection. Increase in somatic cell count, 
mainly due to neutrophil recruitment into the mammary gland, tended to occur faster in 
high responding animals. High responders already had an elevated SCC at 12-hrs. post-
infection, whereby it took low responders until 24-hrs. post infection to see a significant 
SCC increase. The role of the neutrophil as a beneficial first-line responder to clear 
bacteria versus that of a main source of inflammatory-related damage through the 
production of ROS, proteases and NET formation in the mammary gland has been the 
subject of debate (Aitken et al., 2011). Efficient leukocyte influx into the mammary gland 
is, however, thought to be beneficial for mastitis outcome (Burvenich et al., 2007) and in 
the current study we show that early up-regulation of SCC does occur with enhanced 
bacterial clearance. High responding animals that had an elevated SCC at 12-hrs. had 
lower overall bacterial counts throughout the study, and this difference reached 
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significance at several time points. Notably, while high responders peaked in their cfu/ml 
of bacteria by 12-hrs., concurrent with their elevated SCC, cfu/ml of E. coli continued to 
increase until 24-hrs. post infection in low responders. The difference in SCC was 
abolished by 24-hrs., remaining at similar levels between the two groups for the 
remainder of the study, and at 2-weeks post-infection SCC was still up-regulated in all 
animals in comparison to pre-infection levels. There is the potential that if SCC were 
measured for a longer period of time post-infection differences could be detected and 
perhaps longer sampling time should be considered for future experiments.  
Interestingly, in addition to higher SCC at 12-hrs. post-infection, high 
responders had a significantly elevated febrile response at 12-hrs. in comparison to low 
responders, and both groups peaked at 15-hrs. post-infection before returning to baseline 
at 21-hrs. Although hyperpyrexia can be detrimental to the host, the febrile response is an 
ancient and conserved innate defense to infection and is likely another factor that limited 
bacterial growth in high responders (Cavaillon, 2012). Serum cytokine levels of TNF-α 
and IL-6, two of the three main pyrogenic cytokines, did not correlate with fever 
response, however, this may be due to the timing of serum collection and to the 
administration of Banamine® or flunixin meglumine, a non-steroidal anti-inflammatory.  
Flunixin inhibits the activity of cyclooxygenase enzymes that synthesize prostaglandin 
(PGE2) from arachidonic acid, a process known to affect the innate response and systemic 
cytokine production (Kalinski, 2012). The NSAID was administered to 7 of the 12 
animals (4 HR and 3 LR) between 15-18-hrs. post-infection, in accordance with animal 
welfare protocols, and represents one of the major but necessary limitations of the current 
study.  
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No differences were detected between high and low responders in the mammary 
gland proteins that were measured, IL-8, IL-6 and BSA. Nevertheless, a comparison of 
the area under the curve of milk cytokines versus milk BSA showed a significant 
correlation (Figure 3.10) in their production over the duration of the infection, such that 
animals with a prolonged cytokine response also exhibited more tissue damage. 
Concentration of IL-8 was also significantly higher in high responders at 24-hrs. post-
infection and likely contributes to the early elevation of milk SCC in high responders at 
12-hrs. Unfortunately, the lack of any real difference in milk IL-6 and IL-8 indicates that 
the fibroblast model may not accurately reflect the mammary gland environment, 
contradicting the results of our previous studies. The strength and duration of pro-
inflammatory cytokine and chemokine production in the mammary gland is, however, 
directly related to tissue damage. Follow-up experiments should focus on the initial 
response to infection, likely mediated by resident epithelial and immune cells, as this 
response seems to be crucial for efficient leukocytosis and bacterial clearance. In 
addition, more emphasis should be placed on down-regulation of the inflammatory 
response as the majority of animals had a sufficient response to clear bacteria, but those 
that did not recover as well tended to have a sustained inflammatory response. 
Interleukin-10, an anti-inflammatory cytokine that exerts its negative effect on pro-
inflammatory cytokine production through STAT3-dependent upregulation of SOCS3 
(Mosser and Zhang, 2008), is also up-regulated in response to mastitis-related infections, 
however, the role of IL-10 and other anti-inflammatory proteins in between-animal 
variation in mastitis severity has not been established. Proteins, such as WISP-1 and IL-
22 have been shown to mediate epithelial cell recovery and proliferation following 
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mechanical or infection related injury (Pociask et al., 2013, Quiros et al., 2017), a 
response that would be crucial to the recovery of milk-producing cells that become 
damaged during mastitis infection. The ability of the animal to clear apoptotic cells that 
accumulate following infection could also affect recovery efforts since apoptotic cells 
will become necrotic if not efficiently cleared, resulting in chronic autoimmune-related 
inflammation (Munoz et al., 2017).   
Finally, no difference was measured between high and low responders in their E. 
coli-specific circulating IgG response and importantly, antibody response did not 
correlate with ability to clear infection. This result agrees with previous literature stating 
that antibody response is not a major contributor to E. coli or S. aureus clearance within 
the mammary gland (Benjamin et al., 2015b, Herry et al., 2017). The role of the adaptive 
response in determining between-cow differences in mastitis severity and duration should 
be the subject of future research, specifically the role of Th-17 cells, which have been 
shown to be the predominant T-cell responder in E. coli mastitis (Porcherie et al., 2016) 
and are associated with a primarily neutrophilic response. However, other immune cell 
types whose functions remain completely unknown in bovine mastitis, such as innate 
lymphoid cells that are present in high numbers in mucosal tissue and γδ T cells that are 
expressed at much higher levels in the bovine than other species, may also contribute to 
differences in mastitis severity.  
The current study shows that while the primary dermal fibroblast derived from 
ear notch tissue is highly responsive to TLR agonists, the magnitude in innate 
responsiveness does not correlate with severity of E. coli mastitis. This result contradicts 
previous experiments in our lab where high responding animals, based on fibroblast IL-8 
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production, develop more severe mastitis when challenged with either E. coli or S. 
aureus. The main difference between the two studies was the location of fibroblast 
isolation. Previously, fibroblasts were isolated through a shoulder biopsy, whereas in the 
current experiment fibroblasts were isolated using an ear punch biopsy. It is possible that 
cellular phenotype in fibroblasts isolated from shoulder biopsies more accurately reflect 
mammary gland cellular response. Future experiments should consider reevaluating 
whether the fibroblast is a useful model for response to mastitis and if location of 
isolation affects cellular response. Cellular phenotype in the current study did reflect an 
ability to more effectively clear bacteria from the mammary gland, as evidenced by high 
responders having lower bacterial burden throughout the trial. It is tempting to speculate 
that this difference in bacterial clearance is due to an earlier increase in leukocyte influx 
into the mammary gland, but this result should be confirmed in follow-up studies.  
Finally, as has been observed in both natural and experimental mastitis, significant 
animal-to-animal variation was noted in the current experiment, whereby some animals 
recovered very quickly from a milder infection, whereas others experienced severe 
pathology and never recovered from infection. While it is known that in severe cases, 
SCC, cytokine levels and tissue damage are elevated, and that milk production is 
inhibited, the underlying factors that determine mastitis severity remain elusive and are 
reflective of our relative lack of understanding of the optimal immune response to 
mastitis. Future studies should aim to identify the precise cellular and molecular 
components that determine a rapid, efficient and effective response that clears infection 
while limiting collateral damage to mammary gland tissue.  
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Gene Name Primer Sequence (5’ → 3’) Reference 
ß-Actin F: GCAAATGCTTCTAGGCGGACT 
R: CAATCTCATCTCGTTTTCTGCG 
(Pareek et al., 
2005) 
Interleukin-6 F: TGAGGGAAATCAGGAAAATGT 
R: CAGTGTTTGTGGCTGGAGTG 
(Pareek et al., 
2005) 
Interleukin-8 F: GCTGGCTGTTGCTCTCTTG 
R: AGGTGTGGAATGTGTTTTTATGC 
(Pareek et al., 
2005) 


















Figure 3.1: Dermal fibroblast ranking by TLR4 expression and LPS-induced IL-6 
and IL-8 production. 
Fibroblasts were revived from cryopreservation and treated with 100 ng/ml of LPS or 
media alone for 24 hours. Protein levels of IL-8 and IL-6 were measured in challenge 
media. A normalized rank for LPS response was generated by adjusting IL-8 and IL-6 
fg/cell to the challenge batch mean and standard deviation. The resulting variables are 
presented here as an adjusted rank from -1.50 to 2.33 for IL-8 and from -1.65 to 2.54 for 
IL-6. Expression of TLR4 was measured in untreated (media only) cultures using two 
different primer sets, which had a high degree of correlation. Gene expression values are 
presented as the change in cycles to threshold (ΔCT) of TLR4 versus a housekeeping 
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gene, β-Actin. The 6 selected high responders are highlighted in red and the 6 selected 
low responders are highlighted in blue.  
 
 
Figure 3.2: Fibroblast production of IL-6 and IL-8 in response to LPS and heat 
killed E. coli. 
Fibroblasts that were isolated from the 6-selected high (HR) and 6-selected low (LR) 
responders were revived a second time and challenged side-by-side with heat-killed E. 
coli (MOI 10), 100 ng/ml of LPS or media alone for 24 hrs. Protein concentrations of IL-
6 (panel A) and IL-8 (panel B) were then measured in the challenge media and compared 
using an unpaired Mann-Whitney U test. Results are presented as fg/cell ± SEM and 
*=P<0.05 and ***=P<0.001. A Spearman rank correlation analysis was performed to 
compare fibroblast production of IL-6 (panel C) and IL-8 (panel D) when challenged 




Figure 3.3. Fibroblast gene expression in response to LPS treatment. 
 
Fibroblasts from 6 selected high responders (HR) and 6 selected low responders (LR) 
were treated with 100 ng/ml LPS for 0, 2 and 8 hours. Total RNA was extracted at each 
time point to determine gene expression levels of (A) IL8, (B) IL6, (C) TLR4, (D) TNF-
α, (E) SAA3 and (F) CCL20. Values are presented as the change in cycles to threshold 
(ΔCT) ± SEM in comparison to β-Actin. The p-values presented in each panel signify the 
results of a 2-way repeated measures ANOVA that was done to determine the 
significance of Response x Time gene expression. A Bonferroni’s multiple comparisons 
test was then done to determine significance at each time point where *=P<0.05. Values 
presented above each time point indicate fold change in gene expression where 
expression is greater in HR cultures and fold change is ≥2.0. 
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Figure 3.4: Temperature response. 
 
Febrile response to E. coli infection was measured in high (HR, n=5) and low (LR, n=6) 
responding animals by monitoring rectal temperatures for 96 hrs. post infection. 
Temperatures are presented as mean ºC ± SEM. A linear mixed model was used to 
determine significance based on Response x Time and the corresponding p-value is 
presented. In addition, multiple comparisons testing was performed using the least square 
means method to determine significance at each time point where *=P<0.05.  
 





























Figure 3.5: Infected quarter milk production. 
Milk production was measured in the infected right hind quarter for up to 14 days post E. 
coli infection. Milk yield for high (HR, n=5) and low (LR, n=6) responding animals is 
presented as mean milk weight in lbs. ± SEM. A linear mixed model was used to 
determine significance based on Response x Time and the corresponding p-value is 
presented. In addition, multiple comparisons testing was done using the least square 
means method to determine significance at each time point. There was no significant 
difference in milk production between HR and LR animals at any time point infection.  

























Figure 3.6: Infected quarter somatic cell count and bacterial clearance. 
Somatic cell count (SCC/ml) and cfu/ml of E. coli were measured in milk collected from 
the infected right hind quarter for up to 14 days post E. coli infection. Somatic cell counts 
for high (HR, n=5) and low (LR, n=6) responding animals are presented as SCC/ml (x 
106) (panel A) and SCC/ml (x 103) (panel B) ± SEM. Colony forming units (cfu/ml) of 
bacteria were log-transformed and are presented as mean cfu/ml ± SEM. A linear mixed 
model was used to determine significance based on Response x Time for overall SCC and 
bacteria and corresponding p-values are presented in each panel. In addition, multiple 
comparisons testing was done using the least square means method to determine 
significance at each time point where✝=P≤0.10 and *=P<0.05. An unpaired Mann-
Whitney U test was used to determine significance of SCC increase at 12-hrs. post 




Figure 3.7: Infected quarter protein response. 
Concentrations of IL-8 (panel A), IL-6 (panel B) and BSA (panel C) were measured in 
whey collected from the infected right-hind quarter for 240 hours post infection. Levels 
of IL-8 and IL-6 from high responding (HR, n=5) and low responding (LR, n=6) animals 
are presented as ng/ml ± SEM. BSA levels from each group are presented as mg/ml ± 
SEM. A linear mixed model was used to determine significance based on Response x 
Time and corresponding p-values are presented in each panel. In addition, multiple 
comparisons testing was performed using the least squares means method to determine 
significance at each time point and *=P<0.05.  
 






























































Figure 3.8: Systemic response to infection. 
Concentrations of circulating TNF-α (panel A) and IL-6 (panel B) were measured for 36 
hrs. post infection. Serum cytokine concentrations are presented as mean ng/ml ± SEM 
and significance was determined using a 2-way repeated measures ANOVA with 






Figure 3.9: Humoral response to infection. 
 
E. coli-specific total IgG was measured in plasma from high (HR, n=5) and low (LR, 
n=6) responding animals at days 0, 7 and 14 following E. coli infection. Values are 
presented as the mean (± SEM) optical density of E. coli-specific ELISA wells minus 
blank control wells. Significance was determined using a 2-way repeated measures 
ANOVA with Bonferroni’s multiple comparisons testing. No significant differences were 
























Figure 3.10: Comparison of milk cytokine response to tissue damage following E. 
coli infection. 
 
Area under the curve values of IL8, IL6, and BSA concentrations was determined in milk 
of all infected animals (5 high responders and 6 low responders) for 10 days post-
infection. A Spearman rank correlation analysis was then performed to determine 
whether milk concentrations of IL-8 (panel A) and IL-6 (panel B) were significantly 


























































CHAPTER 4: NEONATAL LPS EXPOSURE DOES NOT DIMINISH THE 
INNATE IMMUNE RESPONSE TO A SUBSEQUENT LPS CHALLENGE IN 
HOLSTEIN BULL CALVES. 
4.1. Abstract  
The innate immune response following experimental mastitis is quite variable 
between individual dairy cattle. An inflammatory response that minimizes collateral 
damage to the mammary gland while still effectively resolving the infection following 
pathogen exposure is beneficial to dairy producers. The ability of an LPS exposure in 
early life to generate a low-responding phenotype and thus reduce the inflammatory 
response to a later life LPS challenge was investigated in neonatal bull calves. Ten 
Holstein bull calves were randomly assigned to either an early life LPS (ELL) group 
(n=5) or an early life saline (ELS) group (n=5). At 7 days of age, calves received either 
LPS or saline, and at 32 days of age all calves were challenged with an intravenous dose 
of LPS to determine the effect of the early life treatment (LPS or saline) on the immune 
response generated towards a subsequent LPS challenge. Dermal fibroblast (DF) and 
monocyte-derived macrophage (MDM) cultures from each calf were established at age 
20 and 27 d, respectively, to model sustained impacts from the early life LPS exposure on 
gene expression and protein production of components within the LPS response pathway. 
The ELL calves had greater levels of plasma IL-6 and TNF-α than the ELS calves 
following the early life LPS or saline treatments. However, levels of these two immune 
markers were similar between ELL and ELS calves when both groups were subsequently 
challenged with LPS. A comparison of the in vitro LPS-responses of the ELL and ELS 
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calves revealed similar patterns of protein production and gene expression following an 
LPS challenge of both DF and MDM cultures established from the treatment groups. 
While an early life exposure to LPS did not result in a dampened inflammatory response 
towards a later LPS challenge in these neonatal bull calves, the potential that exposure to 
inflammation or stress in early life or in utero can create an offspring with a low-
responding phenotype as an adult is intriguing and has been documented in rodents. 
Further work is needed to determine if an inflammatory exposure in utero in a dairy 
animal would result in a low-responding innate immune phenotype.  
Keywords: early life LPS, inter-animal variation, inflammatory response 
4.2. Introduction  
 The innate immune system plays a key role in the clearance of pathogens 
following an infection such as bovine mastitis. This acute, non-specific response is 
initiated when conserved pathogen associated molecular patterns (PAMP) from a diverse 
number of pathogens are recognized by germ-line encoded receptors known as pattern 
recognition receptors (PRR) that are expressed on a variety of cell types. 
Lipopolysaccharide (LPS) from the cell wall of Gram-negative bacteria, a major 
causative agent of bovine mastitis, is recognized by the PRR toll-like receptor (TLR) 4. 
Once LPS is recognized by TLR4, an intracellular signaling cascade activates 
transcription factors such as nuclear factor-kappa B (NF-κB) that promote the 
transcription of cytokines including interleukin (IL) -1β, -6, and tumor necrosis factor 
alpha (TNF-α) (Kawai and Akira, 2007). These three cytokines play major roles in 
driving the pro-inflammatory response by promoting febrility, inflammation, and 
activation of leukocytes to aid in the clearance of the pathogen (Bannerman, 2009). 
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However, an excessive inflammatory response can be detrimental to the host, causing 
collateral damage to tissues, such as the mammary gland (Schukken et al., 2011), thereby 
reducing future milk production and profit for dairy producers (Grohn et al., 2004). The 
factors that lead to a more robust inflammatory response in some animals and not in 
others have not been fully elucidated. Even in controlled intra-mammary challenge 
models of mastitis, inter-animal variation has been observed in cytokine concentrations in 
milk or blood, milk bacterial counts, and severity of clinical signs (Schukken et al., 1999, 
Lee et al., 2006, Simojoki et al., 2009), supporting the belief that host factors play a 
major role in determining the severity and outcome of mammary infections (Burvenich et 
al., 2003).  
Genetic polymorphisms in components of the host’s pathogen recognition 
pathways could lead to the variable immune responses between animals. Within cattle, a 
number of single nucleotide polymorphisms (SNP) have been identified in genes 
encoding the toll-like receptors (Novak, 2014), and SNPs in these and other genes 
involved in the inflammatory response have been associated with individual differences 
in their resistance to mastitis (Thompson-Crispi et al., 2014). Epigenetic modifications of 
an animal’s DNA can also contribute to the observed phenotypic differences in the 
immune response of individuals. DNA methylation in particular, has been shown to 
influence transcription of genes (Moore et al., 2013). In human diseases such as 
periodontitis and rheumatoid arthritis, aberrant methylation within immune response 
genes has been linked to an increased risk of disease or severity of signs (Benakanakere 
et al., 2015, Kojima et al., 2015). The role that epigenetics may play in modulating the 
bovine innate immune response is now being investigated (Paibomesai et al., 2013, Green 
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and Kerr, 2014, Chang et al., 2015a) and may provide a more complete picture of how 
genetic and epigenetic factors combine to produce inflammatory responses following 
bovine mastitis that range from mild to severe.  
While pathogen detection by innate immune cells prompts a robust inflammatory 
response that is essential to resolving the infection, this response must be under tight 
regulation to prevent excessive inflammation and extensive tissue damage. There are 
some mechanisms that can generate a low responding phenotype in an animal, either 
transiently or long-term, following pathogen exposure. An animal exposed to a low level 
of LPS can develop a short-term reduction or even an abolished inflammatory response 
towards a subsequent LPS exposure, thereby exhibiting endotoxin tolerance (Biswas and 
Lopez-Collazo, 2009). It has been suggested that this tolerized state, generated primarily 
through macrophages and their reduced production of TNF-α, could be due to a variety of 
events, including methylation of histone tails, which modify the chromatin structure of 
anti- and pro-inflammatory genes (El Gazzar et al., 2007), up-regulation of anti-
inflammatory or inhibitory genes (Fan and Cook, 2004), and micro-RNA regulation of 
immune response genes (Baltimore et al., 2008). Additionally, there is abundant evidence 
that inflammation or disease in early life can have long-term consequences on the innate 
immune response of an animal. Several studies completed on rodents have shown that 
neonatal LPS exposure can cause a reduction in the cytokine or febrile response 
following LPS challenge of the adult rat (Ellis et al., 2005, Spencer et al., 2011). Thus, it 
would appear that an early life exposure to LPS has the potential to modify the 
inflammatory response in the adult animal, creating a low-responding phenotype.   
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In this current study, we investigated if a single exposure to LPS during the 
neonatal period would modify the in vivo inflammatory response to a subsequent LPS 
challenge in dairy calves. Additionally, two cellular models, dermal fibroblasts and 
monocyte-derived macrophages, were utilized to explore if early life exposure to LPS 
would result in sustained epigenetic modifications of the LPS response of these cells, 
thereby influencing the innate immune response.  
4.3. Materials and Methods  
4.3.1 Experimental design and animal use 
Holstein bull calves that were free of clinical disease and had received 4 L of 
pooled colostrum within 1 h of birth and a second feeding of pooled colostrum 12 h later 
were purchased from a collaborating dairy farm. The calves (n=10) were brought to the 
University of Vermont Miller Research Farm at 3.3 ± 0.5 days of age and given a four-
day acclimation period. Calves were housed in individual plastic calf hutches and had 
access to a fenced-in outside area of approximately 3 m x 3 m. Free choice water and a 
commercially available calf starter were offered to each calf throughout the trial. Calves 
were bucket-fed an ad libitum amount of a 23% protein, 22% fat milk replacer (OptiMilk 
Nature’s Formula, Arctic Blend; Poulin Grain, Newport, VT) divided between two 
feedings per day throughout the study period. The University of Vermont Institutional 
Animal Use and Care Committee approved of all experimental procedures prior to the 
commencement of this study.  
4.3.2 Early life treatment  
Calves were randomly divided into two groups: Early Life LPS (ELL) and Early 
Life Saline (ELS), each consisting of five calves. At approximately 7 days of age, 
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roughly 2 h after the morning feeding, the early life treatment was administered to each 
calf. Calves in the ELL group received a jugular injection of 0.5 μg of LPS/kg of body 
weight isolated from Escherichia coli O111:B4 (Sigma, St. Louis, MO) diluted in saline, 
while the calves in the ELS group received an equal volume of saline. The dose of LPS 
was based on our previous experiments with 14 month-old heifers (Green et al., 2011b). 
Prior to a single injection of either the LPS solution or saline, the fur along the jugular 
vein area was clipped and the area was thoroughly cleansed with 70% ethanol. Rectal 
temperatures were collected immediately prior to the injection (hour 0) and hourly for 
seven hours. Blood samples were collected at hours 0, 2, and 6 post-LPS infusion with an 
18-gauge Vacutainer needle (BD, Franklin Lakes, NJ) and a 10 ml Vacutainer tube 
containing 158 USP Units of Sodium Heparin (BD). Tubes were inverted several times to 
ensure adequate mixing of the anti-coagulant and stored on ice for approximately 2 h 
before centrifugation at 800 x g for 20 min at 4°C. Plasma was then collected and stored 
at -20°C for future analysis.   
4.3.3 LPS challenge 
Each calf was fitted with a jugular catheter for the LPS challenge to allow for 
easier administration of the LPS solution and blood sampling. Twenty-four hours prior to 
the catheterization, a 50 cm section of polyethylene tubing (I.D. 1.19mm, O.D. 1.70mm; 
Intramedic, BD) was cut per calf and sanitized in a Nolvasan S solution (Pfizer, NY, 
NY). The day of catheterization, each calf was secured in a headlock, the fur was clipped 
on top of the jugular vein, and the area was cleansed with 70% ethanol. A 12-gauge, 1.5-
inch metal hub needle (Hamilton, Reno, NV) was then inserted into the jugular vein, and 
20-25 cm of the polyethylene tubing was inserted through the needle. The needle was 
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then removed, an 18-guage luer stub adapter (Intramedic) attached, and the catheter filled 
with heparinized saline. The following day, after morning feeding, a single dose of 0.25 
μg of LPS/kg of body weight isolated from E. coli O111:B4 (Sigma) was infused into 
each calf at hour 0. Heparinized blood samples were collected at -30 min, and then at 
hours 1, 2, 3, 5, and 7 post-infusion and stored on ice. Plasma was isolated within 2 h and 
stored at -20°C for future analysis.  
4.3.4 Plasma IL-6 and TNF-α quantification  
Concentrations of IL-6 in plasma samples were determined with a commercially 
available bovine IL-6 ELISA kit (Thermo Scientific, Rockford, IL). The capture and 
detection antibodies were both plated at 1:100 and the streptavidin-horseradish 
peroxidase was plated at 1:400. Recombinant bovine IL-6 (Thermo Scientific) was used 
at the assay standard. Concentrations of tumor necrosis factor alpha (TNF-α) were 
determined via RIA as previously described (Elsasser et al., 2005).   
4.3.5 Dermal fibroblast isolation 
Skin biopsies were collected from the ELL (n=5) and ELS (n=5) calves as 
previously described (Kandasamy et al., 2011). Briefly, dermal fibroblasts (DF) were 
isolated following a 6 h digest with 0.5% collagenase type I enzyme (Life Technologies, 
Grand Island, NY). The collagenase-digested tissue was filtered, centrifuged, and the cell 
pellet was reconstituted with Dulbecco’s modified Eagle medium (DMEM; Hyclone 
Laboratories, Logan, UT) containing 10% fetal bovine serum (FBS; Hyclone 
Laboratories), a 1X antibiotic cocktail (100 U/ml of penicillin, 100 μg/ml of 
streptomycin, and 0.25 μg/ml of amphotericin B; Hyclone Laboratories), and 1X insulin-
transferrin-selenium (ITS; Mediatech, Herndon, VA) and seeded into a 25-cm2 flask 
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(Corning Inc., Corning, NY). Media was replaced after an initial 16 h incubation with 
fresh DMEM (10% FBS, 1X antibiotic cocktail, and 1X ITS). Once confluency was 
reached, cells were detached with 0.25% trypsin (MP Biomedical, Santa Ana, CA) and 
seeded into a 75-cm2 flask. After approximately 4 days, cells were expanded into three 
75-cm2 flasks. Finally, confluent cultures were lifted with trypsin and aliquots of the third 
passage were diluted in DMEM supplemented with 20% FBS and 10% dimethyl 
sulfoxide (Sigma) and cryopreserved in liquid nitrogen for subsequent revival, expansion, 
and challenges.  
4.3.6 Adherent mononuclear cell isolation and culturing 
A 180 ml blood sample was obtained from each of the ELL (n=5) and ELS (n=5) 
calves via jugular venipuncture with a 60 cc syringe pretreated with heparin (10,000 USP 
units/ml; Sagent Pharmaceuticals, Schaumburg, IL) and immediately transferred to 
heparinized vacutainer tubes (BD). Samples were stored on ice for approximately one 
hour prior to processing. Vacutainer tubes were centrifuged at 800 x g for 20 min at 4°C. 
Peripheral blood mononuclear cells (PBMC) were removed and treated with red blood 
cell lysis buffer (Biolegend, San Diego, CA). No more than five buffy coats were treated 
with 7.5 ml of 1X red blood cell lysis buffer and inverted for 30 s. Two washes were then 
performed using sterile Dulbecco’s phosphate-buffered-saline (DPBS, Hyclone 
Laboratories) by centrifuging samples at 500x g for 5 min at room temperature. After the 
second wash, cells were resuspended in 30 ml of DPBS and 10 ml of a Percoll (GE 
Healthcare, Sweden) solution with a specific density of 1.077 g/cm3 (mixture with 1.5 M 
NaCl and 30% endotoxin-free water) was carefully underlain below the sample. The 
Percoll gradient was centrifuged at 400 x g for 40 min at room temperature with no 
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brake. The PBMC layer was removed from the interface of the DPBS and Percoll then 
placed into a clean polypropylene tube. One more DPBS wash was performed as stated 
above to remove residual Percoll. After washing, PBMC were resuspended in 30 ml 
DPBS and centrifuged at 250 x g for 12 min at room temperature to remove platelets. 
After the platelet spin, the cells were resuspended in DMEM, 15% FBS, 1X ITS and 1X 
penicillin-streptomycin (100 U/ml of penicillin and 100 μg/ml of streptomycin). The 
PBMC were then transferred to a 25-cm2 flask and incubated in a humidified chamber at 
37°C and 5% CO2 for 3 h. Non-adherent cells were removed and placed in a clean 
polypropylene tube and adherent cells were washed with DPBS and fresh DMEM media 
was added. Non-adherent cells were transferred to a second 25-cm2 flask and those that 
had adhered overnight were washed the next morning at which time fresh media was 
added. Mononuclear cells were incubated for 5 d and media was replaced as needed. 
After 5 d, cells were lifted with 0.25% trypsin, and the 3 h cultures and overnight cultures 
were combined and transferred to a 12-well plate at a concentration of 1.0 x 105 cells/ml 
in a total volume of 1 ml. The cells were cultured for 3 more days to allow for complete 
macrophage differentiation. 
4.3.7 In vitro challenges  
Aliquots of fibroblast cultures isolated from the ten bull calves were revived in 
parallel and grown to confluency in a 75-cm2 flask. Cells were then detached with 
trypsin, counted, and seeded into 6-well plates at a concentration of 1.25 x 105 cells/ml in 
2 ml total/well. Following a 24 h incubation, cells were exposed to 500 ng/ml of ultra-
pure LPS isolated from E. coli O111:B4 (Sigma) or fresh culture media for 24 h. Media 
was then collected and centrifuged at 10,000x g for 1 minute to remove cell debris and 
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the supernatant was stored at -20°C for future analysis. Cells were lysed at hours 0 and 24 
post-LPS, and RNA was extracted at stored at -80°C (5 Prime, Gaithersburg, MD) until 
future analysis.  
After 8 days in culture, macrophages were treated with either media or media 
containing 100 ng/ml of LPS isolated from E. coli O111:B4 for 24 h, after which media 
was removed and centrifuged at 10,000x g for 1 min and supernatant was stored at -20°C 
until further analysis. Cells were lysed at hours 0 and 24 post-LPS, and RNA was 
extracted at stored at -80°C (5 Prime, Gaithersburg, MD) until future analysis.  
4.3.8 Quantification of in vitro immune response proteins  
Levels of IL-8 protein produced from fibroblast and MDM cultures following an 
LPS challenge were determined in duplicate with a commercially available bovine IL-8 
ELISA kit (Mabtech, Cincinnati, OH) as per manufacturer’s instructions with some 
modifications. A solution of 1 μg/ml of the monoclonal coating antibody (MT8H6) was 
plated in 0.05 M bi-carbonate buffer on a high affinity 96-well ELISA plate (Corning 
Life Sciences, Tewksbury, MA) and incubated overnight at 4°C. Media samples or 
recombinant bovine IL-8 standard (Thermo Scientific) were plated following a series of 
three washes with a solution of DPBS and 0.05% Tween-20 (DPBS-T; Fisher 
Bioreagents, Fair Lawn, NJ) and incubated for 2 h at 20°C. Plates were washed with 
DPBS-T and a monoclonal detection antibody (26ES-Biotin) was plated at 0.025 μg/ml 
and incubated for 1 h at 20°C. After a series of washes, streptavidin-horseradish 
peroxidase (Sigma) was plated at 0.1 μg/ml and incubated for 1 h. Lastly, 3,3′,5,5′-
tetramethylbenzidine (TMB) substrate (Fisher Scientific, Pittsburgh, PA) was added for 
approximately 7 min, and the reaction was stopped with 1M H2SO4.  
 139
Concentrations of TNF-α protein in macrophage-conditioned media were 
determined in duplicate using a custom sandwich ELISA as described above except: 
coating antibody (polyclonal rabbit anti-bovine TNF-α, 1 mg/ml, Thermo Scientific) was 
diluted 1:200 in 0.05 M bi-carbonate buffer, recombinant bovine TNF-α (Kingfisher 
Biotech, Inc., St. Paul, MN) was used as standard, and biotinylated secondary antibody 
(rabbit anti-bovine TNF-α, Thermo Scientific) was diluted 1:1,000 to a concentration of 
0.25 µg/ml in DPBS-T. The detection limit of the assay was 156 pg/ml. The 
concentrations of IL-1β were similarly quantified using a commercially available 
sandwich ELISA (Thermo Scientific). The detection limit of the assay was 62 pg/ml. All 
ELISA reactions were quantitated by measuring absorbance at 450nm and analyzed by a 
4-parameter analysis with optical density corrected against blank wells (Synergy-HT, 
Bio-Tek, Winnoski, VT).   
4.3.9 Quantitative real time-PCR  
Dermal fibroblasts (DF) and monocyte-derived macrophages (MDM) were 
isolated and cultured for an LPS challenge as described above for each of the ten calves 
and cell lysate was collected at hours 0 and 24 post-LPS for each culture. The 
PurefectPure RNA Cultured Cell extraction kit (5 Prime), which includes a DNase 
treatment step to eliminate DNA contamination, was used to extract total RNA from the 
cell lysate. RNA concentration was determined using a Qubit Spectrofluorometer (Life 
Technologies, Carlsbad, CA). The Improm II Reverse Transcriptase Kit (Promega, 
Madison, WI) was utilized to complete first strand cDNA synthesis. The following genes 
were selected for real-time PCR analysis: TLR4, IL6, IL8 (in both DF and MDM cultures) 
and CD14, IL-1β receptor, and IL-1β (in MDM cultures only). Expression levels of these 
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genes were determined by quantitative real-time PCR (qRT-PCR) with a 7500 Fastrun 
Machine (Applied Biosystems, Carlsbad, CA) using Fermentas Maxima SYBR 
Green/Fluorescein qPCR Mastermix (Thermo Scientific). An endogenous control gene, 
β-actin was used for normalization of the target genes. Sequences for the constructed 
primers are listed in Table 1.  
4.3.10 Statistical analysis  
Differences in rectal temperatures, as well as concentrations of plasma TNF-α and 
IL-6, were determined between the ELL and the ELS calves following the early life 
treatment and the LPS challenge by a repeated measures ANOVA using Prism 6.0 
(GraphPad Software Inc., La Jolla, CA). Differences in immune response proteins and 
gene expression following an LPS challenge between the fibroblast and monocyte-
derived macrophage cultures collected from the ELL and ELS calves were determined by 
an unpaired t-test in Prism 6.0. 
4.4. Results   
Blood samples were collected from each calf at hours 0, 2, and 6 following the 
early life treatment (LPS or saline) to determine concentrations of two key inflammatory 
cytokines, IL-6 and TNF-α. Prior to the treatment, levels of IL-6 (Figure 4.2A) and TNF-
α (Figure 4.2B) were similar between the ELL and ELS calves. However, by hour 2 post-
treatment, levels of IL-6 and TNF-α in the ELL calves had reached peak values (P < 0.05; 
14.4 ± 3.1 and 3.2 ± 1.0 ng/ml, respectively), while no increase in either cytokine was 
observed in the ELS calves. At 6 h post-treatment, IL-6 levels remained elevated (P < 
0.05) in the ELL calves, and plasma TNF-α had decreased to pre-treatment levels, with 
no detectable changes in plasma IL-6 or TNF-α from the ELS calves. Moderate 
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respiratory distress and lethargy was typically observed in the ELL animals. Rectal 
temperatures did not increase due to the early life treatment in either group and were 
similar between the ELL and the ELS calves (Figure 4.2C).  
 Twenty-five days after the early life treatment, an LPS challenge was performed 
on all ten calves to compare the LPS response between calves that had received LPS 
(n=5) and calves that had received saline (n=5) in early life. Following an LPS bolus of 
0.25 μg/kg of body weight, plasma levels of IL-6 increased in both the ELL and ELS 
calves, reaching similar peak values (6.7 ± 0.6 and 6.1 ± 0.7 ng/ml) at hour 3, and 
decreasing slightly by hour 7 post-infusion (Figure 4.3A). Plasma TNF-α reached 
maximum concentrations in ELL calves 1 h following LPS (4.8 ± 1.3 ng/ml) while TNF-
α concentrations peaked in ELS calves 2 h post-LPS (3.9 ± 1.1 ng/ml). Despite the early 
temporal differences, TNF-α levels were similar between ELL and ELS calves for the 
remainder of the challenge (Figure 4.3B). Rectal temperatures following the LPS 
challenge decreased slightly in both groups, as shown in Figure 4.3C, however, there 
were no differences observed between the ELL and ELS calves.  
 Skin biopsies were collected from each calf 13 days after the early life treatment 
and 12 days before the LPS challenge to isolate dermal fibroblasts (DF). This time point 
was selected in anticipation that any epigenetic modifications resulting from the early life 
LPS treatment that could influence the fibroblast LPS response would be present in our 
cellular model. Aliquots of fibroblasts from each animal were revived and challenged in 
parallel with LPS (500 ng/ml) for 24 h, and levels of IL-6 and IL-8 protein secreted in 
media were used as indicators of that fibroblast culture’s LPS response. Fibroblasts 
 142
isolated from the ELL and ELS calves at approximately 20 d of age produced similar 
levels of IL-6 (Figure 4.4A) and IL-8 (Figure 4.4C) protein following LPS exposure.  
Mononuclear cell-derived macrophages (MDM) were isolated from each of the 
calves (n=10) 21 days after the early life treatment and 4 days before the LPS challenge 
to determine if the in vitro LPS response from the MDM would be dampened due to the 
early life LPS treatment. MDM cultures were seeded into 6-well plates, incubated for 24 
h, and then challenged with LPS (100 ng/ml) for 24 h. Concentrations of IL-6 and IL-8 
protein produced by the MDM cultures following LPS exposure were similar between the 
treatment groups (Figure 4.4B and 4.4D). Additionally, levels of IL-1β and TNF-α were 
determined in MDM supernatant following LPS treatment (Figure 4.4E and 4.4F, 
respectively). Each of the immune response proteins measured in MDM cultures 
established from the calves were similar between the two early life treatment groups 
(ELL vs. ELS).  
 Expression levels of genes involved with the LPS recognition and response 
pathway were investigated in both the DF and MDM cultures established from all calves. 
Total RNA was collected from DF and MDM at hours 0 and 24 post-LPS, and gene 
message was determined by qRT-PCR. Expression of TLR4, the receptor responsible for 
LPS recognition, was consistent following LPS stimulation and was not different between 
the ELL and ELS groups in either DF or MDM cultures, but was much greater in the 
MDM cultures (Figure 4.5A and D). The cytokine IL6 and chemokine IL8 are critical 
immune response genes following LPS exposure, and the expression of these genes 
increased from hour 0 to hour 24 in both cellular models (Figure 4.5B and E). However, 
no differences were observed between the ELL and ELS calves in either cellular model, 
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although the expression of both IL-6 and IL-8 was much greater in the MDM cultures. 
Levels of expression of three other genes (CD14, IL-1β receptor, and IL-1β) were 
determined in control and LPS-treated MDM cultures from the ELL and ELS calves 
(Figure 4.5G, H, and I). The expression of IL-1β was markedly induced by LPS treatment 
of the MDM cultures, while the expression of CD14 and the IL-1β receptor were not 
affected. However, there were no differences in gene expression between the cultures 
established from the ELL and ELS calves.  
4.5. Discussion  
Previous work from our laboratory and others has shown that dairy cattle manifest 
a wide range of immune responses following experimentally induced E. coli 
(Kornalijnslijper et al., 2003, Bannerman et al., 2004, Kandasamy et al., 2011) or 
Staphylococcus aureus (Schukken et al., 1999, Bannerman et al., 2004, Benjamin et al., 
2015a) mastitis. Some animals exhibit a much more robust inflammatory response during 
mastitis, characterized by high levels of IL-8, IL-6, and TNF-α, which can lead to severe 
clinical signs and damage to the mammary tissue. Inter-animal variation in the expression 
of genes within the LPS response pathway, including TLR4, the receptor for LPS, may 
lead to individual differences in the ability to recognize and respond to Gram-negative 
pathogens (Kandasamy and Kerr, 2012). A genetic component to individual differences is 
highly likely, but new research suggests that epigenetics may also play a role. For 
example, we have found that the LPS responsiveness of an animal’s fibroblasts changes 
with age. In side-by-side cultures of cells recovered from cryopreservation but originally 
collected from the same animals at different ages, we find a marked increase in response 
to LPS stimulation. Furthermore, the age-dependent difference in LPS response of these 
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cells can be abolished by treatment with epigenetic modifiers (Green and Kerr, 2014). 
Expanding on the inter-animal variation observed in the fibroblast model, cultures 
established from dairy and beef animals displayed contrasting responses following an in 
vitro LPS exposure. Whole transcriptome analysis of LPS-treated cultures revealed large 
breed-dependent differences in the expression of many LPS-responsive genes, including 
TLR4, IL8, TNF, CCL5, and CCL20 (Benjamin et al., 2016b). These genes, which are 
associated with the inflammatory response to LPS, were expressed between 2.5- and 7.0-
fold higher in Holstein fibroblast cultures as compared to Angus cultures. While genetics 
may contribute to the contrasting in vitro LPS responses between these breeds, offspring 
from each breed experience very different early life environments, which could lead to 
varying degrees of epigenetic modifications between the dairy and beef breeds, 
potentially moderating inflammatory gene expression.  
4.5.1 Impact of neonatal inflammation  
Several studies have shown that inflammation in the neonatal period (shortly after 
birth) can lead to sustained suppression of the innate immune response to a subsequent 
inflammatory challenge. Ellis et al. (2005) observed reduced plasma levels of TNF-α and 
IL-1β as well as a suppressed febrile response following an LPS challenge of adult rats 
that had been exposed to LPS at 14 days of age compared to saline-exposed controls. 
Similarly, adult rats that had previously received a neonatal dose of LPS (100 μg/kg) at 
14 or 21 days of age produced a lower febrile response compared to neonatal saline 
controls during a subsequent LPS (50 μg/kg) challenge (Spencer et al., 2006). However, 
the timing of the neonatal exposure was found to be critical in that LPS treatments given 
at 7 or 28 days of age were not effective. Additionally, the suppressive effect is not 
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observed if the adult challenge dose of LPS is increased to a septic dose of 1 mg/kg 
(Spencer et al., 2010). In the current study, we hypothesized that an early life LPS 
exposure would generate a low-responding phenotype in Holstein calves towards a 
subsequent LPS challenge. Surprisingly, ELL calves mounted a similar inflammatory 
response as the ELS calves during the later LPS challenge that was completed on all 
calves 25 days after the first LPS or saline exposure. Plasma levels of TNF-α and IL-6 
during the later LPS challenge were comparable between treatment groups, showing the 
early life treatment with LPS (0.5 μg/kg) at 7 days of age did not dampen the subsequent 
inflammatory response to LPS (0.25 μg/kg). The doses used did produce substantial 
inflammation and may have been too high to generate the expected result. 
Although other studies have shown that administering LPS in the neonatal period 
does reduce the LPS response in the adult, most of these studies have been completed in 
rats (Spencer et al., 2011, Wang et al., 2011). Different rates of development and maturity 
within the immune system between calves and rodents may be one explanation for the 
lack of differences between our LPS- and saline- treated calves. Offspring from species 
with a comparatively short gestation period, such as rats (length of 21 days), are born 
with a less mature immune system than offspring from species with a longer gestation, 
for example cattle (length of 9 months) (Holsapple et al., 2003). A less mature immune 
system during the neonatal period in a rat pup may provide an opportunity for 
inflammation to epigenetically modify the genes of the immune response in the adult, 
whereas the immune system of a neonatal calf may be less vulnerable to those types of 
modifications during that same stage of life. Following parturition, the humoral and cell-
mediated immune response of the calf is much lower than an adult cow, but within the 
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first month of life, B-cell numbers increase and the cell-mediated response is similar to 
that of an adult animal (Barrington and Parish, 2001). The immune system in newborn 
rats is immature, and continues to develop during the postnatal period and although an 
immune response can be mounted at 21 days of age, it is not of the same magnitude as an 
adult animal (Holsapple et al., 2003). A comparison of the degree of immune system 
development of the rat pups in studies mentioned previously and the calves in this current 
study suggests the timing of the LPS exposure in the neonatal calves may have been too 
late to obtain a reduction in the inflammatory response towards an LPS challenge.  
4.5.2 Fetal programming: maternal inflammation and nutrition  
Exposure to bacterial molecules or inflammation in utero can also alter aspects of 
an offspring’s behavior, health, and development. Increases in anxiety and depression-
like behaviors, as well as an increased propensity towards developing schizophrenia have 
been observed in rodents whose dams suffered stress or inflammation during gestation 
(Ashdown et al., 2006, Depino, 2015). Additionally, several studies have shown that the 
inflammatory response of the offspring can be suppressed following in utero LPS 
exposure. For example, Lasala and Zhou (2007) found that an intraperitoneal injection of 
LPS given to rats on day 18 of pregnancy greatly reduced the inflammatory response 
(serum levels of TNF-α, IL-1β, and IL-6) of the resulting pups when they were 
challenged with LPS at 21 days of age. In a similar study, adult rats that were exposed to 
LPS in utero at days 16, 18, and 20 of gestation have a blunted inflammatory response 
towards an LPS challenge as compared to saline-exposed rats (Hodyl et al., 2007). 
Similarly, offspring of mouse dams that were administered LPS approximately 12 h after 
fertilization had a diminished cytokine response following an LPS challenge at 40 weeks 
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of age (Williams et al., 2011). Perhaps an in utero exposure of LPS, or maternally derived 
inflammatory cytokines, would cause a reduction in the inflammatory response towards a 
later LPS challenge in dairy calves. However, careful consideration of the timing and 
dosing of the immune stimulant for such a study must be taken, as previous studies 
conducted in dairy cattle have shown that experimental uterine bacterial infections and 
LPS infusions can cause abortions prior to gestational term (Miller et al., 1983, Giri et al., 
1990).  
4.5.3 LPS tolerance  
Endotoxin tolerance is a protective mechanism that allows for innate immune 
cells to experience a transient unresponsive period following exposure to low levels of 
LPS (Biswas and Lopez-Collazo, 2009). Depending on the species, this refractory period 
can vary in duration, from roughly a week in rats (West and Heagy, 2002), 10 days in 
dairy cattle (Petzl et al., 2012), to at least two weeks in human patients suffering from 
endotoxemia (Kox et al., 2011). Several studies have shown that a primary result of 
endotoxin tolerance is a reduction or complete abolishment of TNF-α transcript and 
protein following a second exposure to LPS (West and Heagy, 2002). Within our study, 
the calves that were treated with LPS in early life were likely outside the range of a 
tolerant state during the subsequent LPS challenge that was given 25 days later. The 
levels of plasma TNF-α in these calves were actually higher during the later LPS 
challenge compared to levels reached during the LPS treatment in early life (4 ng/ml vs. 3 
ng/ml, respectively). This demonstrates that the cells primarily responsible for executing 
LPS tolerance, monocytes and macrophages (Kox et al., 2011), were able to mount an 
unabated inflammatory response towards the later LPS challenge. 
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4.5.4 Cellular models of innate immunity  
Extensive use of in vitro models to study the bovine innate immune response is 
evident, with several different cell types, including mammary epithelial cells (Pareek et 
al., 2005, Gilbert et al., 2013), neutrophils (Sohn et al., 2007, Revelo and Waldron, 
2012), and whole blood (Ballou et al., 2015, Jahan et al., 2015) being utilized. However, 
each of these models has drawbacks, including invasive collection procedures, inability 
to cryopreserve for subsequent challenges, and a heterogeneous cell population. 
Conversely, monocyte-derived macrophages do provide a classical innate immune cell 
model that is relatively easy to collect and culture. Bovine monocyte-derived 
macrophages have been shown to be responsive to challenges with Mycobacterium bovis 
(Magee et al., 2012) and LPS (Taraktsoglou et al., 2011), resulting in the induction of 
many immune -response genes such as IL-8, CCL5, and TLR4.  
In the current study, the establishment of fibroblast and adherent mononuclear cell 
cultures from each animal provided two cellular models to determine if the early life LPS 
induced epigenetic modifications within innate immune response genes would be 
reflected in the in vitro LPS-response. Additionally, collection of these two cell types 
from each animal allowed for a comparison of the LPS response of two cellular models 
from the same animal. Fibroblasts are long-lived cells that are capable of modulating the 
inflammatory response as they express innate immune receptors such as TLRs and 
secrete various cytokines and chemokines following pathogen recognition (Buckley et al., 
2001, Kandasamy et al., 2011, Benjamin et al., 2015a). Alternatively, circulating 
monocytes are released from bone marrow, and depending on the environmental 
conditions, undergo apoptosis within a few days or migrate into tissues (Parihar et al., 
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2010). Once inside the tissue, monocytes will differentiate into macrophages that aid in 
the clearance of a pathogen or damaged cells (Parihar et al., 2010). These tissue-resident 
macrophages can survive for days to months depending on the needs of the host. Within 
this study, the main objective in collecting both adherent mononuclear cells and 
fibroblasts from the saline- and LPS-treated calves was to observe if the early life LPS 
exposure created a change, either permanent or temporary, in the in vitro LPS response 
between the early life treatment groups. Monocytes are continually produced in the bone 
marrow by myeloid progenitor cells, and a systemic cytokine response following LPS 
exposure may reach these stem cells and induce permanent epigenetic DNA 
modifications that could be detected in monocytes collected three weeks later. Dermal 
fibroblasts however are a more stable cell type than monocytes, but may still be 
susceptible to epigenetic modifications following exposure to a systemic inflammatory 
response. While epigenetic modifications could be induced within fibroblast progenitor 
cells, it is more likely that the fibroblast cells we collected three weeks post-challenge 
were the same cells present at the time of the early life LPS treatment. This may create 
more transient epigenetic modifications, such as histone modifications, that are still 
capable of influencing the inflammatory response, but are potentially too short-lived to 
detect the effect after several rounds of cell division while in cell culture. While 
progenitor fibroblast cells could be affected, they proliferate at a slower rate, and this 
effect may not be evident only three weeks post early life treatment. Surprisingly, the in 
vitro response following an LPS challenge on each of these cell types revealed similar 
profiles in both cytokine secretion and gene expression between the LPS- and saline-
treated calves, which confirmed the lack of differences observed in vivo during the 
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second LPS challenge. Interestingly, the monocyte-derived macrophages exhibited a 
much more robust IL-6 response following LPS stimulation as compared to the 
fibroblasts (Figure 4). Other groups have observed a similar induction of IL-6 in 
macrophages following LPS stimulation (Jian et al., 1995, Taraktsoglou et al., 2011), but 
there have been few studies examining differences in the IL-6 response following LPS 
stimulation between bovine MDM and DF cultures. A comparison between mouse 
gingival fibroblasts and macrophages revealed that the mouse alveolar macrophage cell 
line produced less IL-6 following stimulation with LPS compared to the fibroblast 
cultures (Jones et al., 2010). While this is inconsistent with our findings, Jones et al. 
(2010) utilized a commercially available cell line from mice and challenged with a LPS 
dose of 1 μg/ml for 24 h. Our MDM model is derived from primary bovine mononuclear 
cells that are allowed to differentiate into macrophages in culture, and we exposed the 
cells to a lower LPS dose (100 ng/ml) for 24 h. Additional challenges that compare the 
LPS response of primary bovine MDM and DF may be of interest.  
4.6 Conclusions   
Variation in the innate immune response towards mammary infections exists in 
dairy cattle, with some animals exhibiting a mild inflammatory response and others 
suffering a severe inflammatory reaction that results in collateral damage or death. It has 
been shown that exposure to inflammation or stress either during early life or in utero can 
cause epigenetic modifications to the animal’s innate immune response. The potential for 
this type of exposure to create a low responding phenotype in the offspring, one that 
mounts an effective inflammatory response without inflicting damage on host’s tissue, is 
exciting. However, based on the results from this study, an early life exposure to LPS 
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does not cause a dairy calf to mount a milder inflammatory response to a subsequent LPS 
challenge 25 days later compared to saline-treated control calves. Through the use of 
mononuclear cell-derived macrophages and dermal fibroblasts, the lack of difference in 
vivo between LPS-treated and saline-treated calves was confirmed in vitro.  
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Table 7: Oligonucleotide primers for expression quantification with real-time PCR 













Gene Name Primer (5’ to 3’) Reference 
Toll-like receptor 4 ACTGCAGCTTCAACCGTATC 
TAAAGGCTCTGCACACATCA 
Ibeagha-
Awemu et al. 
(2008) 
Interleukin - 6 TGAGGGAAATCAGGAAAATGT 
CAGTGTTTGTGGCTGGAGTG 
Pareek et al. 
(2005) 
Interleukin - 8 GCTGGCTGTTGCTCTCTTG 
AGGTGTGGAATGTGTTTTTATG 
Pareek et al. 
(2005) 
Cluster of differentiation 14 CTCCAGCACCAAAATGAC 
TCCTCTTCCCTCTCTTCC 
Sohn et al. 
(2007) 
Interleukin – 1 beta receptor GCTCGTGTCCTCTCATCACA 
ACCTTTGTGCTGGTGAATCC 
Mills et al. 
(2009) 
Interleukin – 1 beta CTCTCACAGGAAATGAACCGAG 
GCTGCAGGGTGGGCGTATCACC 









Figure 4.1: Timeline of the Study 
The effects of an early life LPS exposure on response to a subsequent LPS challenge  
were determined in ten neonatal Holstein calves. Trial days are shown in the gray bar, 
with the calf arrival date on day 0 and completion of the trial on day 30, at which point 
calves were sold. The average age of the calves and key events within the trial are 
denoted below and above the gray bar, respectively. Early life treatment at day 4 
consisted of either an LPS or saline intravenous injection (n=5/treatment). Skin biopsies 
and blood samples were collected from each calf to isolate dermal fibroblasts (DF) and 
adherent mononuclear cell-derived macrophages (MDM), respectively. An LPS 
challenge was completed on all calves at day 29 of the trial to determine the effect of the 
early life treatment on response to the subsequent LPS challenge.  
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Figure 4.2: Plasma cytokine responses and rectal temperatures following the early 
life treatment  
Calves were split into two groups, one of which received LPS and the other received 
saline at 7 days of age. Blood samples were collected from each calf at hours 0, 2, and 6 
following administration of the early life treatment. Plasma levels of IL-6 (A) and TNF- α 
(B) were determined after the early life treatment, and rectal temperatures were taken on 
animals from both groups (C). ELL= early life LPS and ELS= early life saline. Values 
are mean ± SEM.  
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Figure 4.3: Plasma cytokine response and rectal temperature profiles following an 
LPS challenge 
Holstein bull calves were divided into two groups (n=5/group) based on an early life 
treatment consisting of either LPS (ELL) or saline (ELS) that was given at 7 days of age. 
A subsequent LPS challenge was completed on all calves at 32 days of age to determine 
if the early life treatment had an effect on the systemic response to the later LPS. Plasma 
concentrations of IL-6 (A) and TNF- α (B) were measured in the calves from the ELL 
and ELS groups following the LPS challenge. Rectal temperatures (C) of calves  
following the LPS intravenous infusion at 32 days of age were not different between the 
treatment groups. Values are mean ± SEM. 
 












































































Figure 4.4: Effect of early life LPS on cellular response to LPS in vitro. 
Dermal fibroblasts (DF) and adherent mononuclear cell-derived macrophages (MDM) 
were isolated from each calf (n=10) to determine if an in vivo LPS exposure during early 
life would influence the response of these cell types to an in vitro LPS challenge. A 24 h 
LPS challenge was completed on each cell type, however DF were treated with 500 
ng/ml of LPS and MDM were treated with 100 ng/ml of LPS. The amount of secreted IL-
6 from DF (A) and MDM (B), IL-8 from DF (C) and MDM (D) following LPS exposure 































































































secreted by MDM post-LPS (concentrations of IL-1β and TNF-α were undetectable in 
LPS-treated fibroblast cultures). ELL= early life LPS, ELS= early life saline. There were 











Figure 4.5: Expression levels of LPS recognition and response genes.  
Dermal fibroblasts (DF) from each calf were revived and challenged with 500 ng/ml of 
LPS for 24 h and total RNA was collected at hours 0 and 24. A similar challenge was 
completed on adherent mononuclear cell-derived macrophages (MDM) isolated from 
each calf; however, an LPS dose of 100 ng/ml was used. Gene expression levels of 
TLR4, IL-6, and IL-8 post-LPS were investigated on both DF and MDM cultures using 
qRT-PCR. Expression levels from DF cultures are presented in panels (A) TLR4, (B) IL-
6, and (C) IL-8, while expression levels of MDM cultures are in panels (D) TLR4, (E) 
IL-6, and (F) IL-8. Panels (G), (H), and (I) represent the expression levels of CD14, IL-






















































































































































were not determined in DF cultures. ELL= early life LPS, ELS= early life saline. There 






















CHAPTER 5: GENERAL CONCLUSIONS 
  
Both dairy producers and researchers have struggled with the challenge of 
effectively controlling bovine mastitis. Although obstacles still remain in the control of 
contagious pathogens, there has been a significant reduction in cow-to-cow transmission 
since the implementation of mastitis control plans in the 1960’s, specifically the “Five-
Point Plan” developed by the National Institute for Research into Dairying (Bramley and 
Dodd, 1984, Hillerton et al., 1995). Beginning in the 1970’s environmental pathogens 
started gaining attention and have risen to become the most important mastitis-causing 
pathogens in the modern dairy industry (Oliveira et al., 2013, Ruegg, 2017). Although 
limited in their duration, coliform bacteria, such as E. coli, almost always cause clinical 
mastitis that is extremely costly to the dairy industry, mainly due to drastic losses in milk 
production and lowered milk quality. Estimates on the cost of clinical mastitis have 
ranged from $179 to $444 per episode, depending on age, stage of lactation, cow 
productivity and parity (Bar et al., 2008, Cha et al., 2011, Rollin et al., 2015, Liang et al., 
2017).  
There is also substantial between-animal variation in the severity of clinical 
mastitis that appears to be due to innate differences in host response factors. The 
contribution of genetic differences to between-cow variation in susceptibility to mastitis 
has been estimated to be quite low, however the accuracy and magnitude of response to 
infection that results in differential severity can be addressed through the inclusion of 
new, more reliable variables in prediction equations. Currently, genetic factors that affect 
mastitis susceptibility have mainly been linked to infrequent measures of milk somatic 
cell score which has some inherent flaws. First, somatic cell count is typically taken only 
 166
on prescribed monthly basis, without regard to udder health, and will likely miss many 
transient infections that are characteristic of environmental pathogens or have little value 
in relation to the dynamic nature of SCC response to infection. Second, a snapshot of 
somatic cell count shows a very limited picture of the cow’s current health status and it 
may be more valuable to know the duration of elevated somatic cell count and the 
efficiency of response to recovery. Furthermore, the accurate phenotype has been the 
subject of considerable debate, whereby some believe that a higher neutrophil response is 
favorable to infection outcome and others are of the belief that a subdued, but effective 
response is more desirable to limit tissue damage. In support of the latter supposition, 
animals ranked as high responders based on fibroblast phenotype that were 
experimentally infected with E. coli had more tissue damage, elevated somatic cell count, 
and slower return to pre-infection milk production without any benefit in their ability to 
clear bacteria (Kandasamy et al., 2011).  
Although not insubstantial, genetic heritability of mastitis is considered to be 
quite low, indicating that non-genetic factors may have an equal or greater contribution to 
mastitis susceptibility. Epigenetic modifications are known to contribute to inter-
individual differences in disease susceptibility and severity, including in asthma (Runyon 
et al., 2012) and Salmonella enteritidis infection in chickens (Gou et al., 2012), among 
many others. In addition, infection status, such as intra-mammary infection with E. coli 
(Chang et al., 2015a) and bovine tuberculosis (Doherty et al., 2016), has been shown to 
induce epigenetic changes following infection. However, a large gap in knowledge exists 
in the role of epigenetics in regulating between-animal differences in mastitis severity. 
Therefore, there is considerable room to improve on producer selection of replacement 
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calves if epigenetic determinants of mastitis susceptibility are discovered. Selection 
strategies could be improved using technologies similar to SNP-chips that are currently 
advancing genetic selection, such that methylation chips in known susceptibility regions 
could be used to select animals based on epigenetic markers. One concern may be that 
milk production would suffer as a result of selecting calves with lower risk of mastitis, 
since increased milk production has been associated with increased risk of mastitis (Rupp 
and Boichard, 2003). However, knowing the exact genetic and epigenetic factors that 
account for both reduced severity of mastitis and increased milk production would allow 
producers to choose animals based on both superior milk production and disease 
resistance. Furthermore, since epigenetic modifications are closely linked to alterations in 
environment, it may be possible to treat a calf with a genetic predisposition for high milk 
production to be more resistant to severe infection.  
With these goals in mind, I sought to identify the molecular mechanisms that 
regulate response to LPS, given that LPS likely reflects the predominant response to E. 
coli. The role of DNA methylation in within-animal variation in response to LPS was 
first determined with the intent of gaining insight into how between-animal variation in 
response to E. coli is regulated. Dermal fibroblasts isolated from the same animals at 5- 
and 16-months of age, which exhibit a significant age-related up-regulation of IL-8 and 
IL-6 response to LPS, were assessed for differences in DNA methylation in unstimulated 
cultures. Methylation analysis revealed numerous genes that are subject to differential 
methylation as a result of an increase in fibroblast age and showed that DNA tends to 
become less methylated with age, a result that correlates with previous studies (Gowers et 
al., 2011, Marttila et al., 2015). Although we failed to identify any canonical LPS-
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response genes that were differentially methylated between the two sets of cultures, 
numerous innate response genes were hyper-methylated in young cultures, in line with 
their lower response to LPS. Furthermore, many of the genes hyper-methylated in young 
cultures have been shown to be regulated by NF-κB and represent potential biomarkers if 
their relevance can be confirmed with in vivo response to E. coli.   
Next, with a panel differentially methylated genes established, we wanted to 
clarify the role of TLR4 expression and signaling as a potential contributor to mastitis 
severity. As such, fibroblasts were isolated from a cohort of sixty adult, lactating animals 
and differences in baseline TLR4 expression and LPS-induced IL-8 and IL-6 protein 
production were measured. Animals were subsequently ranked from low to high based on 
the three variables, and phenotypes of high and low responders were confirmed. The 
impact of TLR4 expression and signaling on severity of mastitis was then determined by 
challenging six high- and six low-responders with an intra-mammary E. coli infection. 
Interestingly, high responders had an earlier elevation in somatic cell count and fever 
response that corresponded with their ability to clear bacteria more efficiently from the 
infected gland. However, significant between-animal variation in response was still 
evident, and mammary gland recovery, as measured by tissue damage and milk 
production, was highly variable and similar between high and low responders. These 
results suggest that while rapid-responding animals are able to clear bacteria more 
effectively, down-regulation of response and tissue recovery does not differ between high 
and low responders, and likely requires the identification of additional parameters within 
the resolution phase of infection. Furthermore, results from Chapter 3 contradict earlier 
research within the lab that first assessed whether fibroblast responsiveness, based on 
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LPS-induced IL-8 production, could predict mastitis severity. In this study, animals 
whose fibroblasts produce more IL-8 in response to LPS exhibit increased tissue damage 
and lower milk production, but lack any difference in their ability to clear bacteria in 
comparison to animals with lower responding fibroblasts (Kandasamy et al., 2011). 
In light of this discrepancy, I re-analyzed the animals described in chapter 3, in 
addition to a second set of 12 animals that were infected with E. coli in an identical pilot 
study. Using milk production recovery at 14-days post-infection as a marker for mastitis 
severity, the five animals with the most severe mastitis and the five animals with the most 
mild mastitis were identified and compared. As shown in figure 5.1, there is a significant 
variation between-animals in their ability to return to pre-infection milk production that is 
concomitant with large differences in the duration of their neutrophil response. Although 
neutrophil influx is identical between the two groups of animals until 48-hrs. post-
infection, severe animals maintain an elevated response. Milk IL-8 is similarly sustained 
in severe animals and consequently, severe animals have dramatically higher amounts of 
mammary gland tissue damage, as measured by milk BSA (figure 5.2). 
 Interestingly, while it was anticipated that high and low responders would not 
exhibit differences in their ability to clear bacteria, animals ranked as severe responders 
have a much higher bacterial burden (figure 5.3). This led to the question of whether 
initial leukocyte levels differed between animals with varying abilities to recover from 
infection. A Pearson correlation analysis comparing the ratio of baseline somatic cell 
count to bacterial dose and milk production at 10 days post-infection in 32 animals 
infected with E. coli (24 from the previous analysis and 8 from the original 2011 study) 
showed no correlation of initial leukocyte levels and mastitis severity (figure 5.4). At 14 
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days post-infection, there is a small, but statistically significant correlation between initial 
SCC to bacteria ratio (24 animals only, figure 5.4) and mastitis severity, however the 
biological relevance of this association should be confirmed in a much larger cohort of 
animals. Perhaps just as important is the effectiveness of leukocyte response, which may 
be lessened in animals with severe mastitis, as has been shown with patients that become 
septic in response to Gram-negative infection (Rinchai et al., 2012). Future studies should 
assess other cell types, perhaps in conjunction with fibroblasts, to gain a more accurate 
picture of mammary gland response.  
 Finally, to determine whether early life endotoxin would result in a more 
subdued response to a subsequent LPS treatment as was hypothesized, neonatal bull 
calves were treated intravenously with either LPS or saline at one-week of age. Following 
early life treatment, cellular changes were measured in two different cell types, primary 
dermal fibroblasts and monocyte-derived-macrophages. Unfortunately, no differences in 
LPS response were measured in fibroblast cultures and surprisingly, we also failed to 
detect any changes in MDM response, although literature suggests that they are amenable 
to epigenetic modulation following exposure to endotoxin. The second intravenous LPS 
challenge also confirmed the lack of difference in cellular response in that calves treated 
with early life LPS responded similarly to saline treated calves.  
Although much more work is still required, our results lend significant insight 
into the epigenetic regulation of the bovine innate immune response to LPS and how 
differences in TLR4 expression and signaling contributes to mastitis severity. 
Furthermore, this is the first study to determine the effects of neonatal LPS exposure on 
calf innate immunity. While considerable research has focused on the bovine innate 
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immune response to mastitis-causing pathogens, it has been mostly limited to the ideal 
cellular and cytokine response to pathogens. Conversely, there is significantly less known 
about how the mammary gland recovers from the assault of both bacteria and leukocytes, 
and as our results have shown, this may prove to be the missing link into our 
understanding of severe mastitis susceptibility. In addition, as has already been 
established in rodent models, it will be necessary to define the crucial developmental time 
frame when epigenetic modifications exhibit the most plasticity to environmental stimuli 
before early-life interventions can be used to modulate immunity. To conclude, the 
current work is one of the first to integrate the collective impact of DNA methylation, 
differential regulation of TLR4 signaling and neonatal environmental exposures on dairy 
cow response to E. coli mastitis. Our results show that there is still significant room to 
improve on reducing severe mastitis susceptibility based on the collaborative effect of 





Figure 5.1: Infected quarter milk yield and somatic cell count in animals with severe 
and mild mastitis. Milk production was measured in the infected quarter of 24 animals 
experimentally treated with 200 cfu of E. coli in two separate challenges. Animals with 
the highest (Mild, n=5) and lowest (Severe, n=5) recovery at 14-days post infection (milk 
yield day 14 – milk yield day 0) are summarized in panel A and mean milk weight is 
presented in lbs. ± SEM. Somatic cell count (SCC/ml) was also measured in the infected 
quarters of severe and mild animals and is presented as SCC/ml (x 106) ± SEM in panel 
B. P-values presented in each panel were measured using a 2-way repeated measures 
ANOVA with Bonferroni’s multiple comparison testing to determine Phenotype X Time 
significance where *=P<0.05 at each time point. 




















































Figure 5.2: Infected quarter IL-8 and bovine serum albumin in animals with severe 
and mild mastitis. Milk IL-8 and BSA were measured in the E. coli infected quarter of 
10 animals with phenotypic differences in mastitis severity (Mild, n=5) (Severe, n=5). 
Interleukin-8 concentrations are summarized in panel A and presented as ng/mL ± SEM. 
Bovine serum albumin concentrations are summarized in panel B and presented as 
Ug/mL ± SEM. P-values presented in each panel were determined using a 2-way repeated 
measures ANOVA with Bonferroni’s multiple comparison testing to determine 
Phenotype X Time significance where *=P<0.05 at each time point.  














































Figure 5.3: Infected quarter bacterial recovery in animals with severe and mild 
mastitis. Recovery of bacteria was measured in the E. coli infected quarter of 10 animals 
with phenotypic differences in mastitis severity (Mild, n=5) (Severe, n=5) and is 
presented as log-transformed CFU/mL ± SEM. P-values presented above were 
determined using a 2-way repeated measures ANOVA with Bonferroni’s multiple 
comparison testing to determine Phenotype X Time significance where *=P<0.05 at each 
time point.  
  



























Figure 5.4: Correlation of baseline SCC to bacteria ratio and milk yield recovery at 
day 10 and day 14. The ratio of baseline (0 h) somatic cell count (SCC/ml) and initial 
inoculum (200 cfu E. coli) was calculated and compared to milk yield recovery (lbs) at 
day 10 (panel A, n=32) and day 14 (panel B, n=24). A Pearson correlation analysis was 
then conducted to determine whether baseline ratio of SCC to bacteria was associated 
with a difference in ability to recover to pre-infection milk production. Correlation as 
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